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SUMMARY
Ocular infections with herpes simplex virus(HSV) in 
humans vary in clinical manifestation rang ing from self 
limiting benign epithelial disease to nectrotizing stromal 
keratitis and uveitis. A . _ 3 serious clinical problem is 
the recurrence of ocular lesions due to reactivation of 
latent virus from dorsal root ganglia. The rabbit eye has 
provided an efficient experimental model system for study of 
the mechanisms underlying herpes virus keratitis and the 
various factors affecting the establishment, maintenance and 
reactivation of latent HSV. The work described in this 
thesis stems from the observations of Gerdes and Smith(1983) 
who showed that in the rabbit eye model, spontaneous 
shedding of HSV following ocular infection and establishment 
of a latent infection in the trigeminal ganglia, is virus 
strain specific and the virus genes controlling reactivation 
are different from those needed for the establishment and 
maintenance of HSV latency.
Using the rabbit eye model of latency, HSV-1 strain 
McKrae invariably reactivates upon induction with 
epinephrine iontophoresis, whereas HSV-2 strain HG52 fails 
to reactivate. Both strains establish a latent infection of 
the dorsal root ganglia(trigeminal ganglia) with the same 
frequency. The work described in this thesis was aimed at
identifying the viral gene(s) involved in the reactivation 
differential between HSV-1 strain McKrae and HSV-2 strain 
HG52 and has addressed itself to (i) the construction of 
intertypic recombinants between McKrae and HG52,(ii) 
analysis of the genome structure of the recombinant viruses 
by restriction endonuclease digestion ,(iii) the
reactivation and latency potential of the recombinants 
compared to the parental viruses following rabbit ocular 
infection, (iv) the virulence differential of the 
recombinants compared wit^ the parental viruses following 
rabbit ocular infection, (v) the ability of the HSV to go 
latent in the cells of the rabbit cornea and (vi)the 
analysis of the genome structures of the recombinants in 
terms of the positions of heterologous inserts in relation 
to recombination between sequences containig an origin of 
replication.
In order to map the viral gene(s) controlling 
reactivation of HSV from latency, recombinants were 
constructed using intact McKrae DNA and total fragments from 
HG52 DNA digested with either Xbal or Hpal endonucleases. 
Eleven recombinants having a range of HG52 DNA inserts were 
isolated. The structure of the recombinants was deduced 
from analysis of restriction endonuclease digests with a 
number of enzymes and the HG52 inserts were mapped between 
0.35 and 0.576 map units(m.u.) and/or between 0.82 and 1.00 
m.u. of the viral genome. Pour of these recombinants with 
HG52 inserts spanning the above regions were selected to 
study their reactivation and latency potential in the rabbit 
eye model. On induction with epinephrine iontophoresis, the 
4 recombinants reactivated with the same frequency as the 
parental McKrae virus indicating that the genes between 0.3 5 
and 0.576 and/or 0.82 to 1.00 m.u. are not solely or in 
combination involved in determining reactivation 
di f fe rential.
Rabbits could tolerate 3-fold to 40-fold excess doses 
of recombinant virus relative to the pathogenic McKrae 
parent indicating moderation in virulence of the McKrae
genome on insertion of HG52 sequence. The reduction in 
virulence of the McKrae genome was independent of the 
location of heterologous inserts and indicated a multigenic 
control of virulence upon ocular inoculation of HSV in 
rabbi ts.
During the course of this study virus was isolated from 
some of the corneal explants from the rabbits latently 
infected with McKrae and/or recombinant viruses. The delay 
in shedding of virus from corneal explants was similar to 
that from trigeminal ganglia indicating that cells of the 
cornea are capable of harboring a latent as compared to a 
persistent infection. The low frequency of isolation of HSV 
from corneas together with the isolation from a minority 
proportion of the cornea lends support to the findings from 
the human corneas and suggests that the cornea may be a site 
additional to the preferred dorsal root ganglia for the 
establishment of a latent infection.
It was observed that in cotransfection experiments 
involving intact McKrae genomes and Hpal digested HG52 DNA, 
only recombinants containing type II inserts from Hpal 
d(0.35 to 0.576 m.u.) and/or containing an intact type II 
[S.] region(0.82 to 1.00 m.u.) were isolated. Similarly with 
Xbal cleaved HG52 DNA only recombinants containing type II 
sequences from the right hand end of Xbal c(0.0 to 0.45 
m.u.) were isolated. In effect, the type II insert always 
contained one or both origins of replication(OriL /Orig).
In the reciprocal experiments isolation of two recombinants 
from cotransfection of Hpal cleaved McKrae DNA with intact 
HG52 DNA confirmed this finding; one contained both copies 
of Orig and the intervening short region sequences of 
McKrae, the other contained approximately 3 Kb of McKrae in
which OriL is located. These results indicate that either 
(a) the presence of an origin of replication in a 
restriction endonuclease fragment amplifies the fragment 
thereby increasing its concentration and hence recombination 
potential with intact genomes; and/or (b) recombination and 
replication may occur simultaneously. The implications of 
these findings are discussed. In either case isolation of 
the recombinants containing Ori^ and Orig from the 
restricted DNA parent strongly suggests that both origins of 
DNA replication are functional in vitro.
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CHAPTER 1
INTRODUCTION
INTRODUCTION
The aim of the introduction is to provide background information 
on the general biology of herpes simplex virus (HSV).. A brief review 
of current HSV genetics is provided. Particular reference is made to 
advances at the molecular level in understanding the viral factors 
controlling reactivation of HSV from latency and virulence of HSV in 
experimental animals.
2
1.1. FAMILY HERPETOVIRIDAE AND ITS CLASSIFICATION
More than 80 distinct members of the family Herpetoviridae have 
been isolated from hosts as diverse as fish, fungus and man (reviewed 
by Roizman, 1982). Membership of the family is based upon the presence 
of four basic morphological characteristics (Roizman and Furlong, 
1974). (i) An electron dense core containing a double stranded virus 
genome of 80 to 150 x 10^ m w; (ii) An icosahedral capsid consisting 
of 162 capsomeres of 100 nm diameter; (iii) A largely ill-defined 
layer of proteinaceous tegument located between the capsid and the 
envelope; and (iv) A lipid envelope (150 to 200 nm in diameter) 
enclosing the nucleocapsid. The envelope is usually acquired by 
budding through the inner nuclear membrane and contains glycoprotein 
spikes which are virus encoded.
1.1.a.I. Sub-classification on the basis of biological properties 
Because of their morphological similarities, herpes viruses, have
been classified into 3 sub-families on the basis of their biological 
properties such as host range, duration of the reproductive cycle, 
cytopathology and location of the virus genome during a latent 
infection in vivo (Roizman et al., 1981). The 3 sub-families are:
(i) Alphaherpesvirinae: Members of this sub-family have a variable 
host range both in vivo and in vitro and a rapid life cycle of less 
than 24 hr, which results in . destruction of the infected cells. 
The latent infection in vivo is usually established in sensory 
neurones of the ganglia. Herpes simplex types-l, -II (HSV-1, HSV-2), 
varicella-zoster virus (VZV) and pseudo-rabies virus (PRV) are 
included in the alphaherpesvir inae.
(ii) Betaherpesvirinae; Members of this sub-family typified by human 
and murine cytomegaloviruses (HCMV, MCMV) are characterized by a
relatively long (more than 24 hr) reproductive cycle and a narrow host 
range frequently restricted to the species or genus to which the host 
belongs. Enlarged cells (cytomegalia) production is the characteristic 
pathology of Betaherpesvirinae. Sec^ sjfy glands and lymphoreticular 
cells are the main sites of latent infections.
(iii) Gammaherpesvirinae: Hiis group of viruses have a narrow host 
range jLn vivo and in vitro and are either B or T cell lymphotropic. 
Arrest of the virus reproductive cycle either at the prelytic or lytic 
stage results in persistence or cell death without production of 
complete virus. Lymphoid tissues are the site of latent infection. The 
prototype examples of the group include Epstein-Barr virus (EBV) in 
humans, Marek's disease virus (MDV) and herpes virus of turkeys (HVT).
1.1.a.II. Herpes viruses of humans
At least five of the herpes viruses belonging to 3 different sub­
families are known to parasitise man. Hiese include HSV-1, HSV-2, VZV, 
EBV and HCMV. Besides these, a novel herpesvirus has recently been 
isolated from immunocompromised patients (Salahuddin et al., 1986), 
but its genuine role in human pathology awaits confirmation.
Infections with HSV is ubiquitous and is commonly associated with 
lesions of mucous membranes of oral and genital organs. The vesicular 
lesions of lips and mouth commonly known as 'cold sores' are 
frequently caused by HSV-1 whereas HSV-2 is frequently encountered in 
genital tract infections. Spread of infection usually occurs either by 
close contact (HSV-1) or by the venereal route (HSV-2). Other 
important infections caused by HSV include herpes eye disease (see 
section 1.15), herpes neonatorum and herpes encephalitis. The latter 
diseases though rare in occurrence are usually life threatening. Hie 
clinical manifestations of HSV-1 and HSV-2 have recently been reviewed
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by Whitley (1985). Establishment of latency in neurones following 
primary infection at the peripheral site is one of the characteristic 
biological properties of herpes viruses (reviewed by Hill, 1985). 
Recurrent lesions in HSV may occur at the same or at other peripheral 
sites (neurodermatome). Recurrence may result in sytemic illness, 
encephalitis or recurrent keratitis in the eye which may lead to 
blindness. Recurrent infections are usually more severe in 
immunocompromised individuals.
Primary lesions of varicella or chicken pox caused by VZV are 
similar but
^distinguishable from those of HSV and are commonly seen in 
childhood. Reactivation of VZV from latency in adults results in a 
more severe form of the disease i,e, 'shingles' or herpes zoster 
(reviewed by Gleb, 1985).
Infections due to CMV though widespread in the human population 
are usually sub-clinical. Both primary and recurrent disease due to 
CMV is a severe problem in immunocompromised hosts; particularly in 
transplant therapy and in patients with acquired immuno-deficiency 
syndrome (AIDS) (Hamilton, 1982). CMV has also been implicated in the 
development of cervical cancer (Alford and Britt, 1984).
• EBV causes infections of human B lymphocytes and is a causative 
agent of infectious mononucleosis. A strong association of EBV with 
Burkitt's lymphoma and nasopharyngeal carcinoma has been observed 
(Epstein et al., 19C>4).
l.l.b. Sub classification of herpetoviridae on the basis of genome
structure:
Despite similar biological properties, a wide variation has been 
observed in the size (90 to 150 x 106 tose composition (32 to 75%
G+C moles%) and arrangement of DNA sequences within the genomes of 
member viruses of a sub family. Depending upon the arrangement within
5
FIGURE 1
Schematic diagram of the genome structures of channel catfish 
virus (CCV), herpes virus saimiri (HVS), Epstein-Barr virus (EBV), 
pseudoradies virus (PRV) and herpes simplex virus (HSV) representing 
subgroups A, B, Cf D and E respectively of the family Herpetoviridae.
Repeat sequences larger than 1000 bp in length, other than 
terminal reiterations are shown as dot filled rectangles. — ►indicates 
the orientation of the repeat sequences. Vertical lines and letters an 
and bn signify multiple tandem repeat sequences. Numbers above the 
lines represent molecular weight (xlO^ ) while others above the 
vertical lines refer to unit length of the reiterated sequence.
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the genome, of reiterated ENA sequences of at least 100 bp, herpes 
viruses have been sub classified into 5 groups (A to D) (Roizman et 
al., 1981). Although most of the herpes viruses have been classified 
according to their biological properties, only a minority have been 
characterized sufficiently to group them by the criterion of genome 
structures.
(i) Group A: The genome of this group of viruses exemplified by the 
channel catfish virus (CCV) (Figure 1) is characterized by the 
presence of a single set of direct reiterated sequences at the termini 
(Chousterman et al., 1979) and hence only one isomer.
(ii) Group B: The genome of viruses in this group contains multiple 
copies of the same set of sequences at both termini in the same 
orientation e.g. herpesvirus saimiri (Bornkamm et al., 1976).
(iii) Group C: As exemplified by Epstein Barr Virus, the genome of 
this group of viruses is characterized by the presence of multiple 
reiterations of the same set of sequences at both termini in the same 
orientation and a variable number of tandem repeats of a different 
sequence internally. There is no isomerization of the genome (Raab- 
Traub et al., 1980).
(iv) Group D: The genome in this group of viruses e.g. PRV (Ben-Porat 
et al., 1979) occurs as two isomers due to internal reiteration in an 
inverted form of a single set of sequences from the terminus. The 
genome consists of two regions L and S. The unique sequences of S (Ug) 
are bracketed by inverted repeat sequences (IRg and TRg). The S 
component inverts relative to the L component which consists of a 
unique sequence in a fixed orientation thus giving rise to two
isometric forms.
/
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FIGURE 2
Schematic diagram of a HSV virion. The virion is composed of four 
main structural elements - the core, capsid, tegument and- 
envelope. Within the core, viral DNA is spooled around a 
cylindrical protein mass. The virion envelope contains a number 
of glycoproteins, visible on electron microscopy as spikes 
protruding from the envelope.
Six-fold symmetry of the hexameric capsomeres. The hexamers are 
believed to have this symmetry, probably due to the presence of 
six molecules of the major capsid protein, Vmw 155.
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DNA sequence analysis of the 3>S joint and genome termini of VZV 
revealed that UL is flanked by an inverted repeat of 88.5 bp and 
hybridization studies indicated that 5% of VZV DNA molecules have an 
inverted L component (Davison, 1984). Thus VZV could be regarded as a 
member of group E. However the size of IR^/TR^ is less than the 
minimum 100 bp considered as a prerequisite for classification 
purposes (Roizman, 1982).
(v) Group E: Hie genomes of viruses in this group have a single set 
of sequences from both termini reiterated in an inverted form 
internally. Thus the genome has two vrugae regions i.e. UL and Us 
each bracketed by a single set of inverted repeats. Hie inversion of 
both segments relative to each other produces four isomers in equal 
proportion. This group includes HSV-1, HSV-2, MDV and Bovine 
herpesvirus type 2 (BHV-2).
1.2. MORPHOLOGY OF HERPES SIMPLEX VIRIONS
Herpes simplex virions have four distinct morphological elements;
(i) an electron-opaque core, (ii) an icosahedral capsid enclosing the 
core, (iii) an electron-dense amorphous material - the tegument 
surrounding the capsid and (iv) an envelope or lipoprotein membrane 
whose outer surface exhibits small spikes (Spear and Roizman, 1980; 
Dargan, 1986) (Figure 2).
Hie HSV core consists of viral DNA tightly spooled in the form of 
a toroid around a central cylindrical mass with a regular 4 to 5 nm 
spacing (Furlong et al., 1972). Absence of the virion polypeptide VP21 
in empty nucleocapsids led Gibson and Roizman (1972) to suggest that 
the core is composed of the polypeptide VP21 (Vmw43). Hie cylindrical 
core structure appears to be connected to the inner poles of the 
capsid and may provide a mechanical support for the winding of the 
viral ENA (Nazerian, 1974).
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An icosahedral capsid of approximately 100 nm in diameter and 
consisting of 150 hexqmeric and 12 pentameric capsomeres encloses the 
core (Wildy et al., 1960). Capsomeres are hollow, elongated polygonal 
prisms with tapering axial channels (Wildy et al., 1960; Steven et 
al., 1986). On electronmicroscopic examination of partially disrupted 
capsids, hexameres appear to be linked by intercapsomeric fibrils 
(Vernon et al., 1974; Palmer et al., 1975). The hexameres are believed 
to be composed of 6 molecules of the major capsid protein, Vmw 155 or 
pl55 (Spear and Roizman, 1972; Marsden et al., 1976; Vernon et al., 
1981; Steven et al., 1986), whereas pentamers are composed of the 
virion protein p50 (VP19, NC2) (Vernon et al., 1981). Polypeptides p50 
and pl55 have been shown to form a disulphide-linked complex in HSV-2 
nucleocapsids (Zweig et al., 1979! . Studies with virus mutants 
containing a ts lesion within the gene for p40 also called VP22 (a 
member of the 1CP35 family which also includes VP21) (Cohen et al., 
1980; Braun et al., 1984a) has revealed that processing of this 
polypeptide is essential for encapsidation of viral ENA (Preston et 
al., 1983). The exact location of p40 in capsids is yet unresolved.
The tegument is an ill-defined layer located between the capsid 
and the envelope (Roizman and Furlong, 1974). In thin sections of 
budding particles or virions, the tegument has no distinctive 
structural features whereas in negatively stained virions it appears 
to have a fibrous structure (Wild_y et al., 1960; Morgan et al., 1968; 
Schwartz and Roizman, 1969). Its thickness is genetically determined 
and varies considerably between different herpes viruses (McCoombs et 
al., 1971).The tegument is believed to play a role in envelopment of 
the virus (Vernon et al., 1982). The polypeptides constituting the
tegument are of high molecular weight (more than 200,000 mw) and
hz
include VP1, VP2, VP3 and the virus transducing factor, Vmw 65
8
(Batterson and Roizman, 1983; Campbell et al., 1984).
A polypeptide of 10,000 mw the product of the US9 gene (McGeoch 
et al., 1985) has been located around the perimeters of capsids and 
can be precipitated from NP40 extracts of HSV-1 virions using an 
oligopeptide antiserum (Frame et al., 1986). The precise function of 
this polypeptide in the virus life cycle is unclear.
The herpes virus envelope, enclosing nucleocapsids containing 
full length genomes, is acquired by budding through the inner nuclear 
membrane (Darlington and Moss, 1968). It consists of a trilaminar 
membrane and has spikes of about 8 mm in length projecting from its 
surface (Wildy et al., 1960). It contains several viral glycoproteins 
which exhibit a number of important biological functions (see section 
1.10.C)
1.3. GENOME STRUCTURE OF HERPES SIMPLEX VIRUS
1.3.a. General properties of the HSV genome
The genome of herpes simplex virus is a linear double stranded 
DNA molecule of 100 x 10^ daltons about 155,,£60 base pairs (bp)
(Becker et at; 1968; Kieff et al., 1971). A striking feature of the 
genome is its very high guanosine plus cytosine (G+C) content, 6fNJ#X 
overall for HSV-1 (Kieff et al., 1971) and 69% overall for HSV-2 
(Goodheart et al., 1968). These values differ widely from that of BHK 
C13 DNA which has a G+C content of 42% (Subak-Sharpe^  _  . 1969). 
DNA sequence analysis has revealed that different parts of the HSV 
genome vary in their G+C contents. In particular the 6600 bp in length 
short repeats of HSV have a G+C content of 79.5%. Within this region, 
the gene coding for the transcriptional regulatory protein Vmw 175 has 
a base composition of 81.5% G+C (reviewed by McGeoch, 1987).
More than 50% of herpesvirus DNA is found to fragment upon 
denaturation with alkali even after careful extraction from virions
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(Kieff et al., 1971; Frenkel and Roizman, 1972^'Wilkie, 1973). This is 
believed to be due to the presence of ribonucleotides and/or single 
strand nicks or gaps (Hirsch and Vonka, 1974; Biswal et al., 1974).
The single strand nicks are randomly distributed on both DNA strands 
(Wilkie, 1973). Though the presence of ribonucleotides in HSV DNA has 
been shown (Muller et al., 1979), their role in DNA fragmentation is 
not conclusive (Roizman, 1979).
The HSV genome is composed of two covalently linked segments, 
designated as Long (L) and Short (S). Each segment contains unique 
sequences (UL and Us) of 110,000 and 13,000 tip respectively each 
flanked by a pair of repeat sequences in opposite orientation 
(Sheldrick and Berthelot, 1974; Wadsworth et al., 1975, Figure 3). The 
terminal repeats (TR^ /IR^ ) flanking the UL segments are designated ab 
and b'a' (9200 bp each) while those (IRg/TRg) flanking Us are 
designated a'c' and ca respectively (6600 bp each). Besides these a 
direct repeat sequence, called 'a' sequence, which varies in size from 
200 to 550 bp among HSV strains (Davison and Wilkie, 1981 also see 
section - 1.4), is present at the genomic termini and in an inverted 
orientation at the L-S junction (Sheldrick and Berthelot, 1974; 
Grafstrom et al., 1974, 1975; Wadsworth et al., 1976; Davison and 
Wilkie, 1981). One to several copies of the 'a' sequence may be 
present at the L terminus and L-S junction, but only one copy is 
generally present at the S terminus (Wagner and Summers, 1978; Locker 
and Frenkel, 1979).
As a consequence of this genome structure, inversion of the L and 
S segments between the inverted copies of the 'a* sequence generates 
four isomeric forms of viral DNA in equimolar amounts (Sheldrick and 
Berthelot, 1974; Hayward et al., 1975; Clements et al., 1979i Delius 
and Clements, 1976; Skare and Summers, 1977). As depicted in Figure 3, 
these isomers are designated as protoype (P); inversion of the S
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FIGURE 3
Genome arrangement of HSV-1. The long region (L) is composed of a 
unique region (UL) bounded by a terminal sequence (TR^ ) which is 
repeated internally in an inverted orientation (IRl)* Similarly 
the short region (S) is composed of a unique region (Ug) bounded 
by a terminal sequence (TRg) which is repeated internally in an 
inverted orientation (IRg). Terminally redundant sequences are 
designated a (a1). The remaining sequences within TR^/IR^ and 
TRg/IRg are designated b/b1 and c/c' respectively.
The four genome isomers:
P = proto-type orientation
IL = inversion of the long region (L)
Ig = inversion of the short region (S)
Iglj = inversion of both short and long regions
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region (Ig), inversion of the L region (IL), inversion of both S and L
regions (IgL) , (Roizman^ 1979; Hayward et al., 1975). Inversion
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of the genome is due to site specific recombination between the 
repeated sequence arrays (DR2 and DR4) within the 'a' sequence (see 
section 1.4 3 ). All four isomeric forms replicate to produce viable 
progeny (Davison and Wilkie, 1983b; Longnecker and Roizman, 1986). 
Isolation of viable virus mutants deleted in IRg the internal 'a' 
sequence and most of the IRL genes (Longnecker and Roizman, 1986; 
Jenkins and Roizman, 1986) indicates that besides the 'a' sequence, 
the repeat sequences flanking UL and Ug also play a role in genome 
inversions. The S segment in these mutants is frozen in the Is 
orientation while the L segment could invert at a frequency lower than 
that of the wild type.
The ability_pf the HSV genome to invert is not an essential 
prerequisite for virus growth as non-inverting viable populations of 
HSV have been isolated (Preston et al., 1978; Davison and Wilkie,
1981; Kiffenberger et al., 1983; Poffenberger and Roizman, 1985; 
Jenkins and Roizman, 1986).
Sequence analysis of the HSV-1 genome has revealed the presence 
of sets of short, ^ a^/^mly repeated sequences of variable length 
(McGeoch, 1984). Repeats of 12 to 54 bp in length have been reported 
in the non-coding sequences of HSV-1 (Murchie and McGeoch, 1982; 
Davison and Wilkie, 1981; Rixon et al., 1984; Perry et al., 1986; Chou 
and Roizman, 1986).The copy number of these high (G+C) content repeats 
varies between virus stocks and within cloned DNA fragments of the 
same stock. The locations of the short tandemly reiterated sequences 
occurring in the HSV-1 strain 17 genome are indicated in Figure-4. 
Three of these repeats are located in the Ug sequences i.e.(i) within 
the coding region of the US7 gene; (ii) in the intergenic region of
11
FIGURE 4
Locations of short tandemly reiterated sequences within the S 
segment and RL regions of HSV-1 strain 17+ DNA. Positions* of 
reiterated sequences (numbered 1 to 12) are shown relative to the 
locations of mapped mRNA. (-^ ) refers to the locations of spliced 
regions in immediate early (IE) gene -1, -4 and -5. Adapted from 
Watson et al., 1981; ? Rixon et al., 1984; Rixon and McGeoch,
1984, 1985; Perry et al., 1986.
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US 9 and US 10 and (iii) within the overlapping coding regions of 
genes US 10 and US 11 (McGeoch et al.f 1985). Hie other repeats 
present in the S region are (i) in the introns of IE mRNA 4 and 5 
(Murchie and McGeoch, 1982) and (ii) downstream of IE mRNA 3 (Rixon et 
al., 1984). Besides these, occurrence of repeats has also been 
reported in the 'a' sequences (Davison and Wilkie, 1981; Mocarski and 
Roizman, 1981) and downstream of mRNA of the IE 1 (Perry et al.,
1986).
1.3.b. Organisation of HSV genes
The nucleotide sequence of the whole of the HSV-1 strain 17 syn+ 
genome has now been determined (D.J. McGeoch, personal communication). 
The sequence of the whole of the short region and some parts of the 
long region of the genome has been published (Murchie and McGeoch, 
1982; Rixon and Clements, 1982; Rixon and McGeoch, 1984; McGeoch et 
al., 1985; Perry et al., 1986). On the basis of sequence analysis 
HSV-1 strain 17 has been calculated to contain 72. genes (D.J. McGeoch, 
personal communication). Hie orientation of open reading frames of 56 
genes termed UL 1 to UL 56 located in UL and 12 genes termed US 1 to 
US 12 located in Ug along with the genes located in the repeats is 
shown in Figure 5 and Figure 6.
DNA sequence analysis of the HSV-1 genome has revealed: (1) There 
is no clustering of genes which are found in both orientations. (2) 
Each gene has its own promoter (McGeoch et al., 1985; Wagner, 1985).
(3) Hiere is frequent occurrence of 3' co-terminal families of mRNAs 
(Wagner, 1985). In this arrangement several adjacent genes are 
similarly aligned. For each gene transcription starts 5' to that 
gene's coding sequences and continues through the following genes of 
the family until a common distal polyadenylation site is reached. In 
these transcript species only the 5'-proximal coding region is
12
FIGURE 5
Open Reading Frames in HSV-1 (i).
Open reading frames in the left hand half 75 Kbp of HSV-1 strain 
17 (D.J. McGeoch - personal communication). The box is repeated 
sequences, 'a' refers to the 'a' sequences. Genes in UL are numbered 
UL1 to UL36. 15/1 and 15/2 refer to the two exons of gene UL15. Genes 
whose polypeptide product is known are labelled. Challberg indicates 
genes whose products are as yet unknown, but are necessary for plasmid 
based ENA replication. Location of OriL is marked. Dotted lines 
indicate that the open reading frame is continued to the following 
line.
2 5 
kb
FIGURE 6
Qpen Reading Frames in HSV-1 (2).
Open reading frames in the right hand half of HSV-1 strain 17 
(D.J. McGeoch, personal communication). Genes in UL are numbered UL36 
to UL56 and in Ug are numbered US1 to US12. Locations of Orig 
sequences are marked. RRl and RR2 are the large and small subunits of 
ribonucleotide reductase. 65KDBp is the 65K DNA binding protein, which 
is distinct from the 65KjIF (the tegument transactivator polypeptide). 
US5 is numbered g to indicate that it encodes a potential 
glycoprotein which has not yet been identified. Challberg refers to 
the genes, whose products are as yet unknown, but are necessary for 
plasmid based DNA replication.
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translated (Rixon and McGeoch, 1984, 1985). (4) Introns are rare and 
have only been detected in immediate early (IE)- 1, -4, -5 and UL 15
gene transcripts (Rixon and Clements, 1982; Murchie and McGeoch, 1982;
CL
Costa et al., 198^ Perry et al., 1986).
Hie immediate early genes are all located in or close to the 
repeat elements, the inverted repeats flanking UL i.e. ab and b'a' 
contain one copy each of the IE-1 gene while those of Ug i.e. a'c' and 
c a, each contain a copy of the IE-3 gene (Watson et al., 1979; Mackem 
and Roizman, 1980). In HSV-1 strain F, the repeats flanking are 
reported to contain one copy each of a gene encoding the ICP 34.5 
protein (Chou and Roizman, 1986). TRg/IRg contain one copy each of the 
origin of virus DNA replication termed Orig (Stow, 1982; Stow and 
McMonagle, 1983) while oriL is located in the centre of UL (McGeoch,
1987). OriL is located between the divergently transcribed genes for 
the major DNA binding protein (DBP) and the DNA polymerase (Quinn and 
McGeoch, 1985; Weller et al., 1985) analogous to Orig which is located 
intergenically in the region of the divergently transcribed IE genes 3 
and 4/5.
The Ug region of the genome as stated earlier contains 12 open 
reading frames termed US 1 to US 12 (Figure-7). A group of 5 
consecutive genes within Ug (US 4 to US 8) encode known or potential 
membrane proteins. The functional significance of this clustering is 
uncertain. Mapping of the mRNA transcripts in the short region of 
HSV-1 (Rixon and McGeoch, 1984, 1985; McGeoch et al., 1985) has 
revealed the compact organisation of the HSV genome and clearly 
demonstrates that 3' co-terminal families of mRNA occur relatively 
frequently in HSV (Wagner, 1985). Sequence comparison of a portion of 
Ug of HSV-2 (HG52) has established the colinearity of the genes 
between the two strains (McGeoch et al., 1987).
HSV-1 mutants deleted in genes US 1 to US 5 and US 7 to US 12
13
FIGURE 7
Transcript map of the short unique region of the HSV-1 strain 17 
genome adapted from McGeoch et al (1985). The Ug region, approximately 
13,000 bp, contains 12 genes (US1 to 12) which are expressed as 13 
mENAs. The probable polypeptide coding (boxes) and non-coding (single 
lines) portions of mRNAs are indicated, and transcription is in the 
direction of the arrows. 1^3 indicates membrane associated 
glycoproteins.
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(Post and Roizman, 1981; Umene, 1986; Longnecker and Roizman, 1986; 
longnecker and Roizman, 1987; Weber et al., 1987), IE-3 and one copy 
of sequences encoding Orig in HSV-1 (Longnecker and Roizman, 1986) and 
HSV-2 (Brown and Harland, 1987) have been shown to grow normally in 
culture, indicating that these genes are dispensable for the lytic 
growth of virus. The functional significance of clustering of genes 
dispensable for lytic growth in cell culture in the [S] component of 
the HSV genome remains unknown.
1.4. THE HERPES SIMPLEX VIRUS 'a' SEQUENCE
1.4.a. General properties of the 'a' sequence
The HSV genome contains a 200 to 500 bp sequence termed the 'a' 
sequence which is present in the same orientation at the termini but 
in an inverted orientation at the L-S junction (Wadsworth et al. 1975, 
1976). One to ten copies of this sequence may be present at the L- 
terminus and L-S junction but only one copy is invariably present at 
the S-terminus (Wagner and Summers, 1978; Locker and Frenkel, 1979 ; 
Davison and Wilkie, 1981; Mocarski and Roizman, 1981, 1982b).
The size of the 'a' sequence has been shown to vary between 
strains as revealed by DNA sequencing of the 'a' sequence from several 
HSV-1 and HSV-2 strains (Davison and Wilkie, 1981; Mocarski and 
Roizman, 1981, 1982b; Mocarski et al., 1985; Varmuza and Smiley,
1985). As shown in Figure-8, the HSV- 'a' sequence can be divided into 
several structural regions (Mocarski and Roizman, 1982a). These 
regions include unique (U) and directly repeated (DR) elements. 
Variation in copy number of the DR elements is responsible for 
differences in size between 'a' sequences from different strains. The 
'a* sequence in HSV—1 strain F can be represented as DR-j—Ub— (DR2)^ 9— 
(DR^ ) g-u^DR^ (Mocarski and Roizman, 1982a). DR^ is a 20 bp sequence 
present at both ends, Ub and Uc are unique 58 bp and 65 bp sequences
14
FIGURE 8
Structure of the HSV-1 ’a' sequence.
A proto-type virus genome with, below, an expansion showing the 
structure of the 'a1 sequence in the orientation found at the L-S 
junction.
Ub : a unique sequence located toward the b' sequence
Uc : a unique sequence locted toward the c' sequence
DR^ : a 17-21 bp element, present as a direct repeat at the
ends of the 'a' sequence 
DR2 : a 12 bp repeat element, present in 1 to at least 22
copies
DR4 ; a 37 bp repeat element, present in 1 to 3 copies
.wmm : represents regions of unique DNA sequence highly
conserved between different strains of HSV.
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respectively, and are named by virtue of their proximity to the 'b' 
and 'c' repeated regions respectively; DR2 is a 12 bp sequence present 
in 19-22 tandem copies; and DR4 is a 37 bp sequence in 3 tandem 
copies.
Hie copy number of the DR2 repeat element has been shown to vary 
both between and within strains. For example, the HG52 strain of HSV-2 
has only one copy of DR2 (Davison and Wilkie, 1981), while HSV-1 
strain F has 19-22 copies (Mocarski and Roizman, 1981). Similar to 
DR2, variations in copy number of DR4 has also been observed. Many 
strains including HSV-1 strain 17 and HSV-2 strain HG52, contain only 
one copy of DR4 which is regarded as part of Uc (Davison and Wilkie, 
1981). HSV-2 strain HG52 could therefore be regarded as containing a 
single unique sequence bounded by a direct repeat (DR^ ). Some strains 
of HSV-1 like strain Justin contain an extra direct repeat, called DR3 
occuring in two tandem copies (Mocarski and Roizman, 1981, 1982a; 
Mocarski et al., 1985). Despite variations in the number of copies of 
the DR2 and DR4 elements, some areas of the 'a' sequence are highly 
conserved in different strains. Within and Uc there are short, 
well-conserved sequences of about 20 bp located approximately 40 bp 
and 35 bp from the ends of 'a' sequences respectively (Davison and 
Wilkie, 1981; Deiss et al., 1986). These homologous areas in 0^ and Uc 
are shared by the 'a' sequence in CMV (Spaete and Mocarski, 1985) and 
the sequences found at the termini of other herpes viruses (Deiss et 
al., 1986).
Tandem reiterations of the 'a' sequence share the intervening DR^ 
element. The S and L terminal 'a1 sequences differ from the junctional 
'a' sequence in that they contain an incomplete copy of the terminal 
DR^ . For example in HSV—1 strain 17, the Lr-terminus 'a' sequence 
contains 20.5 bp of the 21 bp DR± element with only 0.5 bp at the S-
15
terminus 'a' sequence (Davison and Rixon, 1985). Together the two 
partial sequences form a complete DR-^ .
1.4.b. Functions of the 'a1 sequence
The 'a' sequence has been implicated in a number of processes 
associated with genome organisation and viral DNA replication. Some of 
these functions of the 'a' sequence are described in the following 
sections.
(i) Circularization of the genome
Following infection the rapid circularization of the HSV genome 
is believed to be mediated by the 'a' sequence (Davison and Wilkie, 
1983a; Poffenberger et al. 1983). The circularization of the genome is 
believed to occur by ligation of the two termini aided by the 
complementary single base 3' overhang (Mocarski and Roizman, 1982a,b; 
Davison and Rixon, 1985) as HSV genomes containing heterotypic 'a' 
sequences have been shown to circularize following infection (Davison 
and Wilkie, 1983a). Further circularization of both PRV and VZV 
genomes lacking terminal redundancy, following infection indicates 
that circularization occurs by ligation of the genomic termini 
(Davison, 1984; Wu et al., 1979).
(ii) Isomerization of the genome
As mentioned earlier in section 1.3a, a HSV DNA population 
consists of 4 equimolar isomers differing in the relative orientation 
of UL and Us (Hayward et al. 1975; Sheldrick and Berthelot, 1974; 
Delius and Clements, 1976). The inversion of the genome about the L-S 
junction occurs by site specific recombination mediated by the *a* 
sequence (Mocarski et al. 1980; Mocarski and Roizman, 1981; Smiley et 
al. 1981). The evidence that the 'a' sequence plays a part in 
inversion and isomerization of the genome has come from Chou and
16
Roizman (1985) who carried out a detailed deletion analysis of the 'a' 
sequence and observed that inversion of the genome was impaired on 
deletion of DR4 sequences while it was abolished by deletion of DR2 
and DR^ sequences; thus demonstrating the presence of cis acting 
signals for site specific recombination and inversion in the DR2 and 
DR4 elements. The constructs of Chou and Roizman, however, do not 
exclude a role for DR-^  in inversion since an extremely low frequency 
of inversion has been observed on deletion of both DR^ elements 
(Varmuza and Smiley, 1985).
(iii) Cleavage and packaging of the genome
According to the rolling circle model of HSV replication, unit 
length genomes are generated from cleavage of head-to-tail concatamers 
and are subsequently packaged and encapsidated in the nuclei of 
infected cells (Ben-Porat et al., 1976; Jacob et al., 1979; Ben-Porat 
and Rixon, 1979). The cis-acting signals for cleavage/packaging of the 
viral genome have been shown to be present within the HSV 'a' sequence 
(Stow et al., 1983; Deiss and Frenkel, 1986), in that plasmid 
constructs containing an HSV origin of DNA replication can be 
replicated but are only packaged if they contain an 'a1 sequence. 
Varmuza and Smiley, (1985) and Deiss et al (1986) have localized the 
sequences involved in cleavage/packaging to homologous regions in 
and Uc termed as pac-1 and pac-2 respectively (Deiss et al., 1986).
The cleavage of DNA appears to occur in a sequence independent manner 
at a set distance from the Ub and Uc cleavage/packaging signals. Deiss 
et al (1986) found that amplicon constructs lacking Uc did not result 
in the amplification of the input amplicons, whereas those lacking Ub 
were amplified and propagated at a low frequency only if a wild-type 
'a' sequence from the helper virus was present. Based on these 
observations several models for amplification of the HSV 'a’ sequence
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and cleavage/packaging of DNA have been proposed. Some of these have 
been outlined in section (1.9).
(iv) Promoter activity
The Ujd/DR2 region of the 'a' sequence in HSV-1 strain F has been 
reported to contain the promoter of a gene encoding the polypeptide, 
ICP 34.5, whose coding region is in the long repeat (Ackermann et al., 
1986; Chou and Roizman, 1986) The 5' terminus of the transcript maps 
to DR-j^ and to the long repeat outside the 'a' sequence. The promoter 
of the gene encoding ICP 34.5 is atypical of the HSV genes in that 
there is no 'TATA1 consensus in the normal position (i.e. around -25) 
and the best TATA homology (TTTAAA) lies at -15. Interestingly in HSV- 
1 strain 17, DNA sequence analysis of the corresponding region of the 
genome has not revealed any open reading frame coding for ICP 34.5 
(D.J.McGeoch, personal communication).
1.5. RELATEDNESS OF HERPES SIMPLEX VIRUS TYPE I AND TYPE II GENOMES
Hie DNAs of HSV-1 and HSV-2 are approximately 50% homologous as 
revealed by hybridization studies (Kieff et al., 1972). Genetic 
studies have shown that recombination (Timbury and Subak-Sharpe, 1973; 
Halliburton et al., 1977; Morse et al. 1977; Preston et al. 1978) and 
complementation (Timbury and Subak-Sharpe, 1973; Esparaza et al.,
1974; Schaffer et al., 1980) between different strains of the two 
serotypes can occur and that crossovers are distributed across the 
whole genome indicating homology throughout the genomes. Hiis 
observation was augmented by the cross hybridization studies of 
Davison and Wilkie (1983c) involving the HSV-1 strain 17 and HSV-2 
strain HG52 which showed that both genomes are co-linear and shared 
50% homology. Similarly studies on cross reactivity of proteins 
specified by different strains and analysis of intertypic recombinants 
has indicated the mapping of viral genes at equivalent positions
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(Marsden et al., 1978; Schaffer et al., 1973; Morse et al., 1978;
Spear , 1985).
Recently, DNA sequence analysis has allowed precise comparison 
between some corresponding regions in the two serotype genomes. So 
far, these analyses have been limited in scope to individual genes and 
parts of genes, and to other relatively small, functional sequences, 
including promoters and origins of replication (Swain et al., 1985; 
McLauchlan and Clements, 1983; Whitton et al., 1983; Whitton and 
Clements, 1984a,b). The only detailed sequence comparison of HSV-1 and 
HSV-2 has been made in the short region of the genomes (McGeoch et 
al., 1985; 1987). The study revealed that throughout Ug both viruses 
(HSV-1 strain 17 and HSV-2 strain HG52) possess equivalent genes with 
homology at the amino acid level with the exception of the US4 gene. 
Ihe US4 gene which encodes for the glycoprotein G-2 in HSV-2 is 
homologous to its counterpart in HSV-1 except for an insert of about 
1460 bp in the coding region near the N-terminus in HSV-2.
1.6. LYTIC INFECTION WITH HERPES SIMPLEX VIRUS
1.6.a. Adsorption and penetration
Adsorption of the virus to the cell surface is the first step in 
the sequence of events leading to complex virus-host interactions. In 
permissive cells there is a rapid adsorption of HSV to cells (Hummeler 
et al., 1969; Vahlne et al., 1978) through a process which may involve 
specific cell sujEace receptors. The receptors for HSV-1 and HSV-2 
appear to be different in that infection of cells with one strain 
causes interference with adsorption of a second strain of the 
homologous, but not the heterologous serotype (Vahlne et al., 1979;
Addison et al., 1984).
Adsorption is followed by entry of the virus into the cell 
either by endocytosis (Hummeler et al., 1969) or by fusion of the
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virus envelope with the cell membrane (Morgan et al., 1969). Following 
partial degradation of the viral capsids (Ho" chberg and Becker, 1968) 
in the cytoplasm, virus DNA is transported to the nucleus (Hummeler et 
al., 1969), where it is transcribed (Wagner and Roizman, 1969) by the 
host-cell polymerase II (Gostanzo et al., 1977). During adsorption and 
penetration of the virus, the cell membrane has been shown to become 
less mobile, suggesting a multivalent attachment between virus and 
cell receptors while in the late stages of penetration it becomes more 
mobile than that of control infected cells (Rosenthal et al., 1984).
1.6.b. Effect of HSV infection on host-cell metabolism
Following infection of permissive cells with HSV, a characteri­
stic suppression of host cell DNA, mRNA and protein synthesis occurs 
through a complex multistep process (Fenwick and Walker, 1978;
Nishioka and Silverstein, 1978; Read and Frenkel, 1983). Host 
polyribosomes are disaggregated following infection (Sydiskis and 
Roizman,1968) and contain predominately virus encoded mRNAs (Stringer 
et al., 1977). Similar to inhibition of host protein synthesis host 
RNA sythesis is also reduced (Roizman et al., 1965; Pizer and Beard,
CL
1976) and degradtion of host mRNA released from the polysomes takes 
place (Nishioka and Silverstein, 1977). In addition to these change's, 
stimulation in expression of heat shock cellular genes during early 
infection (Notarianni and Preston, 1982; Lathangue et al., 1984; Patel 
et al., 1986) and inactivation of cellular promoters intergrated into 
the genome of biochemically transformed cells (Everett, 1985) has been 
reported. Generally infection with HSV-2 results in more rapid 
inhibition of host protein synthesis compared to HSV-1 (Powell and 
Courtney, 1975; Schek and Bachenheimer, 1985). However, HSV-2 strain 
HG52 has been shown to be deficient in early shut off of host macro- 
molecular synthesis (Marsden et al. 1978).
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At least two factors appear to be involved in the inhibition of 
host polypeptide synthesis - a virion component (s) and a protein (s) 
synthesised later in infection (Honess and Roizman, 1975; Fenwick and 
Walker, 1978; Read and Frenkel, 1983). The virion-associated component 
is non-essential in tissue culture (Fenwick and Clar^ Read and 
Frenkel, 1983), while the delayed component can function in the 
absence of a functional virion component (Read and Frenkel, 1983), and 
is required for the full inhibitory effect on host protein synthesis.
The disaggregation of host polyribosomes, decrease in RNA 
synthesis and degradation of cellular mRNA all appear to involve a 
component of the virion (Fenwick and Walker, 1978; Nishioka and 
Silverstein, 1978; Schek and Bachenheimer, 1985), although in some 
cell types protein synthesis is required for the degradation of 
cellular mRNA (Nishioka and Silverstein, 1978). Whether one or more 
virion components are involved in inhibition of host polypeptide 
synthesis, is unclear.
The differential shut-off of host macromolecular synthesis caused 
by HSV-2 strain HG52 has been mapped to 0.52 to 0.59 m.u. (Morse et 
al., 1978).Hie inhibition of host cell DNA sythesis also appears to 
involve a virion component (Fenwick and Walker, 1978). The latter 
authors have mapped this function between 0.52 and 0.59 m.u. on the 
viral genome. However, the nature of the product, or products, 
involved in these functions is, as yet unknown.
A number of morphological changes also take place within a cell 
productively infected with HSV. The earliest changes are observed in
the nucleus, and these include margination of host chromatin,reduolication
of membrane n £ _
/.disaggregation of the nucleus, and the appearance of electron-
translucent viral inclusions (Love and Wildy, 1963; Schwartz and
Roizman, 1969; Dargan and Subak-Sharpe, 1983).
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1.7. HERPES SIMPLEX VIRUS TRANSCRIPTION
HSV transcripts are synthesised in the host cell nucleus (Wagner 
and Roizman, 1969). The sensitivity of virus transcription too<- 
amanitin and the absence of any virus coded polymerase activity 
suggested that HSV transcription involved host cell polymerase II at 
all stages of virus infection (Alwine et al., 1974; Ben-Zeev et al., 
1976; Costanzo et al., 1977). HSV transcripts like host cell mRNA are 
internally methylated and capped at their 5'-termini (Bartkoski and
Roizman, 1976; Moss et al., 1977). The 3'-termini of most transcripts
o
contain the polyadenylatip sequence 'AATAAA' which is important for 
cleavage of pre-mRNAs (McKnight, 1980; Fitzgerald and Shenk, 1981). 
Further a (G+T) rich sequence - 'YGTGTTYY' located about 10 bp 
downstream from the poly-A site of several eukaryotic and HSV genes 
has been shown to be required for the efficient formation of the mRNA 
3'-terminus (Taya et al., 1982; McLauchlan et al., 1985). Only a few 
HSV mRNAs have been shown to be spliced (Wagner, 1985); these include 
immediate early (IE) mRNAs -1, -4, -5 and the mRNA for glycoprotein C 
(gC) (Watson et al., 1981; Frink et al., 1981; Rixon and Clements, 
1982; Frink et al., 1983; Perry et al., 1986). Following transcription 
HSV mRNA is transported to the cytoplasm where, after binding with 
ribosomes it is translated into proteins (Wagner and Roizman, 1969).
1.7.a. Temporal regulation of HSV transcription
During its lytic infectious cycle, HSV establishes an orderly 
programme of mRNA and hence viral protein synthesis. This programme is 
composed of three groups of viral proteins that have been classified 
according to their temporal order of synthesis (Honess and Roizman, 
1974, 1975; Clements et al., 1977; Jones and Roizman, 1979). The three 
groups are termed the immediate early (IE or©< ), early (DE, E or ) 
and late (L or y ) proteins. The sequential appearance of these classes
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is regulated in a cascade fashion. That is, IE proteins are required 
for the induction of E protein synthesis, and in turn E proteins are 
required to facilitate L protein synthesis. is a schematic
diagram which depicts the synthesis of HSV-1 proteins during the lytic 
cycle.
1.7.b. Immediate early (IE) gene expression
IE mRNAs are the first set of transcripts to be seen following 
infection of the cell with HSV. IE protein synthesis is detectable by 
one hr post infection in the absence of de novo protein synthesis 
(Honess and Roizman, 1974), peaks at 3 to 4 hr post infection, and 
then declines markedly by 6 hr post infection. Low levels of IE 
protein synthesis continue to be detectable after 6 hr post infection 
(Honess and Roizman, 1974; Harris-Hamilton and Bachenheimer, 1985). 
When the lytic cycle is blocked by inhibitors of protein synthesis 
(such as cycloheximide), IE mRNAs accumulate to the exclusion of mRNAs 
from the other temporal classes (Clements et al., 1977).
Ihe five IE-genes designated IE-1, -2, -3, -4 and -5 encode for 
polypeptides Vmw 110 (ICPO), Vmw 63 (ICP 27), Vmw 175 (ICP 4), Vmw 68 
(ICP 22) and Vmw 12 (ICP 47) respectively (Preston et al., 1978; 
Clements et al., 1979; Watson et al., 1979; Marsden et al., 1982). 
Genes encoding IE-1 and IE-3, because of their location in the repeat 
sequences of the long and short components of the genome respectively, 
are present in two copies each. Soon after synthesis, the IE 
polypeptides except Vmw 12 are phosphorylated and transported to the 
cell nucleus where they are found tightly associated with the cell 
chromatin. Vmw 12 occurs as a non-phosphorylated form in the infected 
cell cytoplasm (Pereira et al., 1977; Preston, 1979a; Hay and Hay, 
1980; Marsden et al., 1982).
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A variety of studies have shown that at least three of the five 
IE proteins regulate ensuing steps of HSV-1 protein synthesis cascade. 
The first example csomes from genetic studies of viral strains carrying 
ts alleles of the gene encoding an IE protein Vmw 175. At the 
restrictive temperature, these mutants fail to make the transition 
from IE to DE protein synthesis (Preston, 1979b; Dixon and Schaffer, 
1980; Watson and Clements, 1980). Moreover, if the temperature is 
shifted to the restrictive condition after the induction of E or L 
protein synthesis, IE mRNA production resumes and E and L gene 
expression ceases (Watson and Clements, 1980). These studies indicated 
that Vnw 175 (ICP4) activity is required continuously for the 
maintenance of both E and L gene expression. Deletion mutants lacking 
one copy of the IE-3 gene have been shown to grow normally in tissue 
culture (Longnecker and Roizman, 1986; Brown and Harland, 1987), 
demonstrating that one copy of the IE-3 gene is sufficient for virus 
growth.
Similar to Vmw 175, at the restrictive temperature, viruses 
carrying a ts allele of the gene IE-2 encoding Vmw 63 (ICP 27) express 
IE and E proteins but fail to synthesise appropriate levels of a 
number of L proteins (Sacks et al., 1985). However, MacLean and Brown 
(1987b) have described a deletion variant of HSV-1 strain 17 which 
fails to synthesise Vmw 63 under immediate early conditions, although 
the production of the polypeptide under early and late conditions 
remains to be determined. The precise role of Vmw 63 in the virus life 
cycle, has yet to be established.
An alternative approach has suggested a regulatory function for 
Vmw 110 (ICPO), the product of the IE-1 gene. Plasmid borne copies of 
the IE-1 gene have been shown to induce expression from cloned E and L 
genes in transient co-transfection experiments. Moreover, a similar 
activity of the cloned IE-3 gene is enhanced when it is transfected
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into cultured cells along with the IE-1 gene (Everett, 1984a; Q’Hare 
and Hayward, 1985 ; Quinlan and Knipe, 1985; Mavromara et al., 1986). 
No ts mutants have been isolated in IE-1 gene. One copy of this gene 
is required for normal virus growth and gene expression in tissue 
culture (Brown et al., 1984; Harland and Brown, 1985; MacLean and 
Brown, 1987b). Stow and Stow (1986) have constructed a virus which 
contains a large deletion in both copies of IE-1, This deletion mutant 
of HSV-1 is capable of growing on a number of cell lines, although the 
virus yield was reduced 20 to 100-fold compared to wild-type HSV-1.
Its ability to plaque was more significantly impaired than its yield, 
indicating that initiation of infection was poor. Infected cell 
polypeptide synthesis in this mutant was normal compared to wild-type 
virus. Sacks and Schaffer (1987) have also isolated two deletion 
mutants in IE-1, which exhibit very similar properties to that of Stow 
and Stow (1986). Sandri-Goldin et al. (1987) have constructed cell 
lines expressing an antisense IE-1 message. Expression of Vmw 110 was 
reduced to less than 1 0% of wild-type levels, with little effect on 
the expression of HSV early and late genes or virus yield.
Thus, it appears that Vmw 110 plays an important though possibly 
not essential role in productive cell culture infections. Its precise 
requirement in vivo remains to be determined, although preliminary 
studies suggest it is non-essential in latency in the mouse model 
(G.B. Clements, personal communication).
The product of the IE-4 gene, Vmw 6 8, is complemented by host 
cell factors as demonstrated by the impaired growth of a deletion 
mutant in some cell lines and not in others (Sears et al., 1985). 
Deletion mutants in the IE-5 gene encoding for Vmw 12 have also been 
shown to grow normally in a number of cell lines (Mavromara-Nazas 
etal., 1986; Umene, 1986; Brown and Harland, 1987). These studies have
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clearly demonstrated that both Vmw 68 and Vmw 12 are not essential for 
virus growth.
Immediate early gene transcription though not requiring de novo 
protein synthesis, is stimulated in trans by a component of the virus 
particle (Post et al., 1981; Batter son and Roizman, 1983), identified 
as the major tegument protein, Vmw 65 (Campbell et al., 1984). 
Transcriptional stimulation by Vmw 65 has only been observed for genes 
containing IE promoters. The role of specific cis-acting DNA sequences 
present in the promoter or 5'-upstream regulatory regions which are 
characteristically unique to each temporal class of genes haVe been 
suggested to take part in the control of HSV transcription. Each IE 
gene promoter has been found to contain (i) a TATA box located 25 to 
30 bp 5' to the mRNA start site. This is required for the accurate 
initiation of transcription; (ii) multiple binding sites for the 
cellular factor Spl (Jones and Tjian, 1985); (iii) proximal promoter 
sequences located at -37 to -108 bp which are required for 
transcriptional initiation in the absence of further upstream 
sequences; (iv) far upstream sequences (-174 to -331), containing one 
to multiple copies of the sequence, 'TAATGARATT' (Mackem and Roizman, 
1982b; Whitton and Clements, 1984b). The highly conserved sequences 
'TAATGARATT' is unique for all the immediate early and not the early 
and late gene promoters (Mackem and Roizman, 1982a; Whitton et al., 
1983; Whitton and Clements, 1984a) and mediates responsiveness to the 
virion trans-inducing factors Vmw 65 (Preston et al., 1984). Recently 
the interaction between 'TAATGARATT' elements and Vmw 65 has been 
shown to occur via a cellular polypeptide (Kristie and Roizman, 1987; 
Preston et al. submitted for publication). The (G+C) rich region 
flanking the 'TAATGARATT' sequences appears to bind to Spl and 
modulates transcription from IE genes (Jones and Tjian, 1985).
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1.7.c. Early (E) gene expression
The early or p polypeptides are characterized by their absolute 
dependence on the prior synthesis of immediate early polypeptides 
(Honess and Roizman, 1974). The synthesis of E proteins begins by 3 hr 
post infection, peaks at roughly 6 hr post infection and declines 
through subsequent time points (Honess and Roizman, 1974; Harris- 
Hamilton and Bachenheimer, 1985, also see Figure 9).
The early class of polypeptides induces many enzymes involved in 
virus nucleic acid metabolism and several structural polypeptides. The 
two classes of early polypeptides, B-^ and B2, have been distinguished 
on the basis of their synthesis in the presence of different amino 
acid analogues (Pereira et al., 1977) and the analysis of polypeptides 
induced by a ts mutant in Vmw 175, (ts K) at the non permissive 
temperature (Preston, 1979b).
Several studies on analyses of early gene promoter regions have 
been undertaken with the aim of identifying cis- and trans- acting 
transcriptional control signals. Investigation of the thymidine kinase 
(tk) gene promoter region by both deletion analysis and insertion of 
clustered sets of point mutations at random locations, enabled three 
distinct cis-acting control signals to be identified within the 106 bp 
upstream sequence required for efficient transcription of the tk gene 
(McKnight and Kingsbury, 1982; McKnight et al., 1984). These included 
a proximal TATA homology and two upstream distal signals which 
exhibited sequence homology and were required for quantitative 
transcriptional control. Experiments designed to determine early gene 
promoter sequences which respond to transactivation by virus immediate 
early polypeptides yielded conflicting results. Zipser et al. (1981) 
and Elkareh et al. (1985) reported that functional domains which had 
differential roles in constitutive and virus-induced expression of the 
gene, could be defined within the tk promoter region. Everett (1984b)
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and McKnight et al., (1984), however using genes containing the gD and 
tk promoters respectively in trans-induction assays, could not detect 
any specific sequences required for transactivation by immediate early 
polypeptides.
Recent experiments revealed that the same early gene upstream 
sequences are required for efficient expression of early genes in 
constitutive (frog oocyte) and regulated (HSV-infected fibroblast 
cells) environments (Eisenberg et al., 1985). Taken together with 
evidence that the mammalian transcription factor Spl binds strongly-to 
IE and early gene promoters (Jones and Tjian, 1985), these findings 
indicate that IE polypeptides transactivate early genes in conjunction 
with, or by modification of, cellular transcription factors.
1.7.d Late (L) gene expression
The late genes are transcribed late in viral infection and 
require functional immediate early and viral DNA replication for their 
efficient expression (Honess and Watson, 1977. ; Jones and Roizman, 
1979; Holland et al., 1980). The two sub groups of the class termed yif 
or 'leaky late' and Y 2 or 'true late' are distinguishable by the fact 
that Y2 9ene expression is barely detectable in a normal lytic 
infection before viral DNA replication, whereas y 1 gene expression is 
readily detectable (Roizman and Batrterson, 1985; Wagner, 1985). The 
polypeptides encoded by the late genes comprise a number of structural 
proteins S'wch as the major capsid protein (Vmw 155, VP 5), glyco­
protein C (gC), and the US-11 gene product, Vmw 21 (Honess and 
Roizman, 1973; Marsden etal, 1976; Costa et al., 1981; Frink et al., 
1983).
The overall mechanism for late gene expression is poorly 
understood. Early and late genes can be distinguished in an in vitro 
trsnscciption system prepared from uninfected cells (Frink et al.,
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1981). In the absence of transactivation, early genes are expressed 
whereas late genes remain transcriptionally silent. One possible 
explanation is that late promoters are intrinsically weak, requiring 
transactivation for efficient expression.
Efficient transcription from a true late gene promoter requires 
fewer regulatory sequences compared to immediate early genes. Only the 
'TATA' box region appears to be required (Homa et al., 1986; Johnson 
and Everett, 1986b). Hie presence of an active origin of replication 
in cis has been shown to be necessary for efficient expression from 
the promoter of a late gene (US 11). Hie necessary DNA sequences for 
the efficient, regulated expression of US 11 lie within 31 bp of the 
RNA cap site (Johnson and Everett, 1986a). A similar sequence 
requirement has been demonstrated for the gC gene promoter - another 
true late gene (Homa et al., 1986). Hie requirement for DNA 
replication for the efficient expression of late genes may reflect 
more than an increase in copy number compensating for a weak promoter. 
An alteration in the genome structure or in the factors binding to 
viral DNA during replication may influence late gene expression 
(Silver and Roizman, 1985; Johnson and Everett, 1986a). Late genes may 
also be subject to negative control by the major DNA binding protein 
Vmw 136 (ICP 8), since ts mutants with lesions in ICP 8 exhibit 
increased levels of late gene expression at the restricted temperature 
(Godowski and Knipe, 1983; 1985).
1.8. HERPES SIMPLEX VIRUS DNA REPLICATION
Hie mechanistic details of HSV DNA replication are not fully 
understood, however, the cis— and some of the trans- acting functions 
have now been identified. Following infection, the viral ENA rapidly 
accumulates in the host cell nuclei where it is rapidly circularized 
presumably by ligation of the terminal 'a' sequences (Davison and
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Wilkie, 1983a; Poffenberger and Roizman, 1985). Electronmicroscopic 
studies of the replicating DNA (Friedman et al.r 1977) and analyses of 
defective virus genomes (Frenkel et al., 1975; Kaerner et al., 1979) 
have revealed that cis- acting sites for the initiation of virus DNA 
replication exist.
HSV DNA replication in BHK cells is first detected at about 3 hr 
post infection, reaching a peak in 9 to 11 hr and being completed by 
16 hr post infection at 37°C (Rixon, 1977). Only 5% of the infecting 
HSV DNA enters the replicating pool (Jacob and Roizman, 1977) whereas 
in PRV up to 80% of the input genomes undergo replication (Jean and 
Ben-Porat, 1976; Ben-Porat et al., 1976).
The nature of the replicating form of HSV DNA is unknown. The 
large size and fragility of virus DNA complicates the analyses. Ben- 
Porat and Rixon (1979) described replicating HSV DNA as 'large, 
tangled masses'. The rapidly sedimenting form of HSV DNA relatively 
lacking in termini seen in later stages of infection has indicated 
that the DNA is either circular or in head-to-tail concatamers (Jacob 
et al., 1979; Jongeneel and Bochenheimer, 1981). It is unclear whether 
DNA replication first undergoes a template amplification as circular 
monomers before packaging into progeny virus. Late in infection a 
rapidly se'^dimenting form of the replicated DNA, thought to be an 
extensive concatameric form, indicates that replication of DNA, at 
least at this stage is by a rolling circle mechanism (Jacob et al., 
1979). The newly synthesized DNA is further processed, cleaved/ 
packaged into nascent nucleocapsids in the cell nuclei (Vlazny et al.,
1982).
1.8.a. Origins of HSV DNA replication
Electronjmicroscopic examination of HSV DNA extracted from 
infected cells revealed that the virus genome might possess one or
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more specific sites which may act as start sites for DNA replication 
(Friedman et aL, 1977). The location of cis-acting sites for DNA 
replication was determined by analyses of the nature of two classes of 
defective HSV genomes which accumulate in virus stocks passaged at 
high multiplicities of infection. Both classes of defective genomes 
contain sequences from the terminus of TRg. Class I molecules contain 
in addition further sequences from the S segment while Class II 
molecules contain sequences from near the centre of UL (Kaerner et 
al., 1979; Vlazny and Frenkel, 1981; Spaete and Frenkel, 1982). The 
ability of both classes of defective molecules to be replicated and 
packaged with the help of wild-type virus indicated the presence of 
cis-acting signals for DNA synthesis and processing within the 
defective genomes. The cis-acting site located in TRg/IRg is termed 
Orig (Stow and McMonagle, 1983) while that in the centre of UL is 
termed OriL (Gray and Kaerner, 1984; Weller et al., 1985).
(i) Orig
Stow and McMonagle (1983) using a plasmid based system, have 
localised the origin of DNA replication in the Rg sequences of HSV-1. 
The HSV-1 Orig a 90 bp fragment is located between the 5' ends of the 
divergent transcripts for IE3 and IE4/5. There are thus 2 copies of 
Orig, one in IRg and the other in TRg (Figure 10). The Orig in HSV-1 
strain 17, contains an imperfect palindrome of 42 bases with an (AT)6 
sequences at the centre. The (AT)g rich central region and the 
sequences surrounding the palindrome are essential for DNA replication 
(Stow and McMonagle, 1983; Stow, 1985).
hcis been
In HSV-2 strain HG52, a sequence similar to OriS 
identified in Rg. The HSV-2 Orig differs from that of HSV-1 in that 
there are two copies of Orig sequences, contained within almost 
identical direct repeats of 137 bp (Whitton and Clements, 1984a).
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FIGURE 10
The 90 bp minimal Orig sequence. The sequence of the 90 bp 
fragment containing the cis-acting sequences required for Orig 
function (Stow and McMonagle, 1983) is shown. This represents the 
upper strand, inthe 5'— > 3' direction, of the Orig sequence within
the short internal repeat. -- > <--  represents the 45 bp imperfect
palindrome within this region. * refers to bases conserved between 
the VZV and HSV Orig fragments, vindicates the sequence deleted by 
Stow (1985), resulting in a plasmid which fails to replicate. ESD 
represents the bases on this strand protected by the Orig-binding 
protein (Elias et al., 1986).
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The nuclei from HSV-1 infected cells are found to contain a 
specific Orig DNA binding protein which protects an 18 bp region 
across one end of the palindrome from DNase digestion (Figure 10) 
(Elias et al., 1986). The 11 bp out of the 18 bp which bind to protein 
are conserved between HSV-1 and VZV (Elias et al., 1986). Hubenthal- 
Voss et al (1987) by cloning and DNA sequence analysis of cDNA from 
the Orig containing region of HSV-1 (F) have reported that each Orig 
sequence is contained in an open reading frame designated Orig ORF.
The transcription of Orig ORF is initiated approximately 860 
nucleotides upstream from that of the IE-3 genes and 162 nucleotides 
downstream but on the opposite strand from the transcription 
initiation site of the IE-4 or IE-5 genes within the inverted repeat C 
sequence. The Orig ORF transcript is 3' coterminal with the mRNA of 
the IE-3 genes, poly adenylated but not spliced and < codes for a 
34,000 mw protein. The insensitivity of Orig ORF transcripts to 
phosphonoacetic acid indicates that it is regulated as either an early 
or delayed early gene.
(ii) OriL
On the basis of analysis of defective genomes, the cis-acting 
site for HSV DNA replication located in UL i.e. OriL was mapped 
between 0.360 and 0.419 m.u. (Spaete and Frenkel, 1982). The 
systematic deletion analyses of OriL were hindered because of the 
occurrence of a 100 to 600 bp deletion within this region (0.360 to
0.419 m.u.) upon cloning in a standard plasmid vector. The deleted 
fragments contained no origin activity. However, following serial 
passage in the presence of wild-type helper virus, the deleted 
sequences were restored presumably through recombination with helper 
virus and the plasmids were capable of replication (Spaete and 
Frenkel, 1982; Weller et al., 1985).
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Successful cloning of OriL in an undeleted form was achieved in a 
yeast plasmid vector which was capable of replicating in a plasmid- 
based system following super infection with HSV (Weller et al., 1985). 
Sequence analysis of OriL from HSV-1 Ang (Grey and Kaerner, 1984), 
HSV-1 strain 17 (Quinn and McGeoch, 1985) and HSV-1 strain KQS (Weller 
et al., 1985) has revealed the presence of a perfect 144 bp palindrome 
which is responsible for deletion and cloning instability (McGeoch, 
1987).
Lockshon and Galloway (1986) have identified and sequenced OriL 
in HSV-2. Hie almost perfect palindrome of 136 residues found in OriL 
of HSV-2 shows a strong degree of sequence homology to that of HSV-1 
OriL (Lockshon and Galloway, 1986). Stow and Davison (1986) could not 
find any sequence counterpart of HSV Ori^ in the equivalent genome 
location of VZV.
Of the 90 bp sequence homology seen in HSV-1 Orig and OriL, 
greatest homology is found near and to the left of the centre of 
symmetry (Figure 11). The short inverted repeat sequences found within 
each arm of the Or i^ palindrome are believed to be the recognition 
sites for a DNA binding protein (Weller et al., 1985). Two of the 
three inverted repeat sequences located on the left side of the 
palindrome are shared by Orig. This may reflect the bi-directional 
mode of replication from OriL whereas that from Orig is unidirectional 
(Quinn and McGeoch, 1985; Weller et al., 1985).
The functional OriL in HSV-1 mapped between 0.398 and 0.413 m.u. 
is situated between the divergent transcripts for the ENA polymerase 
and the major DNA-binding protein (Quinn and McGeoch, 1985; McGeoch, 
1987), Figure 12). The significance of the location of both Ori^ and 
Orig between divergent transcripts encoding polypeptides with a major 
role in virus replication and transcription is unknown.
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FIGURE 11
Comparison between OriL and Orig of HSV-1. The 144 bp perfect 
palindrome from OriL is compared with the similar region in Orig. 
Conserved bases are shown below the two sequences (Weller et al., 
1985). The positions of the 3 inverted repeat sequences present in the
arms of the OriL palindrome are indicated ------ ► . Two similar
inverted sequences, present only on the left hand side, are shown 
below. KS0I refers to the 18 bp region protected from DNAase I 
digestion by the Orig-binding protein.
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FIGURE 12
Locations of genes required for HSV-1 DNA synthesis. The 
prototype HSV-1 genome is shown, with the scale in fractional map 
units. The locations and orientations of seven genes necessary for 
virus DNA synthesis are indicated, together with the positions of OriL 
and Orig.
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1.8.b. Function of HSV orig ins of DMA replication
Although the exact role of various sequences in the Ori elements 
is not fully understood, it is believed that binding of Ori-specific 
proteins at the conserved locus in Ori sequences provides a site for 
assembly of the replicative complex, while the (A+T)n region comprises 
a site for strand separation prior to synthesis of a new DNA strand. 
Also it is not known whether one origin of replication is used in 
preference during virus replication. Similarly the functional 
significance of the presence of two copies of Oris is unknown; 
although viruses lacking one copy of Orig grow normally in tissue 
culture (Longnecker and Foizman, 1986; Umene, 1986; Brown and Harland, 
1987). Polvino-Bodnar et al (1987) have recently reported a virus 
mutant lacking OriL which is capable of replication in cell culture.
1.8.C. Genes involved in HSV DNA replication
Recently, Challberg (1986) using a plasmid assay system involving 
cotransfection of cloned HSV genome fragments and Orig containing 
plasmids has identified cis-acting loci in the HSV genome, necessary 
for plasmid replication. Hiis approach in conjunction with DNA 
sequence information has resulted in identification of seven genes 
essential for virus DNA replication (Figure 12). These genes include 
DNA polymerase (136000 Mr), the major DNA binding protein (128,000 
Mr), UL 9 (94,000 Mr) and ML. $2. (115,000 Mr). The functions of the 
gene products encoded by the last five genes is yet unknown. The genes 
for ribonucleotide reductase, IE—1, —2 and —3 are required for optimal 
plasmid amplification but are not absolutely essential. Some of the 
properties of the proteins encoded by the genes needed for HSV DNA 
replication are described in section 1.10.b.
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1.9. CLEAVAGE/PACKAGING OF HERPES SIMPLEX VIRUS DNA
The head-to-tail concatamers formed during replication of HSV DNA 
are cleaved into unit length genomes and packaged into capsids in the 
nuclei of infected cells (Jacob et al., 1979; Kaerner et al., 1981; 
Vlazny and Frenkel, 1981). Ihe processes of cleavage and packaging of 
the genome are tightly linked (Ladin et al., 1980; Deiss and Frenkel, 
1986; Addison, 1986).
The signals for cleavage and packaging have been located in the 
'a' sequences (Vlazny and Frenkel, 1981; Vlazny et al., 1982; Spaete 
and Frenkel, 1982; Stow et al., 1983; Varmuza and Smiley, 1985; Deiss 
and Frenkel, 1986; Deiss et al., 1986). The presence of partial copies 
of the DR^ sequences at both termini of a mature virus genome led to 
the belief that the cleavage event might have occurred by a single 
double-strand breakage within DR^ .
Varmuza and Smiley (1985), using deleted sub-fragments of the 'a' 
sequence inserted into the viral thymidine kinase gene (tk), observed 
that two separate cleavage/packaging signals are present within the 
and Uc segments of the 'a' sequence with cleavage occurring in a 
sequence independent manner at a fixed distance from these sites.
Since sequences from an intact and an intact Uc were inactive 
individually, the functioning of these two signals in concert was 
indicated. This observation was strengthened by the deletion analysis 
studies of Deiss et al (1986) in which an HSV amplicon containing 'a* 
sequences with deletions within Uc failed to be packaged whereas those 
within were only packaged if they first acquired an insert of a 
wild-type 'a' sequence from a helper virus.
Ihe presence of highly conserved sequences at the termini of 
fully packaged HSV genomes from different herpes viruses and from 
different strains within the same type (Davison and Wilkie, 1981;
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Davison and Rixon, 1985; Deiss et al., 1986) in conjunction with the 
ability of different strains of HSV to package efficiently 
heterologous 'a1 sequence containing ENA. (Vlazny and Frenkel, 1981; 
Deiss and Frenkel, 1986) led Deiss et al (1986) to conclude that these 
highly conserved sequences are the cis-acting sites for cleavage/ 
packaging of the virus genome. The conserved region of homology in Uj-, 
was termed pac-1 and that in uc , pac-2 (Deiss et al., 1986) (Figure 
13). Cfei the basis of these observations different models for cleavage/ 
packaging of HSV DNA proposed by various workers are described in the 
following sections.
1.9.a. Staggered nick-repair model
As outlined in Figure 14, in the ’staggered nick-repair model' of 
Varmuza and Smiley (1985), the L- and S-termini are generated by 
staggered single stranded nicks followed by repair synthesis resulting 
in duplication of the 'a' sequences between adjacent viral genomes. 
Ligation of these termini then results in tandem reiteration of the 
'a1 sequence. In this model it is believed that junctions having two 
or more tandemly repeated 'a' sequences might be processed by a double 
strand cleavage, as a result of cooperation between two adjacent 
recognition signals. However, the model fails to explain the 
production of the 3' single nucleotide extensions found at the L- and 
S-termini of the standard genome.
1.9.b. Wastage or theft model
According to the wastage model of Varmuza and Smiley (1985) the 
genome termini are generated by double strand (ds) cleavage at any L-S 
junction containing a single 'a' sequence (Figure 15). Following 
packaging of a full length genome, cleavage occurs at the next 'a' 
sequence which is stolen from the adjoining DNA. As a consequence, two 
unpackaged termini lacking an 'a' sequence are also generated. Since
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FIGURE 13
Conserved regions within the 'a' sequence
(a) Structure of the HSV-1 'a' sequence
(b) Unique DNA sequences conserved between different strains of HSV
(c) Pao-1 and pac-2 regions (Deiss et al., 1986). These regions are
conserved between a number of herpes viruses as indicated in the 
text. For HSV, pac-1 has the sequence:
[c5] [G6] [TCTGTTT^J [Gg] ... HSV-1
[C51 [g 8 ] [T G r m r r ]  [g 9] ... h sv-2
For HSV, pac-2 has the sequence:
[CGCCGCG]-n3 1-[T6] ... HSV-1
[CGCCGCG]-n29- [Tg] ... HSV-2
where n = any nucleotide.
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FIGURE 14
A) The staggered nick-repair model of HSV DNA maturation proposed by
Varmuza and Smiley (1985). Cpen and filled triangles represent
the S and L terminus recognition complexes bound to signals 
located in Ub and Uc respectively.
B) A model whereby junctions bearing two or more tandemly repeated
'a' sequences give rise to termini, as a result of co-operation
between L and S recognition complexes in adjacent 'a1 sequences 
producing a double stranded break.
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FIGURE 15
'Theft' model for cleavage and packaging of HSV DNA proposed by 
Varmuza and Smiley (1985). Open and filled triangles represent 
packaging signal(s) in alternate phases. The cleavage/packaging 
complex is indicated as an empty caps id particle.
(A) Double stranded cleavage occurs at an L terminus cleavage signal. 
This creates an L terminus carrying an 'a' sequence and an S 
terminus lacking an 'a' sequence.
(B) Packaging proceeds until the next appropriately oriented L-S 
junction is encountered, at which point,
(C) a double stranded S terminus cleavage is made, generating an S 
terminus with an 'a' sequence and a L terminus lacking an 'a' 
sequence.
(D) The model proposes that ends lacking 'a' sequences are discarded 
and rapidly degraded.
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these terminal fragments lacking an 'a1 sequence have never been 
detected experimentally (Mocarski and Roizman, 1982a; Deiss and 
Frenkel, 1986), they must be rapidly degraded.
1.9.c. Directional cleavage - packaging model
Deiss et al (1986) have proposed a directional cleavage-packaging 
model which is essentially similar to the 'theft or wastage model' 
proposed by Varmuza and Smiley (1985), except in the former model a 
polarity in the cleavage-packaging process is included. The first 
cleavage (producing a 3' single-base overhang) of the concatamer ic HSV 
DNA. occurs at the DR^ , element at a fixed distance proximal to the 
first Uc sequence. The directional packaging begins at the generated 
L-ter minus (which contains at least one 'a' sequence) whereas the 
generated S-ter minus (which is devoid of 'a' sequence) is rapidly 
degraded. While packaging in the L-S direction, the DNA is scanned for 
the next directly repeated junction, skipping the inverted junction. A 
second cleavage occurs at a constant distance from the first 
sequence encountered in the second junction, leaving a 3' single-base 
overhang and producing a packaged molecule which carries a ca terminus 
and an unpackaged terminus which is degraded or forms a substrate for 
a new round of packaging into a separate capsid.
The directional model like the theft model of Varmuza and Smiley
(1985) also predicts the generation of S-termini devoid of 'a' 
sequences. Since such S-termini have never been observed 
experimentally they must be rapidly degraded.
1.9.d. Double-strand break and gap repair model
In order to explain some of the anomalies observed in "the theft 
model" and "the directional cleavage-packaging model", Deiss et al
(1986) have proposed a second model based on the double-strand break-
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repair model of Szostak et al (1983). According to this model 
interaction of two directly repeated junctions results in 
amplification of the 'a' sequence by a gene-conversion-like mechanism 
(Figures 16, 17). 'Hie resultant junctions containing double ’a1 
sequences are then cleaved with 3‘ single base extensions to yield the 
genomic termini. The cleavage/packaging process, as outlined in 
Figures 16 & 17, thus includes the following steps: (i) the packaging 
complex travels at random until it reaches the first Uc signal 
(junction A). No cleavage occurs; (ii) Again, packaging occurs in the 
L-to-S direction until the packaging complex meets a directly repeated 
junction (junction B); (iii) the two junctions are juxtaposed (Figure 
17,1) and a Uc signal-directed double-stranded cleavage occurs within 
the DRj_ element of either ’a1 sequences (Figure 17,2); (iv) the 
resultant 3' terminus invades the homologous sequence in the other 
junction and is extended by copying the 'a1 sequence in that juncton 
while displacing the equivalent strand (Figure 17,3,4); (iv) this 
displaced strand serves as the template for repair synthesis of the 
second strand of the invading 'a' sequence (Figure 17,5); (iv) the 
process terminates by the resolution of the two Holliday structures 
(Holliday, 1964) - this will be expected to occur at or near DR^
(vii) if the other junction also cotained a single 'a' sequence, then 
the process would be repeated in the other direction. Thus, the result 
is amplification of the 'a' sequence in both junctions to generate a 
double 'a1 sequence in which DR^ is flanked by both and Uc 
packaging signals; (viii) both double 'a1 sequence junctions are 
cleaved (generating a 3' single base extension) between the newly 
inserted and original 'a' sequence. This cleavage could also be the 
result of staggered single—strand cleavages generated by end Uq of 
adjacent 'a' sequences.
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FIGURE 16
The double-strand gap/repair model (Deiss et al., 1986). Briefly 
DNA is packaged prior to cleavage, the two directly repeated 'a' 
sequences then align and are amplified, by a double strand break/ 
repair mechanism, to generate two double 'a' sequence-containing 
junctions Cleavage between the double 'a' sequences then generates 4
i
'a' sequence - containing termini, refers to 'a' sequences. The
!
detailed steps of this model are outlined in Figure 17. Asapted from MacLean 1987
DOUBLE-STRAND GAP/REPAIR MODEL
PACKAGING
AMPLIFICATION
CLEAVAGE
FIGURE 17
Double-strand gap/repair model as proposed by Deiss et al (1986)
1. DNA is packaged prior to cleavage, and the directly-repeated 'a* 
sequences which will form the L and S termini then align 
(junctions A and B, respectively).
2. A Uc-directed double-strand cleavage occurs through the DR^ (*i ) 
of junction A. The cleaved ends align with the DR-^  elements of 
junction B.
3. One strand from junction A then invades junction B, displacing 
the equivalent strand. (For simplicity this diagram is drawn with 
the top and bottom strands of junction B reversed).
4. The displaced strand from junction B aligns with the partial DRj 
elements of junction A, and serves as a template for repair 
synthesis.
5. Similarly, the non-displaced strand from junction B serves as a 
template for repair synthesis between the invading partial DRj 
elements.
6 . Resolution of the Holliday structure results in the presence of 
two directly repeated copies of the 'a' sequence at junction A.
7. A similar process is then envisaged to take place for junction B. 
Cleavage between the adjacent 'a' sequences then generates the L 
and S termini of the packaged DMA.
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This model again predicts that around 80% of the packaged genomes 
(initial encounter of packaging complex in L) will carry ba and ca 
termini regardless of the number of 'a* sequences in the cleaved 
junctions, whereas the remaining packaged genomes (initial encounter 
of packaging complex in S) will be terminated with ca and ban 
sequences. Hie termini of the free molecules generated by cleavage 
would be of the type baj^  and can or ca, and might be either degraded 
or serve as a target for new packaging cycles.
This model accounts for all the features of HSV cleavage/ 
packaging explained by the directional model (Deiss et al., 1986; 
Section 1.9.c), and also some of the other anomalies; (i) There are no 
termini devoid of 'a' sequences produced, (ii) It also explains the 
finding of multiple 'a' sequence-containing S-termini seen in 
defective-containing stocks (Deiss and Frenkel, 1986). However, the 
drawback of the model is its dependence on the sequence homology at 
the DR^ elements of the 'a' sequence for the correct copy of the 
second ’a’ sequence.
1.10. HERPES SIMPLEX VIRUS INDUCED POLYPEPTIDES
Following infecton of cells with HSV a large number of 
polypeptides are induced. These include IE polypeptides involved in 
HSV transcription, virus-induced enzymes and DNA-binding proteins 
involved in virus genome replication, structural polypeptides and 
glycoproteins involved in virus structure composition. Approximately 
50 HSV induced polypeptides have been detected on SDS-PAGE (Honess and 
Roizman, 1973, 1974; Powell and Courtney, 1975; Marsden et al., 1976), 
while on two-dimensional SDS-PAGE at least 230 distinct polypeptide 
species have been recognised (Haarr and Marsden, 1981). This increased 
number may be in part due to the resolution of families of polypeptide 
species related through post—translational modification. The apparent
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difference in mobilities on SDS-PAGE of some u\ vitro synthesised 
viral polypeptides compared to those from infected cell extracts 
reflects the occurrence of post translational modification of some of 
the HSV-induced polypeptides (Preston, 1977). The four main post- 
translational modification events of HSV induced polypeptides include 
phosphorylation (Marsden et al., 1978; Wilcox et al., 1980); 
glycosylation (Haarr and Marsden, 1981; Palfreyman et al., 1983; Hope 
and Marsden, 1983); sulphation (Hope et al., 1982) and proteolytic 
cleavage (Eisenberg et al., 1984; Balachandran and Hutt-Fletcher,
1985).
1.10.a. HSV-induced enzymes involved in DMA replication
(i) DNA polymerase
HSV induced DNA polymerase is a polypeptide of approximately
150,000 mw (Powell and Purifoy, 1977). This virus encoded enzyme has 
been shown to be essential for virus DNA replication and because of 
its sensitivity to phosphonoacetid or phosphonoformic acid has been 
mapped to 0.40 to 0.42 m.u. of the genome (Hay and Subak-Sharpe, 1976; 
Chartrand et al., 1979, 1980; Crumpacker et al., 1980). Coen et al., 
(1982) showed that HSV polymerase contains at least two functional 
domains and possesses both DNA polymerase and a 3' to 5' exonuclease 
activity for proof reading (Weissbach et al., 1973; Knopf, 1979). ]hi 
vivo the viral polymerase is thought to form a functional complex with 
other viral proteins like the major and other DNA-binding proteins and 
the alkaline exonuclease (Purifoy and Powell, 1981; Littler et al., 
1983; Chiou et al., 1985).
(ii) Alkaline exonuclease
Infection of cells with HSV induces a polypeptide of 
approximately 85,000 mw (Marsden et al., 1978) associated with high 
levels of alkaline exonuclease activity (Keir and Gold, 1963; Morrison
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and Keir, 1968; Hay et al., 1971; Hoffmann and Cheng, 1978). This 
virus coded enzyme has been mapped by marker rescue of ts leisions to
0.145 to 0.185 m.u. of the genome (Preston and Cordingley, 1982). It 
possesses an endonuclease activity besides its 5' and 3' exonuclease 
activities (Hoffmann and Cheng, 1979; Hoffmann, 1981) and appears to 
be essential for viral replication (Moss, 1986). Its function in vivo 
either in DNA replication in association with DNA polymerase (Francke 
and Garrett, 1982) or in degradation of host cell DNA during viral 
infection (Wildy et al., 1961; Hoffmann and Cheng, 1978) is not yet 
clear.
(iii) Topoisomerase
Topoisomerases produce either transient single strand breaks or 
double strand breaks and thus interconvert the topological isomers of 
DNA. Topoisomerases in general are believed to be involved in ENA 
replication, transcription and recombination (Gellert, 1981). HSV-1 
induced topoisomerase activity has been reported (Biswal et al., 1983; 
Leary and Franke, 1984; Muller et al., 1985), and has been suggested 
to be a component of the virion envelope or tegument structure (Muller 
et al., 1985).
(iv) Thymidine kinase (tk)
This enzyme is encoded by a 1.2 kb coding sequence mapping 
between 0.30 and 0.31 m.u. The virus coded thymidine kinase (tk)
(Dubbs and Kit, 1964; Munyon et al., 1971) has been shown to 
phosphorylate thymidine* deoxycytidine (Jamieson and Subak—Sharpe, 
1974; Jamieson et al., 1974) and thymidylate (Chen and Prusoff, 1978).
is also associated with a nucleoside phosphotransferase activity in 
converting thymidine to thymidylate which possibly requires a 
component of the cellular thymidine kinase system (Jamieson et al.,
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1976; Falke et al., 1981). Virus mutants lacking tk activity have 
shown that the enzyme, though non-essential in tissue culture, is 
essential for growth of the virus in serum starved cells (Jamieson et 
al., 1974; Fisher and Preston, 1986). Hie tk enzyme is, therefore, 
important in cells with a low level of de novo pyrimidine synthesis. 
Similarly, viruses with no tk activity have been shown to have reduced 
pathogenicity in experimental animals (Field and Wildy, 1978).
(v) Ribonucleotide reductase
A ribonucleotide reductase activity different from that of the 
cellular enzyme has been demonstrated following infection with both 
HSV-1 and HSV-2 (Cohen, 1972; Ponce de Leon et al., 1977; Averett et 
al., 1983; Huszar et al., 1983). The enzyme catalyses the reduction of 
all four ribonucleoside diphosphates to their corresponding deoxyribo- 
nucleoside diphosphates and thus is essential for DNA replication in 
both prokaryotes and eukaryotes (Thelander and Reichard, 1979). 
Infection of cells at the NPT with the HSV-1 mutant, ts 1207 which has 
a mutation in the gene resulted in 100-fold reduced growth over a 24 
hr period, indicating that ribonucleotide reductase is essential for 
virus replication and is virus coded (Dutia, 1983; Preston et al.,
1984). Like i|> cellular counterpart, ribonucleotide reductase appears 
to be composed of a complex of two polypeptides of approximately
136,000 (RRl) and 38,000 (RR2) mw both of which are thought to be 
essential for the enzyme activity (Frame et al., 1985; Bacchetti et 
al., 1986). Both RRl and RR2 polypeptides encoded by HSV-1 and HSV-2 
have been seguenced (McLauchlan and Clements, 1983< ,1 Swain and 
Galloway, 1986; Nikas et al., 1986). Virus-induced enzyme activity 
encoded by seguences between 0.51 and 0.587 m.u. of the HSV genome has 
been shown to be abolished by a synthetic oligopeptide corresponding 
to the carboxyterminus of the 38,000 mw polypeptide component (Frame
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al., 1985). The lack of enzyme activity is believed to be due to 
the inhibition of an interaction between the two sub-unit polypeptides 
(Cohen et al., 1986; Dutia et al., 1986).
(vi) Deoxyuridine-51—triphosphate nucleotidohydro 1 ase (dUTPase)
The enzyme dUTPase catalyses the hydrolysis of dUTPr to dll.MP
^  / 
i
and pyrophosphate. In cells it reduces the intracellular concentration 
of dUTP and, as a consequence, minimises incorporation of dUTP into 
DNA. Hius it provides the cell with a pool of dUMP which is converted 
to TMP by thymidylate synthetase.
Virus specific dUTPase activity is induced in cells following 
infection with HSV-1 or HSV-2 (Wohlrab and Francke, 1980; Williams^
1984). Unlike the host cellular dUTPase, most of the HSV-1 induced 
enzyme activity is found in the nuclear fraction of cells and is 
active at 4°C (Wohlrab and Francke, 1980; Caradonna and Cheng, 1981) 
while HSV-2 induced activity is found predominantly in the cytoplasmic 
extracts of fractionated cells (Wohlrab et al., 1982). dUTPase 
activity in HSV-1 has been mapped to a gene between 0.69 and 0.70 m.u. 
(Preston and Fisher, 1984) which codes for 39,000 mw polypeptide. HSV- 
1 mutants lacking dUTPase activity have been shown to grow normally in 
cell culture (Fisher and Preston, 1986).
(vii) Uracil-DNA glycosylase
A virus-specific uracil-DNA glycosylase activity has been 
detected in cells infected with HSV (Caradonna and Cheng, 1981). 
Though the virus—induced enzyme differs from the host cell enzyme on a 
biochemical basis (Caradonna and Cheng, 1981), it is yet to be shown 
to be virus encoded. The host cell counterpart has been shown to be 
involved in removal of deaminated cytosine residues produced as a 
result of deamination of incorporated deoxycytidine monophosphate 
(dCMP) residues from DNA. The enzyme is thought to act as an
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antimutator or editing enzyme.
(viii) Protein kinase
DNA sequencing studies have revealed that the US3 genes of HSV-1 
and HSV-2 (McGeoch et al., 1985, 1987) and the corresponding gene of 
varicella zoster virus (Davison and Scott, 1986) encode proteins that 
are clearly homologous with the members of the protein kinase family 
of eukaryotes (McGeoch and Davison, 1986b). The predicted mw of 
polypeptides encoded by the US3 genes of HSV-1 and HSV-2 are 53,000 
mw. Recently Frame et al (1987) using an oligo-peptide induced 
antiserum specific for the HSV-1 US3 have identified a 68,000 mw 
protein from cells infected with HSV-1.
l.lO.b. HSV-induced DNA-binding proteins
Among the various proteins induced following HSV infection, 
atleast 17 have been reported to have DNA binding properties, as 
monitored by DNA-cellulose affinity chromatography (Bayliss et al., 
1975; Powell and Purifoy, 1976). Some of these like the major DNA- 
binding protein (MDB) (Littler et al., 1983), the viral DNA polymerase 
(Powell and Purifoy, 1977) and the 65,000 (65K) mw DNA binding protein 
(Marsden et al., 1987; MacLean et al., 1987) are well characterized. 
The functions of most of the other DNA binding proteins are not yet 
known.
(i) Major DNA binding protein (MDB)
The 128,000 mw major DNA-binding protein (ICP8), an abundant 
delayed early gene product is implicated as an important regulatory 
factor in HSV replication (Lee and Knipe, 1983). It has been 
extensively purified, found to be nonphosphorylated (Powell et al., 
1981) and to bind preferentially to single-stranded DNA (Ruyechan and 
Weir, 1984; Lee and Knipe, 1985). The gene coding for the enzyme has
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been mapped to 0.38 to 0.41 m.u. (Rafield and Knipe, 1984). The enzyme 
has been shown to be essential for viral DNA replication and for 
normal levels of synthesis of late polypeptides (Conley et al., 1981) 
as mutants in the gene gave altered patterns of delayed early and late 
gene products (Godowski and Knipe, 1983). Genetic studies of Leinbach 
©t al (1976) and Chiou et al (1985) have demonstrated that the MDB 
functionally interacts with DNA polymerase, the alkaline exonuclease, 
and 65,000 mw DNA binding protein. Temperature sensitive mutants 
within or near the gene fail to synthesise HSV DNA at the NPT (Conley 
et al., 1981; Littler et al., 1983; Weller et al., 1983) indicating 
its absolute requirement for virus DNA replication.
(ii). The 65,000 mw (65K) DNA-binding protein
Plasmid borne assays to identify essential genes for HSV 
replication have indicated that the 65K DNA binding protein is one of 
the seven genes essential for replication of plasmid molecules 
containing an HSV-1 origin of DNA replication (Challberg, 1986, 
reviewed by McGeoch, 1987). The 65K DNA binding protein is distinct 
from the 65K virion transactivating factor (Marsden et al., 1987). It 
has a strong DNA binding property and can bind to ENA in the absence 
of other proteins, except HSV DNA polymerase (Bayliss et al., 1975; 
Powell and Purifoy, 1976; Vaughan et al., 1985). The gene coding for 
the 65K DNA binding protein is located between 0.574 and 0.682 m.u. on 
the HSV-1 genome and the polypeptide is post-translationally modified 
by phosphorylation. Hie exact function of this polypeptide is not yet
fully understood.
Besides the above a number of other virus polypeptides have been 
reported to interact with virus DNA. Hnese include the IE polypeptide 
Vmw 175 which specifically interacts with the promoter-regulatory 
regions of a number of HSV genes (Beard et al., 1986; Kristie and
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Roizman, 198$; Vmw 21 and Vmw 22 which specifically interact with the 
HSV 'a' sequence (Dalziel and Marsden, 1984; MacLean et al., 1987). 
Some of the structural polypeptides like Vmw 145K, 87K, 43K, the major 
capsid protein of HSV have been reported to have DNA binding 
activities (Bayliss et al., 1975; Powell and Purifoy, 1976). Hie 
precise functions of these polypeptides are not yet known. Elias et al 
(1986) from nuclear extracts of HSV infected cells, have partially 
purified a polypeptide which specifically binds to Orig in a 
nitrocellulose filter-binding assay. Hie exact role of this 
polypeptide remains to be determined.
l.lO.c. HSV-induced glycoproteins
HSV induced glycoproteins besides polyamine and spermidine 
(Gibson and Roizman, 1971) form the major constituents of the virus 
envelope. Of seven glycoproteins i.e. gB, gC, gD, gE, gG, gH and gl 
(Spear, 1976; Marsden et al., 1978, 1984; Bauke and Spear, 1979; 
Buckmaster et al., 1984; Roizman et al., 1984; Longnecker et al.,
1987; McGeoch et al., 1987), encoded by HSV-1, all except gl, have 
been shown to be constituents of the virus envelope. An HSV-2 
counterpart for gB, gC, gD, gE and gG has been reported on the basis 
of biochemical or immunological criteria or on DNA sequence analysis 
(reviewed by Spear, 1985; Marsden, 1987). Hie map locations of genes 
encoding various glycoproteins is indicated in Figure 18.
Studies with ts mutants and deletion mutants in genes coding for 
various glycoproteins have indicated that gC, gE, gG and gl are 
dispensable for growth of virus in tissue culture (Hoggan and Roizman, 
1959; Heine et al., 1974; Cassai et al., 1975/76; Holland et al.,
1984; Zezulak and Spear, 1984; Longnecker and Roizman, 1986, 1987; 
Longnecker et al., 1987; Weber et al., 1987; Harland & Brown, 1988). 
Inability of ts mutants, having mutations in genes encoding for gB and
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FIGURE 18
Location of the genes encoding HSV glycoproteins (Marsden, 1987). 
The HSV genome is represented in the prototype orientation with 
fractional genome length (m.u.) above the line. Hie approximate map 
locations of the glycoproteins are indicated. I refers to genes which 
have been sequenced. 0  indicates genes which have not been sequenced. 
HSV-1 encoded glycoproteins are indicated above the line while HSV-2 
encoded counterparts are indicated below the line.
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gH, to grow at the non-permissive temperature (Manservigi et al.,
1977; Little et al., 1981; Weller et al., 1983) indicates that gB and 
gH are essential for lytic growth of the virus. The requirement for gD 
in a lytic infection with HSV is at present unknown.
Some of the important properties of HSV glycoproteins are 
summarized in Table 1. Glycoproteins gB and to a lesser extent gD are 
involved in adsorption of virus to cells as antibodies to gB and to a 
lesser extent to gD and gC, inhibited the attachment of virosomes 
(liposomes containing purified virion polypeptides) to cells (Johnson 
et al.f 1984). Fuller and Spear (1985) have also demonstrated that 
antibodies against gC and high concentrations of the Fc fragments of 
immunoglobulin (Ig)G can inhibit adsorption. However, it is unlikely 
that either gC, gE or gl are essential components of the virus 
receptor because all the three have been shown to be non-essential for 
virus growth, at least, in tissue culture.
Glycoproteins gB and gD have also been shown to play a role in 
virus penetration. Temperature sensitive mutants containing mutations 
in the gB gene although adsorbing to cells, fail to penetrate 
(Sarmiento et al., 1979; Haffey and Spear, 1980; Little et al., 1981). 
Recently Fuller and Spear (1987) and Highlander et al (1987) while 
investigating, by immuno gold electron microscopy the fate of 
infectious virus and virus neutralized with monoclonal antibodies 
against gD, concluded that the neutralizing antibodies inhibited 
fusion of the virion envelope (penetration) with the plasma membrane 
but not its attachment (adsorption).
A number of glycoproteins have been reported to be involved in 
syncytium formation following infection of cells with virus. At least 
seven, and possibly eight, genetic loci have been mapped for syncytium 
formation (reviewed by Spear, 1985; Marsden, 1987). The glycoproteins
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TABLE 1
Properties of HSV-encoded glycoproteins
Glycoprotein/map location Possible functions
gB 0.35 - 0.37 Essential for lytic growth; implicated
in adsorption, penetration and cell 
fusion.
gC 0.63 - 0.64 Dispensable for growth in tissue
culture. Implicated in adsorption, 
penetration and cell fusion. gC-1 can 
act as a C3b-receptor. 
gD 0.91 - 0.927 Implicated in adsorption, possibly
penetration, and in cell fusion. No ts 
mutants have yet been described. 
gE 0.924 - 0.951 Dispensable for lytic growth, implicated
in adsorption, interacts with gl to form 
a Fc-receptor.
gG 0.89 - 0.9 Dispensable for growth in tissue culture.
gH 0.27 - 0.312 Essential for virus replication in
tissue culture. Implicated in cell 
fusion and cell-to-cell spread of 
infectious virus, 
gl 0.919 - 0.927 Dispensable for growth in tissue
culture. Interacts with gE to form a Fc- 
receptor.
involved in this process include gB, gD and gH (reviewed by Marsden, 
1987).
A possible role of gH in egress of virus from infected cells has 
also been shown. A monoclonal antibody against gH has been shown to 
inhibit plaque formation suggesting the involvement of gH in cell—to- 
cell spread of infectious virus (Buckmaster et al., 1984).
Glycoprotein gC-1 and not gC-2 has been shown to act as the 
receptor for the C3b component of complement (Friedman et al., 1984). 
This property of gC-1 has been attributed to a sequence of 28 amino 
acids which are absent in gC-2 (Frink et al., 1983; Dowbenko and 
Lasky, 1984? Swain et al., 1985).
Glycoprotein gE has been shown to bind to the Fc portion of IgG 
(Bauke and Spear, 1979; Johansson et al., 1984).
On immunizing animals with HSV virions or virus infected cells, 
all the HSV glycoproteins except gl have been shown to elicit the 
production of neutralizing antibodies (reviewed by Marsden, 1987). 
Monoclonal antibodies specific for gB, gC, gD, gE and gH have been 
reported to have neutralizing activity (Pereira et al., 1980; 
Balachandran et al., 1982; Holland et al., 1983) and have been shown 
to confer possible protection on laboratory animals against a 
potentially lethal dose of HSV (Marsden, 1987).
HSV encoded glycoproteins also appear to be involved in cell 
mediated immunity. Passive protection conferred by the non­
neutralizing antibodies to gB, gC, gD, and gE against a lethal HSV 
challenge indicates that these glycoproteins act as targets for 
antibody—dependent cell—mediated cytotoxicity (Balachandran et al., 
1982; Schrier et al., 1983). Rector et al (1984) demonstrated that 
antigB and gD antibodies which did not recognise cell-free virus were 
able to confer passive protection in mice against a lethal challenge 
dose of HSV, again demonstrating the role of HSV glycoproteins in
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induction of cell mediated immunity.
1.11. HERPES SIMPLEX VIRUS GENETICS
Hie genetics of HSV has for the most part be gun4. with 5 the 
isolation and characterization of virus mutants. These mutants enable 
individual genes to be identifi|fi and their functions analysed. 
Isolation of a wide variety of conditional lethal mutants such as 
temperature sensitive (ts), drug resistance and host range and other 
mutants such as deletion mutants and restriction enzyme site deletion 
mutants has, helped in our understanding of HSV gene functions. Hie 
various classes of HSV mutants isolated and analysed are summarised in 
this section.
1.113. Temperature sensitive (ts) mutants
Temperature sensitive mutants are generally produced by missense 
mutations, which alter the nucleotide sequence of the wild type virus 
in such a way that the resulting protein is uni able to assume or 
maintain its correct functional configuration at the non-permissive 
temperature (NPT). Because of the very low level of spontaneous ts 
mutations in wild-type virus stocks, most ts mutants of HSV have been 
obtained by artificially induced mutagenesis with a variety of agents 
like bromodeoxy "uridine, nitrous acid, hydroxylamine, nitrosoguanidine 
or UV light (Schaffer et al., 1970; Timbury, 1971; Schaffer et al., 
1973; Brown et al., 1973; Manservigi, 1974; Esparza et al., 1974). 
Although, theoretically, ts mutations can be introduced into any gene, 
the screening procedure results in the selection of ts mutants with
defects in essential genes only.
Complementation analysis and marker rescue of ts mutants with 
purified dna fragments has identified and mapped more than 35 genes 
(Schaffer et al., 1978; Stow et al., 1978; Stow and Wilkie, 1978).
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Interestingly, no ts mutants have so far been reported in the Ug 
region of the genome. Characterization of ts mutants of HSV has helped 
the understanding of molecular events involved in various stages of 
the virus replication cycle such as penetration (Sarmiento et al., 
1979; Little et al., 1981; Addison et al., 1984), uncoating (Batterson 
et al., 1983), regulation of virus gene expression (Preston, 1979b; 
Sacks et al., 1985) and DNA encapsidation (Preston et al., 1983). 
Grouping of various ts mutants of HSV into different complementation 
groups and their recombination analyses has led to construction of 
linkage maps (Brown et al., 1973; Brown and Ritchie, 1975a,b; Schaffer 
et al., 1974; Timbury and Calder, 1976).
l.ll.b. Drug resistant mutants
Use of antiviral drugs such as 5-bromo-2-deoxyuridine (BUDR) -~
 ^ . ' has resulted in production of mutants
of HSV and indirectly the identification of virus genes conferring
resistance to these drugs.
Virus growth in the presence of the thymidine analogues BUDR (Kit
and Dubbs, 1963; Dubbs and Kit, 1964) or the deoxycytidine analogue,
5-bromo-2'-deoxvcvtidine (BCDR) (Brown and Jamieson, 1977; Stow et 
in tk- cells
al., 1978)£gives rise to thymidine kinase negative (tk“) mutants which 
utilise the de novo pathway of thymidine synthesis and thus avoid the 
incorporation of lethal quantities of nucleoside analogues into the 
virus DNA. Mutants resistant to acycloguanosine (ACG or Acyclovir) 
have been reported (Field et al., 1980). These mutants are generally 
tk”, but tk+ ACG-resistant virus specifying a DNA polymerase which
CL
fails to recognise the phosphorylated form of ACG fcjve been isolated 
(Elion et al., 1977; Crumpacker et al., 1980; Darby et al., 1981; 
Larder and Darby, 1985). Mutations in the HSV DNA-polymerase gene also 
confer resistance to ACG (Schnipper and Crumpacker, 1980; Coen and
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Schafer, 1980).
The drug, phosphonoacetic acid, directly interacts with the 
phosphate binding site on the DNA polymerase (Leinbach et al., 1976) 
and has been shown to inhibit not only in vivo replication of HSV but 
also its activity in vitro (Mao et al., 1975). Mutants of both HSV-1 
and HSV-2 showing resistance to PAA have been isolated (Hay and Subak- 
Sharpe, 1976; Purifoy and Powell, 1901; Lee et al., 1978).
1.11.C. Host range mutants
Two host range mutants of HSV which are able to grow in some cell 
lines but not in others, have been documented. (1) A mutant of HSV-1 
strain MP able to grow: in non-permissive dog kidney cells after 
several weeks of continuous propagation of wild-type virus (Roizman 
and Aurelian, 1965) has been shown to have overcome a block at the 
nucleocapsid envelopment stage of virus morphogenesis observed in 
infection with the wild-type virus (Spring et al., 1968). (2) A ts
Idhtch
host range mutant of HSV-2,/in contrast to the parental virus, fails 
to replicate in hamster embryo fibroblasts and mouse fibroblasts cells 
at 39°C, has been reported (Komet and Rapp, 1975a,b). The growth of 
the ts host range mutant Jji vivo corresponded with its in vitro growth 
properties, as the mutant was virulent in mice but attenuated in 
hamsters.
Recently a number of cell lines which carry stably integrated HSV
oL
genes such as the IE-3 gene (Davijson and Stow, 1985; DeLuca et al.,
1985) and the IE-1 gene (Stow and Stow, 1986) have been constructed.
In contrast to their parent cell lines, these biochemically 
transformed cell lines, because of induction of the resident wild-type 
gene, allow the propagation of mutant virus having a deletion in that 
gene. Analysis of such host range mutants helps in the study of virus 
induced polypeptide functions and their essentiality in the virus
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replicative cycle.
1.11.d. Plaque morphology mutants
In contrast to the individual cell rounding (syn+ plaques) 
normally associated with the cytopathic effect of HSV, variants have 
been isolated which produce cell fusion or syncytia (syn plaques) 
formation (Roizman, 1962; Ejercito et al., 1968; Brown et al., 1973; 
Timbury et al., 1974). Hie plaque morphology phenotype has been used 
as an unselected marker in three-factor reciprocal genetic crosses 
(Brown et al., 1973). Formation of heteroduplex molecules during 
genetic recombination has been speculated to generate mixed plaques 
containing both syn and syn+ morphologies (Brown and Ritchie,
1975a,b). In doubly infected cells, the syn+ allele is dominant, but 
as the plaque grows, syn+ and syn segregate and form sectors (Keller, 
1976). Eight different loci involved in syncytium formation have been 
mapped on the HSV genome (reviewed by Marsden, 1987).
1.11.e. Immune cytolysis-resistant mutants
Hie immune cytolysis-resistant mutants of HSV are characterized
mutant
by their ability to render^virus-infected cells resistant to 
complement-mediated immune cytolysis with antisera directed against 
virus specific glycoproteins, due to altered synthesis, processing or 
incorporation of glycoproteins into infected cell membranes (Machtiger 
et al., 1980; Glorioso et al., 1980; Pancake et al., 1983).
Similarly monoclonal antibody-resistant (mar) mutants possess
mutations affecting the antigenic sites of glycoproteins exposed on
these
the virion envelope, and hence are resistant to^monoclonal antibodies 
plus complement (Holland et al., 1983).
1.11.f. Restriction endonuclease site deletion mutants 
Mutants of both HSV-1 and HSV-2 deleted in Xbal restriction
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endonuclease sites have been isolated (Brown et al., 1984; Harland and 
Brown, 1985; MacLean and Brown, 1987a; Harland and Brown, 1988). These 
mutants have been shown to exhibit normal growth characteristics in 
tissue culture and have been used in super-infection experiments to 
rescue viral DNA information from latently infected cultures (Cook and 
Brown, 1987). Hie mutants will be useful in the analysis of the 
mechanisms and kinetics of HSV recombination. The use of restriction 
endonuclease sites as unselectable markers in conjunction with 
selected ts markers to study both intertypic and intratypic 
recombination in HSV will elucidate the role in recombination of 
parental and progeny molecules and genome homology.
Hie restriction site deletion mutants by virtue of their 
structure allow the possibility of introducing new restriction sites 
at desired positions for use as eukaryotic vectors or as recipients 
for mutagenized cloned viral fragments.
l.ll.g. Deletion mutants
Although ts mutants have been useful in determining essential HSV 
genes, they have a number of drawbacks. Firstly, ts mutants are only 
isolated in essential genes; secondly, the leakiness or reversion of 
the ts mutation to the parental phenotype makes their analyses more 
difficult. Hiese problems have been overcome by the use of deletion 
mutants sometimes in conjunction with complementing cell lines.
Removal of the entire or a large part of the open reading frame 
of a gene in deletion mutants will unambiguously determine its 
essentiality and no reversion is possible. Deletion variants which 
arose spontaneously or by deliberate construction have determined 
several non-essential genes jLn vitro including IE-1 (Stow and Stow, 
1986; Sacks and Schaffer, 1987); two genes at the right of UL, UL55 
and UL56 encoding for polypeptides of 20K and 22K respectively (Perry
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et al., 1986; MacLean and Brown, 198^b); tk (Sanders et al., 1982) and 
all the genes located in Us except US6 which codes for gD (Longnecker 
and Foizman, 1986; Umene, 1986; Brown and Harland, 1987; Longnecker et 
al., 1987; Weber et_al., 1987).
l.ll.h. Complementation in HSV
Complementation is a non-genetic interaction between the products 
of the different genomes in cells simultaneously infected with two 
mutants. On the basis of complementation tests most ts mutants of HSV 
have been assigned to different cistrons (Timbury, 1971; Brown et al., 
1973; Crombie, 1975; Schaffer et al., 1978). Two types of complementa­
tion namely intergenic and intragenic have been reported. In inter- 
genic complementation, mutants with defects in different genes are, at 
the restrictive temperature, able to supply the functional product 
required by the other mutant while in intragenic complementation the 
function of the defective gene may be restored, at least in part, by 
the formation of a hybrid protein containing two defective products
from mutants which have the mutation at different sites in the same
a _
gene. This type of complementation has been observed between tk
A.
mutants of HSV-1 where it was detected biochemically (Jamieson and 
Subak-Sharpe, 1978).
Of the two main quantitative complementation tests namely the 
progeny yield test and the infectious center test (Brown et al., 1973; 
Messer, 1978) the former is generally considered more reliable since 
fewer recombinant viruses are generated. Complementation indices more 
than 2 or 4 are considered positive which means that the mutants under 
test lie in different genes (Timbury, 1971; Brown et al., 1973).
Intertypic complementation between HSV-1 and HSV-2 has also been 
demonstrated (Timbury and Subak-Sharpe, 1973).
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l.ll.i. Recombination HSV
Using lesion morphology on chorio-allantoic membranes and 
virulence of progeny virus in mice as indicators, recombination in HSV 
was first demonstrated by Wildy (1955). Recombination in HSV was later 
confirmed by Subak-Sharpe (1969) by detecting ts+ recombinants among 
the progeny of crosses between pairs of ts mutants. Genetic linkage 
maps based on the analysis of recombination frequencies between ts 
mutants, were constructed for HSV-1 (Brown et al., 1973; Schaffer et 
al., 1974) and HSV-2 (Benyesh-Melnick et al., 1974; Timbury and 
Calder, 1976). These investigators observed that efficient 
recombination occurred between mutants which complemented well whereas 
mutants in the same complementation group either failed to recombine 
or recombined poorly. Mostly recombination analysis involved two 
factor crosses whereas Brown et al (1973) and to a limited extent 
Timbury and Calder (1976) by incorporating a plaque morphology marker, 
were able to use reciprocal three factor crosses. The linkage maps 
have generally been correct in the orders of ts lesions but the 
genetic distance between the markers did not accord with their 
physical map locations possibly due to multiple cross-overs between 
distant markers (Stow et al., 1978; Wilkie et al., 1978). The close 
correlation between the genetic and physical maps was observed but the 
case of HSV-2 strain HG52 (Timbury and Calder, 1976; Wilkie et al.,
1978), was an exception to this observation.
Intertypic recombination has also been observed between HSV-1 and 
HSV-2 as evidenced by isolation of ts+ virus from crosses of ts 
mutants of HSV-1 and HSV-2 (Timbury and Subak-Sharpe, 1973; Esparza et 
al., 1974). Such recombinants contain DNA sequences derived from both 
parental viruses and specify both HSV-1 and HSV-2 polypeptides and 
antigens (Halliburton et al., 1977; Wilkie et al., 1977; Morse et al.,
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1977, 1978; Preston et al., 1978; Marsden et al., 1978). Intertypic 
recombinants have been invaluable in mapping virus genes encoding 
specific polypeptides but of little use in understanding recombination 
in HSV per se.
Site specific recombination has also been observed in HSV. The 
sequences within the 'a' sequence promote recombination that results 
in inversion of the and Ug components of the genome leading to the 
generation of four isomers in equal proportions. Evidence for this has 
come from the studies indicating that (1) insertion of an additional 
'a* sequence into the tk gene results in novel rearrangements of the 
genome, consistent with inversion of any genome segment bounded by 
inverted copies of the 'a' sequence (Chou and Poizman, 1985; Mocarski 
et al., 1980; Mocarski and Roizman, 1981, 1982a). (2) deletion of 
sequences containing the *a' sequence from the junction between the L 
and S components prevents inversion of the L and S components 
(Poffenberger et al., 1983). The functional significance of inversions 
in the HSV genome is yet obscure.
Sequences present in the BamHI fragment _1 (0.706 to 0.744 m.u.) 
have also been shown to cause inversions (Fogue-Geile et al., 1985) in 
that insertion of a second copy of these sequences in an inverted 
orientation into the tk gene results in inversion of unique sequences 
bounded by these inverted repeats due to recombination between copies 
of the BamHI 1_ sequences. This recombination event was later on found 
to be intramolecular since the genetic marker (syn"1 or syn"1+) 
originally present in one copy of BamHI _1 appeared in progeny at both 
normal and inserted loci at a high frequency (Pogue-Geile and Spear,
1986).
The mechanism of recombination in HSV is yet relatively poorly 
understood. Very little, if at all, is known about the virus factors 
such as genome sequences (hot spots) involved in recombination and
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what role, if any, the different genomic isomers play in recombination 
(Honess et al., 1980). It is also unclear whether recombination 
involes both progeny and parental molecules. The role played by host 
factors, if any, is also far from clear (Das Gupta and Summers, 1980).
Intratypic recombination between two strains of HSV-1 using 
restriction enzyme sites as unselected markers, has indicated that no 
area of the virus genome has an excess of recombination from the 
overall recombination frequency of 0.007 per Kbp (Umene, 1985). Honess 
et al (1980) while studying recombination between pairs of selected 
and unselected markers in two different strains observed two-factor 
recombination frequency of 2 to 40% and no satisfactory correlation 
with distance between the markers was found. In this case a lack of 
homology in different areas of the genome or incompatibility of gene 
products from different strains may have influenced the recombination 
process.
Occurrence of four isomeric forms of the HSV genome complicates 
the analysis of recombination. Although analysis of recombinants 
involving markers within Ug or UL is not affected, the analysis of 
recombinants between markers located in the two different segmens of 
the genome is complicated by the genome isomerization. Honess et al 
(1980) while investigating recombination between structural and 
regulatory genes of HSV-1, using a variety of markers of known 
physical map locations in addition to ts mutations suggested a 
circular recombination map. This could be explained by involvement of 
either all the 4 isomers, or recombination between 2 circular 
molecules formed following infection (Davison and Wilkie, 1983a; 
Poffenberger et al., 1983; Poffenberger and Roizman, 1985) or between 
the long concatamers of head—to-tail molecules formed during 
replication (Jacob et al., 1979). Taken together these reports
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indicate that more than one isomer and probably either circular or 
concatameric molecules are involved in recombination.
It is not yet resolved whether both progeny and parental 
molecules take part in recombination. Ritchie et al (1977) 
demonstrated that recombination in HSV increases with time, indicating 
that both parental and progeny molecules are involved. The evidence 
for this was obtained from two and three factor crosses with ts 
mutants and syncytial plaque morphology (syn) mutants of HSV. Under 
the conditions of a standard genetic cross until about 20 hr post 
infection about 5% of plaques were of a mixed syn/syri4' morphology. 
These mixed morphology plaques remained constant and did not increase 
with time unlike the proportion of ts+ recombinants. However, in the 
presence of 5-fluorodeoxyuridine, an inhibitor of DNA synthesis, a 
several fold increase in the frequency of recombinants and mixed 
morphology plaques was observed. These observations are in contrast to 
those in PRV in which only parental molecules were shown to be 
involved in recombination (Ben-Porat et al., 1982). Recombination 
studies with restriction site deletion mutants of HSV (Brown et al., 
1984; Harland and Brown, 1985; MacLean and Brown, 198^ will allow not 
only investigation of the role of parental and progeny molecules in 
recombination but also the contribution of specific viral factors such 
as specific DNA sequences/genes.
1.12. MORPHOLOGICAL TRANSFORMATION BY HERPES SIMPLEX VIRUS
Transformation of cultured cells by HSV was first reported by 
Duff and Rapp (1971) using UV-inactivated HSV-2 to morphologically 
transform mouse 3T3 cells. Subsequently specific fragments of HSV-1 
and HSV-2 DNA were shown to induce morphological transformation of 
rodent cells in culture (Camacho and Spear, 1978; Reyes et al., 1979; 
Galloway and McDougall, 1981; reviewed by Macnab, 1987). An unexpected
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outcome of this work was the finding that most of the viral ENA was 
lost from the transformed cells (Galloway and McDougall, 1983).
Skinner (1976) suggested a 'hit and run' mechanism to describe this 
type of transformation in which there was no continuous expression of 
virus DNA. Later on this was shown to be due to successive loss of HSV 
DNA sequences on passage of transformed cells (Minson et al., 1976).
Three diffeent regions of HSV DNA have been implicated in 
morphological transformation of cultured cells, i) MTRI (morphological 
transformation region of HSV-1 (Camacho and Spear, 1978) maps in Xbal 
f (0.29 to 0.45 m.u.) and Bglll ^  (0.311 to 0.415 m.u.) (Reyes et al.,
1979). ii) MTRI I is the morphological transformation region of HSV-2 
which maps in Bglll n (0.58 to 0.62 m.u.) (Reyes et al., 1979; Macnab 
and McDougall, 1980; Galloway and McDougall, 1981; Cameron et al.,
1985); iii) MTR III or second region of HSV-2 (Pejflen et al., 1982) 
maps in HSV-2 Bglll c (0.54 to 0.58 m.u.) (Jariwalla et al., 1983).
A small stem/loop structure of 737 bp in HSV-2 Bglll n was 
proposed to induce morphological transformation (Galloway et al.,
1984). This subfragment is not large enough to encode a transforming 
protein and lies completely outside the coding sequences of both the 
large and small units of the ribonucleotide reductase gene. Hie 
transforming ability of the sub-fragment has been attributed to its 
apparent potential to adopt a stem/loop structure like that of 
insertion-like sequences and may cause activation of cellular genes 
through enhancer-like activity (Galloway et al., 1984). HSV-1 lacks a 
similar structure in the corresponding region of the genome.
Similarly Jariwalla et al (1986) suggested that the Bgl II c 
fragment of HSV-2 contains two independent transforming and 
immortalizing functions. Hie tansforming function was mapped to a 480 
bp subfragment which was subsequently sequenced (Jones et al., 1986). 
Hie sequences within this subfragment are considered to adopt a
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stem/loop structure and may be involved in activation of cellular 
genes. No DNA sequences of more than 500 bp from the corresponding 
region of HSV-1 are consistently retained in transformed cells 
(Cameron et al., 1985). Hie insertion like sequences reported by 
Galloway et al (1984) have frequently been found in other regions of 
HSV DNA; proof of a biological function therefore, for these is 
required (reviewed by Macnab, 1987).
The precise mechanism of transformation by HSV is still unclear 
but two observations whereby specific fragments of HSV could transform 
cells in culture, are as follows:
1. Mutagenesis: Infection with inactivated HSV-1 was mutagenic for the 
hypoxanthine-guanine phosphor ibosyl transferase (HGPRT) gene of HSV 
replication permissive human rhabdosarcoma cells (Schleh^er and zur 
Hausen, 1982). Similarly, infection with HSV-2 in non-permissive XC 
cells increases the natural mutation frequency of the cellular HGPRT 
gene by up to 10 times (Pilon et ^ ., 1985). Such mutagenic activity 
may be an important role of HSV in oncogenesis but the molecular 
mechanisms deserve further investigation.
2. Gene amplification: Infection of some SV-40 transformed hamster 
cells with HSV-1 induces amplification of SV40 DNA in these cells 
(Schlehofer et al., 1983) and is dependent upon the presence of a 
functional HSV-1 DNA polymerse (Ma^tz et al., 1984). Infection with 
HSV-1 or HSV-2 also causes upregulation of some cellular polypeptides, 
some of which accumulate to higher levels in transformed cells than in 
controls (Macnab et al., 1985; r - ' " • reviewed by
Macnab, 1987).
However, the fragments of HSV-1 and HSV-2 DNA shown to transform 
cells are not homologous (Reyes et al., 1979) and do not contain the
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gene for DNA polymerase. The mechanism by which these small pieces of 
DNA carry out transformation, either by their ability to mutagenise 
cells, to amplify cellular DNA sequences or by upregulating host cell 
proteins, is yet to be deteimined.
1.13. HERPES SIMPLEX VIRUS AND CERVICAL CARCINOMA
Itie association between HSV-2 and cancer of the cervix has long 
been speculated upon (Naib et al., 1966; Nahmias et al., 1969). The 
basis of these observations had been the presence of high titers of 
antibodies to HSV-2 in patients with an increased risk of developing 
cervical carcinoma. HSV-2 DNA has been detected at least once in a 
cervical carcinoma biopsy (Frenkel et al., 1972). Besides the presence
of HSV-2 DNA in preneoplastic lesions and carcinomas (McDougall et
Park et at 19 80,
al., 1980, 1982;  ^Egiin et al., 1981); the causal relationship between 
the presence of viral RNA in biopsies and the severity of disease has 
not been established (Maitland et al., 1981). It is very likely that 
more than one factor is involved in the development of cervical 
cancer. Several types of human papilloma viruses have been detected in
cervical carcinomas (Durst et al., 1983). It is probable that HSV-2
co
may be a cofactor (jbarcinogen) in causation of cervical carcinoma by 
other infectious agents (Vonka et al., 1984).
1.14. HERPES SIMPLEX VIRUS LATENCY
Unlike many other human viruses which are eliminated by host- 
mediated defence mechanisms soon after primary infection, HSV-1 and 
HSV-2 have evolved a complex strategy of replication and survival 
wherby they persist in a latent state within the host for extended 
periods of time and avoid immune clearance. The complex and little 
understood mechanisms underlying establishment, maintenance and 
control of HSV latency have been the subject of many reviews
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(Kirchner, 1982; Wildy et al., 1982; Blyth and Hill, 1984; Hill,
1985). In spite of elegant advances in molecular virology made in 
recent years, our definition of HSV latency still remains an 
operational one i.e. infectious virus can not be recovered from 
latently infected ganglia or peripheral tissues following 
homogenisation. However, recovery of infectious virus can be made 
following explantation or co-cultivation of the tissues which harbour 
latent virus (Wildy et al., 1982).
In the present chapter an attempt has been made to provide a 
brief over-view of recent developments underlying the establishment, 
maintenance and control of HSV latency with reference to its molecular 
biology. Much of the information on latency has been derived from 
studies in experimental animals and where available corresponding 
information from the human disease is incorporated. Infection with 
HSV-1 is not considered separately from that with HSV-2. Information 
from human studies and from animal models is included in the first 
section whereas that from in vitro models of latency is in the second 
section of this chapter.
Section I
1.14.a. SITES OF LATENCY
1.14.a.I. Neural sites
(i) Peripheral nervous system (P.N.S.)
The role of the peripheral nervous system in harboring latent HSV 
was first postulated by Goodpasture (1929) in observations of the 
pathogenesis of ocular HSV infections in rabbits. In human patients 
undergoing surgery of the trigeminal tract, Carton and Kilbourne 
(1952) observed that 2 to 4 days after section of the root of the 
fifth cranial nerve, oral or facial herpetic lesions (but not 
ophthalmic) occurred in about 90% of individuals provided that the
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ganglion was not destroyed. These observations of Carton and Kilbourne 
(1952) were interpreted as indicating that virus was latent in the 
trigeminal ganglion and reactivation of latent virus in the skin was 
caused by the surgery.
Experimental evidence that HSV can indeed establish a long-term 
'silent-infection' in neurones began to appear in the 1970s when 
Plummer et al (1970) demonstrated that 9 to 11 months after the 
intramuscular injection of HSV-2 into rabbits, virus could be 
recovered from their central nervous system (brain) and sensory 
ganglia by inoculation of trypsinized suspensions of these neural 
tissues onto cell monolayers. Such observations were confirmed and 
much extended in mice (Stevens and Cook, 1971) and rabbits (Stevens et 
al., 1972) where recovery of the latent virus was achieved 7 to 14 
days after cultivation of sensory ganglia proximal to the site of 
inoculation, explanted 4 months after the primary infection.
Using explantation methods, HSV was isolated from 9 to 86% of
human trigeminal ganglia taken at post-mortem (Bastian et al., 1972;
Baringer and Swoveland, 1973; Rodda et al., 1973^  Plummer et al.,. 1973; 
■etgfj
Warrery, 1977). Lumbosacral ganglia have been shown to have latent 
HSV-2 infections in mice (Walz et al., 1977), monkeys (Reeves et al., 
1976) and humans (Baringer, 1974) who had previously recovered from 
experimental or natural HSV-2 vaginal infections.
Cook and Stevens (1976) rigorously tested many tissues of mice 
that had been intravenously injected with herpes simplex virus and 
could only get reactivating virus from sensory ganglia, brain tissues 
and adrenal glands. Nesburn et al., (1972) made similar observations 
in rabbits. Puga et al., (197^ ) using Sa^ ut.Con hybridization 
techniques detected HSV specific nucleotide sequences in sensory 
ganglia from a large number of latently infected mice.
In addition to the sensory ganglia, latent virus has been
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reactivated from the autonomic nerve ganglia of humans. Warrren et 
al., (1978) recovered latent virus from vagus ganglion (part of the 
autonomic nervous system) explants of humans. Autonomic ganglia of 
mice (Price et al., 1975; Price and Schmitz, 1978; ’ j.-.- ,
1980) and rabbits (Martin et al., 1977) have also been shown to 
harbour latent HSV infections.
Within ganglia the neuronal body has been presumed to harbour 
latent HSV. The evidence for this presumption came from studies in 
mice and rabbits in which virus was regularly reactivable from ganglia 
(which contains neuronal bodies) and never from nerve roots which do 
not contain nerve bodies (Baringer and Swoveland, 1973; Cook et al., 
1974). Cook et al., (1974) while following the time course of 
reactivation of virus from ganglia from latently infected mice i. 
implanted in millipore chambers found^  that virus antigen as detected 
by immunofluorescence, virus particles as detected by electron 
microscopy and thymidine incorporation into the virus DNA as detected 
by autoradiography, all commenced in neurones before being detectable 
in satellite cells, thus indicating that neuronal cell bodies harbor 
latent virus. The fact that neuronal cell bodies harbor latent virus, 
was unambiguously revealed by studies in mice with a ts mutant of HSV 
(McLennan and Darby, 1980). Some weeks after the primary infection 
explanted ganglia were incubated at either the permissive temperature . 
(PT) or non-permissive temperature (NPT). Reactivation was regularly 
observed at the PT but at the NPT only the development of viral 
antigen as detected by immunofluorescence was observed in single 
neurones. Confirmation of this observation was also achieved by 
reactivation in vivo after nerve section.
(ii) Central nervous system (CNS)
Studies in experimental animals have revealed that HSV can be
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latent in brain tissues. Cook and Stevens (1976) reported the 
isolation of virus from brain explants of latently infected mice in 
which virus had been administered intravenously. Similarly recovery of 
latent virus has been reported from co-cultivation of tissue explants 
from the CNS of latently infected rabbits (Plummer et al., 1970) and 
guinea-pigs (Tenser and Hsiung, 1977). Openshaw (1983) demonstrated 
recovery of the virus from tissue explants of retinas of mice that had
survived the acute corneal infection. Embryologically and
*
anatomically, the retina forms a part of the CNS.
Fraser et al (1981) using DNA-DNA hybridization techniques
detected virus specific DNA in 7 of 11 human brains and in most cases
complete virus genomes were present. Recently EfstaTthiou et al (1986)
have confirmed the findings of Fraser et al (1981) by demonstrating
virus specific ENA hybridization in cjjs andj'fi of latently 
* infected mice. "
Similarly Cabrera et al (1980) demonstrated DNA homologous to viral
DNA in the brains of 30% of mice in which the incidence of latent
infection by the explantation method in the brain was 5% and in the
trigeminal ganglia 95%. It was argued that the apparently low level of
incidence of latency on explantation of brain tissue may be due to
difficulties in demonstrating its presence by the usual explantation
techniques.
1.14.a.II. Extra neural sites
(i) Skin
Peripheral tissues such as skin which exhibit recurrent herpes 
lesions have long been suspected as sites of latent infection (Carton 
and Kilbourne, 1952; Carton, 1953) but attempts to culture virus from 
explants of human skin from areas prone to develop HSV lesions have 
been unsuccessful (Smith and McLaren, 1977). However, studies on the 
pathogenesis of HSV in experimental animals have indicated that the
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virus can be latent in the skin. Sc riba (1981) has shown that HSV-2 
could be isolated from foot pad explants of the majority of latently 
infected guinea pigs in the absence of clinical lesions and any nerve 
supply from the lumbosacral ganglia. In guinea pigs infected with HSV- 
1, virus was found to persist almost entirely in the skin tissue i.e. 
at the site of inoculation, with little or no latent infection in the 
lumbosacral ganglia (Scriba, 1977; Scriba and Tatzpr, 1981).
^  _ ,i  -• fsvidence that HSV can establish a latent infection of skin 
has come from studies by Al Saadi et al (1983) in which mice were 
injected in the foot pad with HSV-2 strain HG52 and various of its ts 
mutants. Uiree months after primary infection, mice foot pads (site of 
inoculation of virus) and lumbosacral ganglia were explanted and 
infectious virus was recovered from both (skin and ganglia) several 
days after explantation. No infectious virus was detected in the cell 
free homogenates of ganglia or foot pad immediately after 
explantation.
It is not yet certain which cell types in skin harbor latent 
virus. In limited studies on foot pads of latently infected mice, 
viral KNA, has been demonstrated by in situ hybridization in the cells 
lying at the base of the hair follicles as early as 3 days after 
explantation (Clements ,G.B.; personal communication). However, the 
precise cell type harboring the viral RNA has not been identified.
(ii) Cornea
Besides skin, latent virus has also been recovered from the 
corneal explants of latently infected rabbits (Cook et al. 1987 and 
this thesis) simulating the findings of latent virus in human corneal 
explants removed during the course of treatment for chronic stromal 
keratitis (Shimeld et al., 1982; Tullo et al., 1985; Easty et al., 
1987).
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Cook and Brown (1986, 1987) have shown that in vitro cultures of 
the 3 corneal cell types i.e. epithelial cells, keratocytes and 
endothelial cells of rabbits support latent infection with HSV induced 
by high temperature (42°C). The recovery of virus at 37°C from the 
three cell types cultured in the presence of the virus inhibitor 
acycloguanosine at 42°C demonstrated that corneal cells can support 
HSV latency and not merely virus persistence.
1.14.b. ESTABLISHMENT OF A LATENT INFECTION WITH HERPES SIMPLEX VIRUS
(i) Definition
/
Functionally, the latent phase of HSV infections is established 
when infectious virus can only be isolated from explant cultures but 
not from cell free homogenates of tissues or organs. Before coming to 
this final phase in the process, there are other important and 
distinct but interrelated phases, namely growth of virus in the 
peripheral tissues such as skin, transport of virus to the ganglion 
and acute infection of the ganglion which need to be mentioned.
(ii) Virus replication during primary infection
The first stage of peripheral infection with HSV in mice involves 
replication of virus at the site of inoculation (Hill et al., 1975) 
which results in characteristic lesions (Klein, 1985).
Ebllowing inoculation of virus in the ear (Hill et al., 1975) or 
footpad (Stevens and Cook, 1971), virus titers reach a peak in 3 to 4 
days and by 14 days virus is no longer detectable from the cell free 
homogenates of infected skin. Kristensson et al (1971) and Cook and 
Stevens (1973) demonstrated that infectious virus can be isolated from 
the ganglia 2 days after infction of the skin or cornea even with 
relatively small doses (104 to 105 pfu) of virus. Studies of Field and 
Hill (1974) with PRV which has a similar pattern of pathology to HSV
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in mice, have shown that replication of virus in the peripheral 
tissues is not an absolute necessity for latent infection of the 
nervous tissue, since with large inocula of PRV, virus was found in 
the ganglia as early as 17 hr after inoculation into the skin. However 
in HSV symptomatic primary disease has been shown to result in rapid 
and widespread latent infection of the CNS (Harbor et al., 1981).
(iii) Acute ganglionic infection
FoUpswing peripheral inoculation of mice, HSV can be 
demonstrated in spinal ganglia within 20 to 24 hr post infection. The 
amount of infectious virus that can be detected in the corresponding 
ganglia increases for the first 4 to 7 days post infection and then 
subsequently declines. The increase in amount of virus in the ganglia 
leads to the assumption that a productive neuronal infection occurs 
during the acute phase (Cook and Stevens, 1973). The topical 
application of 2% phosphonoacetic acid at the inoculation site has 
been shown to suppress virus multiplication at the site of inoculation 
with subsequent drop of virus titer in corresponding ganglia (Klein 
and Destefano, 1981), thus indicating that local antiviral treatment 
could reduce the viral titer in ganglia by halting continuous virus 
supply from the site of primary infection. However, the possibility 
that productive virus infection may occur to a limited extent has not 
been totally excluded. On the other hand good evidence has indicated 
that a productive infection is not necessary for the establishment of 
latent infection in the neurones of ganglia. Using HSV-1 ts mutants, 
Lofgren et al (1977) showed that there is no apparent relationship 
between the capacity of the mutants to induce encephalitis and the 
subsequent establishment of latent infection in brains of mice. 
Similarly, McLennan and Darby (1980) from their studies with ts 
mutants in mice concluded that there is no absolute requirement for a
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productive infection during establishment of latency in neurones. Al— 
Saadi et al (1983) were able to recover virus from the ganglionic 
explants and footpad skin of mice latently infected with ts mutants of 
HSV— 2, thus demonstrating that replication of virus was unnecessary 
for latent infection of ganglia as the core temperature (39°C) of the 
mouse is non-permissive for replication of ts mutants.
(iv) Virus pathways to the nervous system
The failure to detect HSV in the distal and proximal sections of
the sciatic nerve (during the first two days after infection) and the
fact that HSV is first detected in the ganglia and only afterwards in
the nerves (Wildy, 1967; Kristensson et al., 1971) suggested that an
alterative (haematogenous or lymphatic) route may be involved in the
dissemination of virus to the nervous system. Studies of Cook and
Stevens (1973) involving passive administration of anti-HSV sera in
mice, demonstrated that latent infection of the ganglia could be
established even in the presence of significant levels of neutralizing
antibodies, thus indicating that haematogenous or lymphatic routes are 
essential
not . L. --/ in spread of virus to the nervous system. Kristensson et 
al (1971, 1978) could not detect any virus in the blood of mice after 
subcutaneous inoculation of virus in the footpad, while in some other 
studies HSV was detected in the blood of new born mice following 
intranasal inoculation of virus (Kern et al., 1975). It is not known 
whether virus invades the nervous system subsequent to viraemia or 
whether viraemia is due to spill over from the peripheral nervous 
tissues. Direct evidence for the possible involvement of the 
circulatory system is the demonstration that HSV-1 selectively 
establishes latent infections in mouse neural tissues, particularly 
sensory ganglia, after intravenous inoculation. Hiis was shown 
conclusively when inoculation of virus in tail veins was immediately
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followed by tail amputation at 2.5 cm proximal to the infection site 
(Cook and Stevens, 197$,. However, it is possible that nervous tissue 
may not be infected directly by virus in the blood stream but 
indirectly by virus travelling in the nerves associated with vessels 
or other organs that became first infected through viraemia.
Wiidy (1967) showed that sciatic nerve sectioning three days 
prior to virus inoculation, prevents HSV spread to the spinal ganglia 
in 80% of mice. Moreover, Kristensson et al (1971) reported that 
colchicine treatment, ligature or freezing of sciatic nerve 0 to 4 
days before virus inoculation into the foot pad of mice reduced the 
mortality rate to 10% compared to 100% if the treatment was carried 
out after inoculation. In neither of the above reports were attempts 
made to recover the virus from ganglia. Scriba (1981) demonstrated 
that total surgical section of the sciatic and femoral nerves 
completely prevented the establishment of latent HSV infection in 
sensory ganglia of guinea pigs inoculated into the foot pad as 
detected by the explantation technique. Similar experiments in mocce 
(Klein, 1982) revealed that establishment of acute infection in spinal 
ganglia was prevented by section of both femoral and sciatic nerves in 
about 80% of mice. Free virus, however, was regularly demonstrated on 
the 4th and 7th day after infection in spinal ganglia of mice in which 
either the sciatic or femoral nerves were severed.
Further evidence supporting the axonal transport hypothesis has 
come from the Jn vitro study of attachment of HSV to rabbit astrocytic 
glia, neuronal perikarya and synaptosomal (nerve terminal) fractions 
(Vahlne et al., 1978). HSV preferentially adsorbs to the synaptosome 
fraction rather than neuronal perikarya. However it remains unclear 
whether this difference in virus attachment was due to the presence of 
specific HSV receptors on the synaptosomes or merely reflected a high 
endocytic activity of the synaptosomes.
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Another observation is the rate of HSV transloction from the skin 
to the ganglia which has been measured for HSV (Kristensson et al„ 
1978; Cook and Stevens, 1973) and for FRV (Field and Hill, 1974). In 
all cases rates obtained were in the range of 2 to 10 mm per hr which 
is consistent with the rates of movement of macromolecules and 
organelles by retrograde axonal transport (reviewed by Kristensson, 
1978).
Taken together it seems that axonal transport is the most 
important method of virus translocation but the virus may also travel 
by other routes. Irrespective of the way the virus travels to the 
nervous system, the subsequent result is the establishment of latent 
infections.
(v) Establishment per se
-* Following primary infection, the amount of detectable HSV in cell 
free ganglion homogenates decreases gradually, and by 14 days post 
infection, virus can no longer be detected. However, HSV can still be 
recovered by explantation or cocultivation of ganglia. At this point 
the acute phase is terminated and the latent phase of the infection 
begins (Openshaw et al., 1979^ Klein, 1982). The transition from the 
'acute' to the 'latent' phase of infection, coincides with the 
appearance of immune responses particularly high levels of antibodies. 
It has been proposed that immune factor (s) play a major role in the 
switch from the acute to the latent phase of infection (Openshaw et 
al., 1979a, 1981), though the mechanism by which these immune 
responses could produce transition from the acute to the latent state 
of infection is not clear. Openshaw et al (1981) have proposed some 
hypothetical models to explain the role of the immune response in 
modulation of HSV infection. These models are: (1) The immune 
modulation model which assumes that ganglion cells are permissive but 
the immune response to HSV modulates the infection at the level of the
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ganglion; converting a potentially lytic infection into the non-lytic 
or latent infection. (2) The immune elimination model; there are two 
populations of ganglionic cells: permissive and non-permissive. A 
productive HSV infection occurs in the permissive cells and a non- 
lytic or latent infection occurs in the non-permissive cells. The host 
immune response strictly has nothing to do with the establishment of 
latency, but just eliminates only acutely infected cells. (3) The 
third model assumes, that ganglion cells are ordinarily non-permissive 
for HSV replication, however they become permissive after receiving 
'signals' induced by inflammatory reactions in the skin due to virus 
replication. The host immune response then turns off these signals by 
decreasing virus replication in the skin, returning ganglion cells to 
the non-permissive state hence latency is established.
The above three models rely solely on immune mechanisms to 
account for the transition from the acute to the latent state of 
infection. Another model has been proposed by Klein (1982) which 
assumes that ganglion cells are non-permissive; colonization of the 
ganglia is achieved by continuous virus supply from the site of 
primary infection. Immune responses restrict virus replication in 
mucocutaneous tissue. It is suggested that the majority of virions in 
neurones are inactivated by cellular enzymes and only a minority will 
be in a latent form in cellular structures.
It must be emphasised, that the above models are merely 
hypothetical and there is no hard evidence to support them. Besides, 
the models do not consider the possible establishment of latent 
infection in tissues other than ganglion cells.
1.14.C. MAINTENANCE OF HERPES SIMPLEX VIRUS LATENCY
The factors involved in maintenance of HSV latency have not been 
fully identified.- Studies with immunized and nude mice showed that
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the immunological status of the host is one of the factors that 
controls the number of cells in ganglia that become infected (Walz et
CL
al, 1976). However, in vitro studies (Openshaw et al, 197^ ; Wohlenberg 
et al, 1979) have shown that neither antibodies or interferon 
treatment prevented reactivation. Sekizawa et al. (1980) was able to 
establish latent HSV infection in mice passively immunized with rabbit 
anti-HSV serum administration at various times post infection. A few 
months later, neutralizing antibody was undetectable in passively 
immunized mice which remained latently infected (ganglionic 
homogenates were negative but ganglionic explants yielded virus). 
Persistence of virus in the absence of neutralizing antibody suggests 
that once latency is established, serum neutralizing antibody does not 
appear to be required to maintain the latent state (Openshaw et al.,
1981). However, a role for non neutralizing antibodies has not been 
excluded (Nash, 1981).
Klein (1976) has proposed two mechanisms for the maintenance of 
latent infections with HSV. In both mechanisms namely "one-way" 
transmission and the "round-trip" transmission it is assumed that the 
neurone is destroyed and reactivation occurs in all latently 
infected neurones. The "one way" trip proposed that the number of 
latently infected neurones is fixed, and the virus is reactivated from 
the neurone, travels to the skin. However, the information for renewed 
recurrence is never lost from latently infected neurones. Hie "round- 
trip", mechanism proposes that infection of a new set of
neurones is possible. After reactivation, some virions escape the 
elimination process at the neural level, and travel to the skin where 
they producb lesions. Hie virus synthesised in the skin migrates 
towards the neurone and re-establishes a latent infection.
Recent studies of Gordon et al; (1987) counter argue the "round-
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FIGURE 19
Hie round trip of herpes simplex virus during the acute phase of 
infection. Details described in the text. Arrows indicate direction of 
spread of virus from skin to the ganglia and vice versa.
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trip' mechanism of maintenance of latency proposed by Klein (1976). 
Gordon et al; (1987) infected rabbits with a tk negative strain of 
HSV-1 in the eye and the phenotype of the emergent virus following 
iontophoresis of adrenalin was taken as a criterion to test the 
"round-trip" hypothesis. Repeated adrenalin induced ocular shedding of 
latent HSV-1 was observed in 100% of rabbits. It was observed that the 
tk positive isolates and syncytial variants of the tk negative 
inoculating strain recovered at the ocular surface after the initial 
iontophoresis could not be demonstrated following subsequent trials of 
iontophoresis, indicating a lack of the "round-trip" hypothesis of 
latency.
1.14.d. STATE OF THE VIRUS DURING A LATENT INFECTION
(i) Infectious virus
It is not known whether the virus on establishing a latent 
infection, exists in a static state or replicates at a very low level 
(dynamic) state (Roizman, 1965, 1 ). Baringer and Swoveland (1974)
by electron microscopy of serial sections of trigeminal ganglia from 
latently infected rabbits found a very small number of productively 
infected cells (presumably neurones), indicating a dynamic state of 
virus latency. However, in other studies treatment of latently 
infected rabbits and mice with various potent antiviral drugs did not 
decrease the incidence of ganglionic latency (Field et al,, 1979;
Klein et al., 1979; Field and DeClerc^ 1981; Svennerholm et al., 1981; 
Nesburn et al., 1983) indicating a non-dynamic or static state of 
latency, as such drugs only affect replicating virus.
(ii) The viral genome
Lonsdale et al, (1979) studied infected cell polypeptides and the 
DNA restriction profiles of 31 HSV-1 isolates from the trigeminal, 
superior cervical and vagus ganglia from 17 individuals. Analysis of
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the DNA restriction profiles indicated that virus isolates from the 
trigeminal, superior cervical and vagus ganglia of the same 
individual, or virus isolates from the left or right ganglia of the 
same individual or multiple isolates from different explants of a 
single ganglion were indistinguishable, indicating that only one 
strain of the virus is predominately latent in the ganglia of each 
individual. Studies of Centifanto et al; (1982) supported these 
findings in humans by demonstrating that initial infection of rabbit 
corneas with a less virulent HSV strain prevents subsequent ganglionic 
superinfection by a more virulent strain of HSV-1.
Hie recovery of infectious virus from explanted ganglia clearly 
indicates that the complete virus genome must be contained within the 
cells of the ganglia. However, Brown et al; (1979) and Lewis et al; 
(1984) have shown that by super infection with ts mutants of HSV, 
viral information could be rescued from explanted human ganglia that 
had spontaneously failed to yield infectious virus after a period of 
time in culture. Hi is indicated that some ganglia that are "latency 
negative" by the standard criteria contain non-inducible viral 
genomes. A low incidence (0.1 genome equivalents per cell) of viral 
DNA in latently infected mouse ganglia has been detected by .. y 
hybridization techniques (Puga et al., 1978; Cabrera et al., 1980;
Rock and Fraser, 1983).
The state of viral DNA in latently infected neurones is unknown. 
Southern blot hybridization of BamHI restriction enzyme digested DNA 
from latently infected mouse brain gave signals with HSV-1 cloned 
fragments from the joint region of the genome and not with the cloned 
termini, indicating that the virus DNA is present in an endless 
configuration (Itock and Fraser, 1983, 1985). The endless configuration 
of virus DNA has also been observed in latently infected human ganglia
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(Efstantiou et al., 1986). It is not clear whether the endless form of 
HSV DNA detected in latently infected cells is due to the integration 
of the viral genome into cellular DNA or its maintenance extrachromo- 
somally in a circular or concatameric form. However, in a recent 
limited study based on analysis of caesium chloride buoyant density 
gradient banding patterns of host and viral DNAs, HSV-1 specific DNA 
from latently as well as acutely infected mouse brains was found
to band at the buoyant density of virion ENA. These results indicated 
an extra chromosomal state of latent HSV-1 DNA in the mouse model 
(Mellerick and Fraser, 1987).
(iii) HSV transcription in latency
It is not conclusive whether HSV gene expression occurs during a 
latent infection. Initial attempts using liquid-phase hybridization 
techniques to detect viral transcripts in mouse ganglia either soon 
after the establishment of latency or at later times were unsuccessful 
(Puga et al., 1978). However, using in situ hybridization, limited 
transcription from the left hand end of the HSV genome has been 
detected in thoracic and lumbo-sacral ganglia of humans (Galloway et 
al., 1979, 1984), in trigeminal ganglia of latently infected guinea 
pigs (Tenser et al., 198I&) and lumbar ganglia of latently infected 
mice (Stroop et al., 1984). Hie presence of Vmw 175 in the ganglia of 
latently infected rabbits was demonstrated by immunofluorescence 
(Green et al., 1981). However, the presence of Vmw 175 in the ganglia 
of latently infected rabbits was thought to be due to reactivation of 
the latent virus.
The occurrence of the hypomethylated form of HSV-1 DNA in the CNS 
of latently infected mice suggests the transcriptionally active nature 
of the viral DNA (Dressier et al., 1987). A more interesting recent
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finding by jji situ hybridization and Northern blotting techniques is 
the identification in the spinal ganglia of mice latently infected 
with HSV-1 KOS-M, of transcripts co-mapping with the IE-1 gene 
region. The transcripts from the anticomplementary strand of the 
virus DNA (Puga and Notkins, 1987; Stevens et al., 1987) and the 
puiajtlve polypeptide is thought to play a role in the maintenance of 
the viral genome in a latent state in host neurones.
1.14.e. REACTIVATION OF HERPES SIMPLEX VIRUS FROM LATENCY
Reactivation as defined by Wildy et al (1982) is the reawakening 
of virus from the latent state either spontaneously or as a result of 
external stimuli, so that infectious virus may be isolated. Following 
reactivation, the released virus may produce observable lesions 
(recrudescent lesions) in the neurodermatome (Figure 20) related to 
the sensory ganglion, or alternatively the virus travels to the 
periphery (where it probably multiplies and can be isolated) without 
the development of a noticeable lesion, called recurrence (Wildly et 
al., 1982).
Various physical and chemical methods have been used to induce 
reactivation. Good and Campbell (1948) were able to reactivate HSV in 
rabbit brain (with subsequent development of encephalitis) by 
subjecting the latently infected rabbits to anaphylactic shock (by 
intravenous injection of 0.2 to 0.6 ml of egg white), or by the 
injection of synthetic adrenalin (Schmidt and Rasmussen, 1960) 
intramuscularly with a total dosage of 2.0 mg. Electrical stimulation 
of the trigeminal ganglion has been described as inducing jLn vivo 
reactivtion of HSV in tear films (Green et al., 1981). Epinephrine 
iontophoresis of the cornea has also been used to induce reactivation 
(Hill et al., 1981). Reactivation of HSV-1 (Sekizawa et al., 1980) and 
HSV-2 (Kurata et al., 1978) has been successfully demonstrated in mice
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FIGURE 20
Diagrammatic representation of relations of sensory neurones 
(Dorsal root ganglia) to other types of tissues. AaaP*feQ irom Al Saadi,1984
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(inoculated by lip or by the corneal route) by the use of cyclophos­
phamide. Reactivation has been shown to precipitate by burning with 
CO2 (Qgenshaw et al., 1979b), hair plucking (Hurd and Robinson, 1976), 
U.V. and x-ray treatment (Blyth et al., 1976? Openshaw et al., 1979b). 
Sectioning of the nerve has been shown to reactivate virus in the 
spinal ganglia of mice (Price and Schmitz, 1978; McLennan and Darby, 
1980; Klein, 1982). It is not known whether reactivation positive 
stimuli act directly on the latent virus or through mediator, or 
whether they only promote the development of recurrent lesions by 
virus already reactivated (Wildy et al., 1982).
Two theories have been proposed to explain the process of 
reactivation. (1) According to the first theory called the "Ganglion 
Trigger" theory (Hill and Blyth, 1976) (Figure 21a), a stimulus acts 
on the latent infection in the ganglion to "switch on" virus from the 
latent state. The virus then travels down to the peripheral nerve, and 
epidermal cells are infected so that a skin lesion develops (Cook and 
Stevens, 1973; Lehner et al., 1975). The theory is widely accepted, 
however, it does not explain (at least in man) the development of a 
lesion in a relatively short time after stimulation or injury, or how 
certain stimuli like exposure of surface skin in U.V. light can affect 
virus latent in the ganglion. Moreover, reactivation of virus in 
ganglia does not automatically produce recurrent disease (Hill and 
Blyth, 1976).
(2) "The Skin Trigger" theory (Hill and Blyth, 1976; Figure 21b) 
assumes that a reactivating stimulus acts on virus in the skin rather 
than in the ganglion. This postulates that virus is often produced in 
the ganglion and as a result reaches the skin cells via a nerve 
perhaps every few days, then microfoci of infection develop which are 
usually eliminated by host defence mechanisms; most of these 
infections may be abortive. Changes in the skin occasionally allow
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FIGURE 21
Diagrammatic representation of the (a) 'ganglion trigger' theory, 
(b) 'skin trigger theory' and (c) 'ganglion and skin trigger theory of 
virus reactivation during latency as proposed by Hill and Blyth (1976)
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these microfoci to grow into visible lesions either by stimulating 
virus replication or by temporary suppression of local defence (Hill 
and Blyth, 1976). The theory explains that inducing agents like U.V. 
light and trauma do not act directly upon latent virus in the 
ganglion, instead the stimuli induce some physiological changes 
(inflammation) in the skin which provoke the development of lesions. 
Among the local changes that may be induced in the skin after exposure 
to U.V. light is the release of prostaglandin (Eagljstein and 
Weinstein, 1975) particularly prostaglandin E2 (PGE2). PGE2 has been 
shown to reactivate latent virus in mice after 2 to 3 days of 
intradermal administration (Blyth et al., 1976) and to increase the 
size of the plaque but not the virus yield in Vero cells (Harbour et 
al., 1978) probably by enhancing the cell to cell spread of virus. 
However, the skin trigger theory fails to explain the mechanism of 
action of some inducing agents which do not act on skin e.g. stress, 
anxiety, depression, fatigue (Klein, 1982). A further possibility is 
that effective inducers of recurrent disease may produce changes both 
in the skin and ganglia (Figure 21c). This hypothesis was supported by 
the observation of Hill (1981) who demonstrated that infectious virus 
can be found in cervical ganglia of 10% of latently infected mice 1 to 
4 days after ear stripping with sellophane tape.
1.14.f. IMMUNOLOGY OF LATENT HERPES SIMPLEX VIRUS INFECTION
The precise role of the immune response in latent HSV infection 
is not known. Several elements of the immune system have been shown to 
be involved in the response to herpes infection including: macrophages 
(Zisman et al., 1970), cytotoxic T cells (Nash et al., 1980), natural 
killer cells (NK) (Ching and Lopez, 1979), suppressor T and suppressor 
B cells (Nash and Gell, 1980; Nash et al., 1981), interferon (Gresser 
et al., 1976), antibody and complement (Burns etal., 1975; Oldstone
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and Lampert, 1979). Humoral immunity alone, has been found of limited 
importance both in eliminating acute infection at least in nude mice 
(Openshaw et al., 1979a) and in maintaining latency (Sekizawa et al., 
1980). On the other hand cell-mediated immunity (CMI) has been shown 
as an important factor for host protection against herpes infection 
(Ixximell et al., 1973; Oakes, 1975; Rager-Zisman and Allison, 1976) 
and in recovery from HSV-1 infection in mice (Nagafuc&i et al., 1979).
The fact that T cells (a component of CMI) play a role in the 
maintenance of latency was demonstrated by Kastrukoff et al., 1981). 
They showed that in C3H mice where CMI is acutely suppressed (i.e. 
mice were thymectomized one month after infecting with HSV and later 
irradiated, then reconstituted with anti-Thy 1.2 hybridoma antibody 
plus complement treated bone-marrow, and subsequently given 
antilymphocyte serum) a severe illness developed and the virus was 
observed in trigeminal ganglia, lip and CNS at a time when anti HSV 
antibody was present. Control (uninfected) or chronically infected but 
sham treated mice remained well. However, some mice in the 
experimental group did recover, possibly due to the action of 
circulating antibody.
Wildy et al (1982), based on the analysis of the results in the 
mouse ear model (Nash and Gell, 1980; Nash et al., 1980, 1981), have 
proposed that three immune mechanisms are initiated following herpes
virus infection: (i) delayed type hyper sensitivity (DTH), (ii)
CtXt)
cytotoxic T cell responses and^neutralizing antibody. All the three 
immune responses are believed to be active during the primary, 
recurrence and recrudescence stages of infection, and that T helper 
cells (Figure 22) play a key role essential for the induction of all 
three responses.
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FIGURE 22
A schematic representation of the proposed T cell mechanisms 
involved in the induction of protective immune responses, as defined 
using the mouse ear model. Adapted from Wildy et aL (1982).
Ts, suppressor T cells; Th, helpter T cells; Tdh, delayed 
hypersensitivity T cells; Tc, cytotoxic T cells; pT, precursor T 
cells; mT, memory T cells; Bs, suppressor B cells; B, activated B 
cells; pL, plasma cells, M0, activated macrophage; NK, natural killer 
cell; ADCC, antibody-dependent cell cytotoxicity; IF, interferon, C1, 
complement; VITC, virus infected target cell (neurone or epidermal 
skin cell); A , herpes virus antigens;— <, suppression of immune 
cell functions.
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1.14.g. VIRUS AND HOST FACTORS IN HERPES SIMPLEX VIRUS LATENCY
(i) Viruses
Temperature sensitive mutants of both HSV-1 and HSV-2 have been 
shown to vary in their ability to establish a latent infection in 
animal models (Lefgren et al., 1977; Watson et al., 1980; Al-Saadi et 
al., 1983) indicating a role of virus factors in latency. Moreover, in 
latently infected tree-shrew, HSV-2 ts mutants can be recovered from 
the spleen and not from other tissues (Darai et al., 1980).
Virus genes required for the establishment of latent infections 
have not been defined. The role of the thymidine kinase (tk) gene has 
long been speculated upon in the establishment and maintenance of 
latency. Thymidine kinase negative mutants of HSV-1 which have been 
found to be extremely avirulent and multiply poorly in vivo, were 
found to induce latency in trigeminal ganglia of mice (Field and 
Wildy, 1978; Ttenser and Dunstan, 1979; Field and Darby, 1980) and 
guinea pigs (Tenser et al., 1979) after corneal inoculation but with 
more difficulty (approximately 106 to 108 pfu of input virus) than the 
wild-type viruses and their multiplication is often restricted in the 
nervous system. In many instances, a great difference is noticed 
between the wild-type and tk negative mutant latency capacity (Tenser 
and Jones, 1982). It is interesting that tk negative mutants of HSV-1 
replicate efficiently in actively growing cells but fail to replicate 
in non-multiplying serum starved cells (Jamieson et al., 1974), an 
observation which suggests that HSV specified deoxypyrimidine kinase 
activity is essential for HSV replication under conditions where the 
host cells are not making thymidilate. Since neurones are non-dividing 
cells, it is hypothesized that HSV tk expression is important in the 
pathogenesis of HSV infection and necessary for the establishment of 
sensory ganglion neurone infection (Tenser and Dunstan, 1979).
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A number of deletion mutants in viral genes including the** 22 
gene (Sears et al., 1985) and HSV-1 Ori^ (Polvino-Bodnar et al., 1987) 
have been shown to establish latent infections of sensory neurones in 
mice.
Studies with ts mutants of HSV-1 (Watson et al., 1980; Stevens, 
1981; Clements and Subak-Sharpe, 1983) and of HSV-2 (Al-Saadi et al., 
1983) revealed differences in the capacity of the mutants to establish 
latent infections in the mouse brain and ganglia. Comparison of 
latency phenotype (i.e. latency positive and latency negative) with 
the properties of the mutants expressed under restrictive conditions 
(Brown et al., 1973; Subak-Sharpe et al., 1974; Marsden et al., 1976; 
Stow et 1978; Gerdes et al., 1979) led to the following 
conclusions: (i) viral ENA synthesis (HSV-1 and HSV-2) may be 
irrelevant to the establishment of a latent infection, as some DNA 
positive and some DNA negative mutants were equally able to establish 
latent infections, while other DNA positive and DNA negative mutants 
were latency negative (Watson et al., 1980; Stevens, 1981; Al-Saadi et 
al., 1983); (ii) there is a loose correlation between absence of 
morphologically identifiable type I viral products in infected cells 
(neuroblastoma cells in culture; neurones in brain) and the capacity 
to establish latent infection.
(ii) Host factors
Studies in mice have revealed that inbred strains of mice differ 
in their ability to resist infection in that susceptible mice develop 
paralysis and death (Lopez, 1975) and Wiisc strains have been 
categorized as resistant (C57BL/6) moderately susceptible (Balb/c) or 
very susceptible (A/J). Similar observations of strain susceptibility 
in mice are made by Kirchner et al (1978). Lopez (1980) reported that 
differences in strain susceptibility to HSV in mice are genetically
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determined and appear to be mediated by natural killer cells. 
Similarly intraperitoneal inoculation of HSV-2 (Mogensen, 1976) in a 
series of inbred strains of mice revealed that some strains of mice 
were resistant while others were susceptible to focal necrotic 
hepatitis caused by the HSV-2. Resistance to HSV-2 seems to be sex 
linked (i.e. the resistance gene is located on the X -chromosome) and 
it is involved in macrophage function (Mogensen, 1980).
In the guinea pig model, much more frequent (45 to 90% occurrence 
of HSV recrudescence has been observed than that in mice (Scriba,
1975; Donnenberg et al., 1980), indicating the importance of host 
factors.
In man, when the histocompatibility antigen types of 260 patients 
(who had a clear history of frequent circumoral herpes infection) were 
compared with 606 normal (control) subjects, a positive association 
between the HLA antigen Al and the incidence of recrudescent herpes 
was observed (Russell and Schlaut, 1977). A suggestive association 
with antigen A29 and B8 was also noticed. However, this association 
has not been explained and it is not known whether such individuals 
are susceptible to infection with the virus. Nevertheless, the 
observation is, that one factor that increases susceptibility to this 
condition in man (recrudescence) may be inherited (Russell and 
Schlaut, 1977).
Section II
1.14.h. IN VITRO MODELS OF LATENCY
While animal models have been used to mimic in vivo latency in 
humans, in vitro systems using cell cultures are being developed to 
gain insight into the molecular processes involved in the establish­
ment and maintenance of HSV latency (Wigdahl et al., 1983; Nilheden et 
al., 1985; Russell and Preston, 1986; Cook and Brown, 1986; Yura et
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al., 1987).
To establish
."X in vitro latency systems, virus replication has been
suppressed by (i) treatment of the infected cells with inhibitors of
virus replication such as bromo-vinyl deoxyuridine, in conjunction
with interferon (Wigdahl et al., 1982a,b), (ii) infecting the cells at
a low multiplicity of infection (0.003 pfu/cell) and incubating the
infected cells at the elevated temperature of 42°C (Russell and
Preston, 1986; Cook and Brown, 1987) or (iii) infecting cells in the
presence of anti HSV antibodies for the first one or two passages
(Nilheden et al., 1985). Reactivation of the virus is achieved by down
shift to a permissive temperature, or by super infection with (i)
homotypic HSV (Cook and Brown, 1987), (ii) human cytomegalovirus
(Wigdahl et al., 1982a,b), (iii) intertypic HSV (Nilheden et al.,
1985) or (iv) intertypic ts mutants of HSV (Russell and Preston,
1986).
The in vitro models of latency have yielded useful information 
towards an understanding of the molecular biology of latent HSV 
infections.
HSV-1 was shown to grow lytically in all the three cell types
namely epithelial, keratocytes and endothelial cells of rabbit cornea
at 37°, however at supra optimal temperatures of 42°C, the 3 cell
types were found to support a non-productive infection with HSV (Cook
and Brown, 1986) as no infectious virus was observed for up to 28 days
post-infection. However, on reducing the incubation temperature to
37°C infectious virus was again obtained from all the cell types. In
further studies with rabbit corneal cell cultures, Cook and Brown 
found
(1987)/ that incubation of the infected cells in the presence of the 
viral inhibitor acycloguanosine during the last five days of a 14 day 
incubation at 42°C, did not reduce the frequency of viral shedding 
following transfer to 37°C, indicating that the rabbit corneal cells
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support a latent as opposed to persistent infection. Further, 
super infection of cells (which failed up to 29 days post infection to 
shed virus spontaneously^ with an Xbal site deletion mutant of HSV-1 
at 37°C, yielded both the initial infecting virus and recombinants 
between the parental and super infecting genomes.
HSV-2 has been shown to produce a latent infection of human 
foetal lung cells incubated at supra optimal temperature of 42°C 
(Russell and Preston, 1986). Transfer of the infected cultures from 
42°C to 37°C did not yield any infectious virus for at least 6 days. 
Reactivation of the latent virus was generally achieved by intertypic 
super infection at 38.5°C with ts mutants of HSV-1, or with human 
cytomegalovirus but not with adeno virus type 2 or 5. In further 
studies in the in vitro system, Russell et al (1987) demonstrated that 
latent HSV-2 could be reactivated by super infection with HSV-1 tsk (a 
ts mutant in the IE-3 gene of HSV-1) but not with dl 1403 (a deletion 
mutant in the IE-1 gene, Stow and Stow, 1986), indicating that the IE- 
1 gene product, Vmw 110 is required for reactivation of latent HSV in 
the in vitro system. Further, tsk and dl 1403 were able to establish a 
latent infection of human foetal lung cells with an efficiency similar 
to the wild-type, indicating that, at most, only limited gene 
expression is necessary for the establishment of latency.
Using an in vitro system of HSV latency in neurones isolated from 
dissociated rat foetus sensory ganglia or of human foetal lung (HFL) 
fibroblasts, Wigdahl et al (198^ investigated the state of the latent 
viral DNA by the Southern hybridization techniques. No detectable 
alterations in the size or molarity of the HSV-1 terminal or junction 
genomic DNA fragments obtained by Hindlll, Xbal or BamHI digestion of 
the latently infected neuronal or HFL cells DNA, as compared with 
digestion of a reconstruction mixture of purified HSV-1 virion and HFL
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cell DNA, were observed. Interpretation of the data was that the 
predominant form of the HSV-1 genome in latently infected cell 
populations is nonintegrated, linear and nonconcatameric.
All the JLn vitro models of HSV latency have been criticised on 
the basis that the treatments used including elevated temperature and 
drugs probably block virus replication rather than establish a latent 
infection (Price, 1982). Caution must, therefore, be exercised in 
extrapolating in vitro results to in vivo experiments or to the 
natural host i.e. humans. For example, a nonintegrated, linear, 
nonconcatameric form of the HSV genome in latently infected cells
£X
reported by Wigdahl et al (1984), is in contrast to the findings of an 
endless configuration of the HSV genome in human brains (Efstanthiou 
et al., 1986) and in mouse brain (Rock and Fraser, 1983, 1985).
1.5. EYE INFECTIONS WITH HERPES SIMPLEX VIRUS
Herpes simplex virus infection is ^  ihdemic, with 60 to 70% of 
children aged 5 and 90% of adults having neutralizing antibodies 
against HSV (Leopold and Sery, 1963; Smith et al., 1967). However, 
only 20 to 30% are estimated to ever manifest clinical disease and 
less than 1% exhibit ocular disease (Kaufman et al., 1983). HSV is the 
most common infectious cause of central corneal ulcers and corneal 
blindness in developed countries (Foster and Duncan, 1981). HSV 
keratitis most frequently occurs between ages 30 to 70 (Leopold and 
Sery, 1963). Approximately 98% of non-neonatal ocular infections are 
from HSV-1 (Neumann-Haefelin et al., 1978); 70% to 80% of ocular 
herpes presenting in the first month of life is from HSV-2 (Nahmias
t til 1970). Clinically the two types of HSV disease cannot be
ci rcums tances
differentiated. Depending upon the /\ of infecting virus HSV 
ocular diseases are divided into (1) primary and (2) secondary 
infections and are outlined in brief, as follows:
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1.15.a. PRIMARY OCULAR HSV INFECTION
Humans who have no previous immunity to HSV, on first exposure to 
the virus, may develop primary eye disease. It can be present in 
various forms and affects different components of the eye. The 
incubation period ranges from 2 to 12 days and the infection occurs in 
both sexes. Depending upon the part of the eye involved, and the 
strain of the infecting virus, the clinical manifestations of the 
primary disease vary in severity. Some of the important clinical 
manifestations are described in the following sections.
(i) Eye lids: Primary ocular HSV infection of eye lids is manifested 
by vesicle eruptions on the lids and lid margins. After 1 to 2 weeks 
vesicles may ulcerate, followed by crusting, desiccation and healing 
within 4 weeks. In the absence of secondary bacterial infections, the 
disease is usually self limiting.
(ii) Conjunctiva: Hie most constant finding in primary ocular HSV 
infection is acute follicular conjunctivitis with or without 
involvement of eye lids (blepharoconjunctivitis). The primary 
conjunctivitis is self limiting and lasts for 2 to 3 weeks.
(iii) Cornea: Epithelial keratitis usually accompanies or closely 
follows the onset of follicular conjunctivitis, but can occur late in 
primary disease. Initially groups of superficial cells are infected 
but as the disease progresses, the infected cells may desiccate and 
punctate keratitis resolves, or the lesions may extend to form a 
coarse punctate, stellate or dendritic keratitis. A basic feature of 
all these forms of herpetic epithelial keratitis is the poor adherence 
of infected cells to each other and to the basement membrane (Coster 
et al., 1977).
Epithelial keratitis in primary disease is self limiting and
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resolves usually without scarring within 4 weeks (Thygeson, 1967). 
Damage to the ocular tissues is mainly due to replication of the virus 
in the epithelial cells.
1.15.b. PATHOGENESIS OF OCULAR HERPES SIMPLEX VIRUS
Much of the information on the pathogenesis of ocular herpes has 
been obtained f^dm studies in experimental animals including rabbits 
(Irvine and Kimura, 1967; Nesburn et al., 1967, 1972; Wander et al., 
1980; Green et al., 1984), mice (Hill et al., 1975; Lopez, 1975; 
Stulting et al., 1985) an<J guinea pigs (Tabbara et al., 1974; Wander 
et al., 1987).
Following intra corneal inoculation of the virus in rabbits and 
mice, the pattern and course of the clinical disease simulates that of 
humans (Williams et al., 1965; Metcalf et al., 1976; Hill, 1987). In 
rabbits the clinical symptoms of stromal keratitis include development 
of epithelial lesions reaching a peak in severity in 5 to 7 days post 
infection, followed by disciform oedema lasting for several weeks. 
Infiltration with lymphocytes, macrophages and polymorphonuclear cells 
renders the stromal layer opaque, followed by vascularization of the 
cornea and tissue necrosis (Irvine and Kimura, 1967). Tissue 
destruction is mainly due to the host immune response to antigens 
present in the stroma (reviewed by Easty, 1985).
Loss of corneal sensitivity is a common feature of HSV keratitis 
in humans (Easty, 1985) and a similar loss of sensation has been 
reported in mice following infection of the cornea after scarification 
(Tullo et al., 1983) and in rabbits after intrastromal inoculation 
(Metcalf, 1982). The precise mechanisms of such disfunction are not 
clearly known but are believed to be due to direct or indirect effects 
of the virus on the sensory nerve (Hill, 1987).
In mice, following direct corneal inoculation of HSV, often with
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scarification (though this mode of virus entry into the eye is rare in 
humans), virus can be isolated for about 9 to 10 days and clinical 
disease rapidly ensues (Tullo et al., 1983). For example, severe 
keratitis develops by the 4th to 5th day post inoculation. Peripheral 
replication of the virus is associated with rapid invasion of virus 
into the nervous system.
Before describing the mechanisms of spread of the virus in the 
nervous system, it would be appropriate to describe some of the 
salient features of the : - innervation- &f the anterior portion of
the eye. The cornea and iris receive their sensory innervation from 
the trigeminal ganglion. The sympathetic nerve supply is from the 
superior cervical ganglion (SCG) and the parasympathetic nerve fibres 
are derived from the ciliary ganglion. The ciliary ganglion is linked 
to the nasociliary branch of the ophthalmic division of the trigeminal 
nerve, whose fibres traverse the ganglion and run through the short 
ciliary nerves to the eye where they subserve sensation in the cornea, 
iris and choroid. The trigeminal ganglion (TG), unlike other sensory 
ganglia, may best be considered as a fusion of 3 ganglia (ophthalmic, 
maxillary and mandibular divisions; see Figure 23).
(i) Spread of the virus after corneal inoculation in mice
Or
Tullo et al (198$ observed that after inoculation of the mouse 
cornea, virus was isolated on day 2 from the ophthalmic part of the TG 
and the ipsilateral brain stem. Two days later virus was found in the 
maxillary part of the ganglion and after a further day, in the 
mandibular branch. These observations of spread of virus in the TG 
were interpreted as demonstrating that after ocular infection, the 
non-ophthalmic parts of the TG may become infected via the "back door 
route".
The course of events in the spread of virus within the nervous
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FIGURE 23
Diagrammatic representation of the three branches of the human 
trigeminal ganglion (TG). Adapted from Al Saadi,1984.
A. Lateral view
B. Superior view
1. Ophthalmic branch
2. Maxillary branch
3. Mandibular branch

system following ocular infection of HSV have recently been reviewed 
by Hill (1987). Briefly, as shown in Figure 24, (i) Penetration of HSV 
in the nervous tissue occurs by the fusion of the virus envelope with 
the cell membrane as evidenced by the presence of particles resembling 
naked viral nucleocapsids, on electromicroscopic examination of 
neurites soon after inoculation of HSV in cultures of sensory neurones 
(Lycke et al«, 1984). (ii) Hie viral nucleocapsid is transported 
within the axon by retrograte axonal flow towards the CNS. (iii) The 
loss of envelope renders the virus non-infectious, thereby damaging 
its ability to leave the axon. The inability to isolate infectious 
virus from nerves (Klein, 1985) supports the speculation of the non- 
infectious nature of the virus, (iv) Hie nucleocapsids transported to 
the body of the neurone may interact with its nucleus resulting in 
either a latent infection or productive replication (Hill, 1985). (v) 
It is possible that some of the naked nucleocapsids may be transported 
beyond the ganglion into the CNS. (vi) Productive infection of 
neurones results in release of enveloped particles from the neuronal 
nucleus within 24 hr of infection, (vii) Ctei electronmicroscopic 
examination of neurones at this stage of infection, a number of 
cytoplasmid vesicles containing groups of enveloped particles are seen 
(Hill and Field, 1973). (viii) Enveloped virus particles, as revealed 
by electr6m?jS£opic examination of neurones infected with HSV and PKV 
(Hill et al., 1972; Field and Hill, 1974) are transported intra- 
axonally either towards the periphery or towards the central nervous 
system, (ix) Virus transported centrally reaches the nerve root and by 
virtue of the envelope it may leave the axon to infect astrocytes and 
oligodendroglial cells (Hill, 1983). (x) Within the CNS the virus may 
infect other neurones by crossing synapses (Bak et al./ 1977). (xi) 
Virions transported centrifugally by virtue of their envelope, have
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FIGURE 24
Diagrammatic representation of the main events in the spread of 
HSV in a sensory nerve.
The upper part of the diagram (events 1-5) refers to the original 
input virus and the lower part (events 6-14) to stages that may occur 
after replication of virus in the neurone.
A, is a myelinated fibre and B non-myelinated.

the ability to leave axons, but in myelinated fibres (A in Figure , 
the myelin and the complex interdigitation between Schwann cells may 
act as a physical barrier, (xii) in non-myelinated fibres there is no 
such barrier and Schwann cells which enwrap several axons in their 
cytoplasm may become infected 'from within', (xiii) Virions produced 
from Schwann cells because of their ability to support an abortive 
infection (Hill, 1985) in vitro may be sufficient to infect cells of 
adjacent myelinated or non-myelinated axons, (xiv) Ihe enveloped virus 
particles are transported centrifugally to the site of primary 
infection and the infectious virus may be isolated from 2 to 3 days 
after inoculation at the peripheral site (Klein, 1985).
Depending upon the severity of and amount of virus replication in
primary disease, virus may reach the contralateral eye through the
t
parasymp^hetic and optic nerve and clinical disease may follow. In 
fact in rabbits, the development of herpetic keratitis followed by 
retinitis was first seen in the infected eye within a few days and in 
the contralateral eye 8 to 12 days later (Goodpasture and Teague,
1923; Kimura, 1962; Kaufman, 1982). Pettit et al (1968) using 
fluorescent antibody techniques investigated the route of virus spread 
in ocular herpes in rabbits and demonstrated virus specific antibody 
fluorescence along the ciliary nerve neurones in a centripetal fashion 
to the optic nerve, brain, optic chiasma and over to the other eye. 
However, the spread of virus by the haematogenous route in these 
diseases was not investigated.
(ii) Role of virus factors in ocular disease pathogenesis
Both host and virus factors are believed to modulate the outcome 
of ocular infections with HSV. Besides host factors including the host 
immune response which plays a significant role, the genetic properties 
of the infecting virus strain have also been shown to modulate the 
disease pattern. Specifically (i) Wander et al (1980) from their
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studies on the pathogenesis of ocular herpes in rabbits, using various 
strains of HSV, concluded that the type of ocular disease produced in 
rabbit eyes is an inherent property of the infecting strain and is 
independent of the titer of the infecting virus. Strains that produce 
epithelial disease fail to produce stromal disease regardless of the 
inoculum size, (ii) Clinical isolates from human epithelial HSV 
disease failed to produce stromal disease when tested in animals, 
whereas known stromal disease producing strains regularly reproduce 
this disease pattern even after serial propagation in cell culture 
(Irvine and Kimura, 1967; Metcalf et al., 1976). The stromal or 
epithelial disease producing property of the virus was mapped between
0.70 and 0.83 m.u. by analysis of recombinant virus isolated from 
stromal and epithelial disease producing parents.
Day et al (1987) observed that after corneal infection in mice, 
the ability of the virus to spread from the cornea to the CNS is 
determined by the nucleotide sequences within a 6 Kb viral genome 
fragment. Analysis of recombinants isolated from the encephalitis 
producing virus (HSV-2 strain 186) parents, demonstrated that the 6 Kb 
virus DNA sequences include the HSV-1 (17) Ori^ , the HSV-1 (17) gene 
for DNA polymerase and portion of the HSV-1 (17) gene coding for the 
major DNA binding protein.
1.15.C. LATENCY FOLLOWING HERPES SIMPLEX VIRUS OCULAR DISEASE
The various processes underlying the establishment maintenance 
and control of HSV latency have been discussed in section 1.14, and 
the same are relevant to the establishment of latency ensuing HSV 
ocular disease. However, some relevant observations on ocular disease
latency are discussed.
As shown in Figure 25, following ocular infection, HSV 
establishes a latent infection in sensory (trigeminal) ganglia as well
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FIGURE 25
Schematic representation of the spread of virus to the ganglia in 
ocular infection with HSV.
1. Infection with HSV in the region of the eyelids
2. Virus may enter the tears
3. Invasion of corneal epithelium by the virus
4. Spread of virus via the sensory neurones to become latent in the
posterior root ganglion
5,6. Virus may penetrate the deeper tissues of the eye.
Virus from orolabial lesions may also spread to the brain and 
then to the ipsilateral and contralateral eyes.

as in the superior cervical (SCG) and ciliary ganglia (Martin et al.,
<X
1977; Tullo et aL, 198^ ). Infection of the trigeminal ganglia may 
also occur from the mandibular or maxillary divisions (Tullo et al., 
1982j). Virus may spread to the central nervous system and may pass 
across the synapses and enter the sensory neurones of the other 
dermatomes (Tullo et al., 1983). It is likely that the number of 
neurones involved by latent virus infection would be less in the other 
dermatomes.
Recovery of latent virus from the TG is achieved by in vitro 
growth after explantation or by cocultivation of the ganglion tissues 
with cells permissive for HSV.
HSV has also been shown to establish latent infections in the 
corneas of man and experimental animals. Human corneal explants 
removed during the course of treatment for chronic stromal keratitis 
have shed virus 5 to 11 days post explanation (Shimeld et al., 1982; 
Tullo et al., 1985; Easty et al., 1987; S.D. Cook, personal 
communication). Similar to the findings of latent virus in human 
corneas, HSV has been recovered from the corneas of latently infected 
rabbits (Cook et al., 1987 and this thesis) and mice (Easty et al.,
1987). Cook and Brown (1986) observed that HSV-1 can grow in all the 
three cell types namely epithelial, keratocytes and endothelial cells 
of rabbit corneal cultures. However, growth of the virus was fastest 
in epithelial cells compared to keratocytes or endothelial cells. 
Epithelial and keratocyte cultures were shown to support a latent as 
compared to a persistent infection with HSV-1 (Cook and Brown, 1987; 
also see section 1.14).
1.15.d. REACTIVATION OF HERPES SIMPLEX VIRUS FROM LATENCY
The mechanisms of HSV reactivation from latency are not well 
understood. Probably both host and viral factors are involved. As
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shown in Figure 26, virus reactivated from the sites of latency (TG 
and SCG) travels down the neurones and frequently results in either 
symptomless shedding of virus in the tearfilm or in an evident 
recrudescent disease (Stevens et al., 1972; Asbell et al., 1904). 
Periodic recurrence with shedding of virus in the tear film has been 
observed both in humans (Easty, 1985) and latently infected rabbits 
(Stevens et al., 1972).
of the eye
The recrudescent disease^due to reactivated HSV . may be more 
severe than the primary disease. The most common target of recurrent 
HSV ocular disease is the cornea, with the conjunctiva usually spared. 
Whereas in primary disease keratitis is generally confined to the 
epithelium, it is self limiting and heals without scarring. In 
recurrent disease keratitis may extend to the stroma and endothelium, 
persists for months and results in permanent visual loss (Blodi,
1985). The common pathways in the clinical course of HSV keratitis are 
displayed in Figure 27.
Epithelial keratitis is best characterized by the presence of 
active virus. Clinical manifestations of epithelial keratitis in 
recurrent disease are similar to those in primary disease, but tend to 
be associated with greater underlying stromal inflammation. Dendrites 
may occur at the primary sites or at any other corneal location. 
Patients with recurrent epithelial keratitis have a 33 to 68% chance 
of having another episode within 2 years (Shuster et al., 1981).
Metaherpetic ulcers are sterile, de-epithelialized lesions that 
follow epithelial or stromal disease in which the basement membrane 
has been disrupted and most often arise in a quiet eye after active 
keratitis has subsided (Blodi, 1984). These ulcers may persist for 
weeks to months. A major complication of the ulcers is stromal melting 
due to collagenase production (Kaufman, 1964).
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FIGURE 26
Schematic diagram showing routes of entry of virus into the 
tissues of the eye.
Vi refers to the three divisions of the trigeminal ganglion, SCG 
refers to superior cervical ganglion, © indicates virus" particles.
SCG
FIGURE 27
Common pathways of herpes simplex virus keratitis.
* HSV recoverable, +  HSV recoverable in some cases
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Stromal keratitgs due to recurrent HSV are of two major types and 
both are thought to be predominantly immunologic in pathogenesis 
(Meyers and Chitjian, 1976). (1) Hie disciform subtype of stromal 
keratitis is postulated to result from delayed hypersensitivity (CMI) 
whereas (2) the non-disciform or interstitial subtype results from 
immune complex hyper sensitivity (antigen-antibody-complement- 
mediabed).
Besides keratitis the other infrequent ocular diseases due to 
recurrent HSV include (1) uveitis associated with epithelial 
keratitis. Hie severe form of uveitis results from the presence of 
viral replication in aqueous and uveal tissue. (2) HSV retinitis 
associated with HSV encephalitis.
(i) The genome of reactivated HSV
Hie genotypes of virus isolates obtained from recurrent herpes 
keratitis in humans (Asbell et al., 1984; Easty et al., 1987) or in 
mice or rabbits (Gerdes and Smith, 1983; Easty et al., 1987) have been 
found to be stable over a period of time in that the viral restriction 
endonuclease profiles from different episodes of recurrent keratitis 
in one individual are identical.
Gerdes and Smith (1983) and Hill et al (1987) in rabbit 
experiments observed that different strains of HSV despite 
establishing latent infections of TG with equal frequency were 
heterogenous in their spontaneous or epinephrine induced shedding in 
the tearfilm, and concluded that reactivation potential, both 
spontaneous and induced, is determined by the genotype of the strain. 
Gerdes and Smith (1983) also observed that establishment of latency by 
a superinfecting strain was inhibited in ganglia previously latently 
infected with HSV. However, an acute infection of a latently infected 
ganglion could be established by superinfection with a heterologous
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strain.
(ii) Experimental models for reactivation of HSV from latency
Reactivation of the latent virus has been reported in response to 
diverse stimuli (see section 1.14). In latently infected animals, 
ocular shedding of virus can be achieved experimentally by (1) 
electrical or mechanical stimulation of the TG (Green et al., 1979).
(2) manipulation of the corneal epithelium to induce Arthus type 
hypersensitivity (Anderson et al., 1961) or (3) topical or 
intramuscular administration of epinephrine (adrenalin) (Laibson and 
Kibrick, 1966, 19691. Epinephrine (0.01%) iontophoresis (0.8 mAmps for 
8 min) son 3 consecutive days (Kwon et al., 1982) facilitates the 
uniform application of epinephrine to the cornea and causes 
reactivation of virus in 100% of rabbits latently infected with the 
HSV-1 strain McKrae (Hill et al., 1983, 1987; Dunkel and Pavan- 
Langston, 1987).
The precise mechanism of action of epinephrine induced 
reactivation of latent virus from the trigeminal ganglia is not fully., 
understood. Following iontophoresis of latently infected rabbit eyes, 
epinephrine has been shown to localise in the epithelium and stromal 
layers of the cornea as detected by the histochemical adrenochrome 
oxidation method (Dunkel and Pavan-Langston, 1987) and the induction 
of ocular and ganglionic HSV reactivation from latently infected 
rabbit eyes was postulated to be due to the synergistic action of 
epinephrine on the corneal epithelium and of epinephrine metabolites 
at the ganglionic level.
During investigation of the kinetics of virus replication in 
neural tissues of rabbits, Hill et al (1983) observed that epinephrine 
iontophoresis to the eyes of latently infected rabbits resulted in 
reactivation of HSV-1 in both the trigeminal and superior cervical
96
ganglia. The TG is sensory while the SCG is autonomic. The iris 
contains primarily sympathetic receptors, the ciliary body contains 
parasympathetic and the cornea contains mostly sensory fibres and some 
sympathetic fibres. The epinephrine activated sympathetic nerve fibres 
in the cornea may act to stimulate sensory fibres, reactivating HSV-1 
in both the TG and SCG and ultimately leading to HSV shedding into the 
tearfilm. However, the precise mechanism of action of epinephrine in 
reactivation of the latent virus is unknown.
1.16. HERPES SIMPLEX VIRUS VIRULENCE
Besides causing pathology at the site of infection, significant 
acute replication in the peripheral nervous system after a primary 
infection can result in infection of the central nervous system. The 
disease thus produced ranges in severity from transverse myelitis to 
fatal encephalitis, indicating the neuro invasive and neurovirulent 
nature of HSV (Fenner et al., 1974).
The molecular mechanisms underlying the neurovirulence of HSV are 
largely unknown. Pathogenesis studies of HSV in experimental animals 
have shown that different strains of HSV are heterogenous in their 
virulence. Isolates of HSV-2 are found to be normally more neuro­
virulent than HSV-1 when inoculated by various routes into 
experimental animals such as rabbit (Plummer et al., 1968? Oh et al.,
1972, 1973), guinea pig (Scriba and Tatzar, 1981) and mouse (Nahmias
P V
et al., 1969? McKendell, 1980? Thoii^ son et al., 1986? Halliburton et 
al., 1987). Within one serotype different strains also differ in their 
neurovirulence (Dix *et al., 1983? Sedarati and Stevens, 1987).
Studies aiming to identify the viral gene(s) controlling 
pathogenicity of the virus in laboratory animals have been 
inconclusive. Hie viral thymidine kinase gene (tk) had been shown to 
be essential for the display of neurovirulence in guinea pigs
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following intra vaginal inoculation. No clinical signs were observed
on infection with tk deficient strains of HSV-2, though virus growth
was similar to highly pathogenic tk producing strains (Stanberry et
al.f 1985). Studies in mice with various HSV—1 strains have revealed
that tk though inessential for virus growth (replication) in actively
growing tissue culture cells, its failure to be expressed in vivo
results in a marked reduction in neurovirulence (Field and Wildy,
h
1978; Field and Darby, 1980; Tenser et al., 19811). However in 
subsequent studies in mice on the pathogenesis of various HSV strains 
or intertypic recombinants, no correlation was observed between tk 
activity and virulence of the virus (Sedarati and Stevens, 1987; 
Halliburton et aL, 1987).
Low neurovirulence of HSV-1 DNA polymerase mutants has been 
observed following intracerebral but not on peripheral inoculation of 
mice (Field and Coen, 1986). Larder et al (1986) were able to restore 
the wild type pathogenicity of the DNA polymerase attenuated strain 
RSC-26 by marker rescuing the mutation with the genetic information of 
the virulent parental strain - SC16. Studies in mice with a
glycoprotein C (gC-2) deletion mutant of HSV-2 strain 333 have
from
excluded^ having a role in neurovirulence as the virulence
(indicated by the mortality rate) of the deletion mutants was similar
to that of the wild type strain (Johnson et al., 1986).
Recently various studies have been carried out to localise the
P
region of the virus genome involved in neuropathogenicity, 'ftiomjson et 
al (1986) have demonstrated that in mice the avirulent phenotype of 
the HSV-1 strain KOS could be attributed to 0.25 to 0.53 m.u. of the 
genome as the substitution of this region from the virulent HSV-1 
strain 17 syn+ in a KOS x 17 syn+ recombinant produced enhanced 
virulence. Genes encoded between 0.25 to 0.53 m.u. include those for 
tk, DNA polymerase and the major DNA binding protein (reviewed by
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Wagner, 1985).
Studies with the HSV-1 strain HFEM in the tree shrew system 
(Darai and Scholz, 1984) indicated that the genes controlling 
virulence lie between 0.73 and 0.82 m.u. A similar region of the 
genome (0.79 to 0.83 iruu.) has also been implicated in virulence in 
the mouse model system using the avirulent intertypic recombinant REg 
(Javier et al., 1987). However, studies of Halliburton et al (1987) 
involving 31 HSV-1 x HSV-2 intertypic recombinants in mice ha^ -e 
demonstrated that the recombinants were attenuated independently of 
the virulence of the parent virus. The recombinants were derived at 
different times from diverse HSV-1 and HSV-2 strains having variable 
neurovirulence for mice and had crossovers throughout the genome.
These results indicated that virulence of HSV is not confined to a 
single region but is controlled multigenically. Similar findings have 
been reported by Sedarati and Stevens (1987) in their studies with 
three different HSV-1 strains in mice. It was demonstrated that 
lesions for neurovirulence in HSV-1 strains F, HF and HFEM were 
located in different regions of the genome as complementation of 
neurovirulence of strains HF, HFEM by the strain F was observed and 
all three strains were able to complement the non-neuroinvasive strain 
KOS.
1.17. AIMS OF THE PROJECT
Herpes simplex virus infections are important not only because of 
their primary disease pathology but also because of the ability of the 
virus to establish latent infections in the neurons of the ganglia of 
the peripheral nervous system and to a lesser extent at peripheral 
sites. The ability of the virus to go latent results in recurrences 
throughout life caused by a variety of stimuli.
Herpes virus keratitis in man is widespread and is a common cause
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of non-traumatic blindness. Following primary infection of the eye, 
the virus efficiently establishes a latent infection in the sensory 
neurones of the trigeminal ganglia and probably less efficiently in a 
small proportion of the cells of the cornea. Recurrent episodes of 
keratitis due to reactivation of endogenous virus frequently result 
in corneal ulcers which can progress to impair vision and eventually 
result in blindness.
The rabbit eye has provided an efficient model system in which to 
study herpes virus keratitis and the various factors affecting the 
establishment, maintenance and reactivation of latent HSV.
The work described in this thesis has addressed itself to (i) the 
analysis of virus genes controlling HSV reactivation potential and
(ii) the analysis of virus genes determining virulence of HSV.
Previous work using the rabbit eye model has shown that different 
strains of HSV although establishing latent infections of trigeminal 
ganglia with equal frequency, varied considerably in their ability to 
reactivate spontaneously from latency. This led to the conclusion that 
some insight into the viral genes controlling reactivation could be 
gained by the construction of recombinants between HSV strains of low 
and high recurrence phenotypes and determining variation of 
reactivation potential correlated to the DNA structure of the 
recombinants.
This thesis describes (1) the construction of recombinants 
between HSV-1 strain McKrae and HSV-2 strain HG52, (ii) the analysis 
of the genome structure of the recombinants by restriction 
endonuclease digestion, (iii) the reactivation potential and latency 
potential of the recombinants compared to the parental viruses in the 
rabbit eye model, (iv) the virulence of the recombinants compared to 
the parental viruses after corneal infection, and (v) the ability of
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HSV to go latent in rabbit corneal cells.
In addition, the construction and genome analysis of HSV-1,
McKrae X HSV-2, HG52 recombinants has led to an important and 
significant observation which may provide some insight into the 
relationship between HSV replication and recombination. Unselected 
recombinants isolated after cotransfection of intact genomes of one 
parent with the total products from restriction endonuclease cleavage 
of the DNA of the other parent have demonstrated, on genome analysis, 
preferential recombination between sequences containing an origin of 
replication. All the recombinants isolated though predominantly of one 
parental type contained at least one heterologous origin of 
replication. The implications of this finding are discussed.
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Chapter 2 
MATERIALS AND METHODS
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MATERIALS
TISSUE CULTURE CELLS
The baby hamster kidney fibroblastic cell line (BHK 21/C13) 
established by Macpherson and Stoker (1962) was used throughout this 
study.
VIRUSES
The viruses used in this study were:
1) HSV-1 strain McKrae (Williams et al., 1965) which forms non- 
syncytial (syn+) plaques on BHK 21/C11 cells.
2) HSV-2 strain HG52 (Timbury, 1971) and its temperature sensitive 
mutants ts 1, ts 5, ts 9 and ts 13 derived by 5-bromodeoxyuridine 
mutagenesis (Halliburton and Timbury, 1973, 1976). The type 2 
viruses form mixed morphology (syn/syn+) plaques on BHK 21/C13 
cells.
3) HSV-1 strain 17 syn+ (Brown et al., 1973) and its variant X2 
(Brown et al., 1984) and a temperature sensitive (ts) mutant ts 
1201 (Preston et al., 1983) which form non syncyntial (syn+) 
plaques on BHK 21/C13 cells.
TISSUE CULTURE MEDIA 
Growth media
Glasgow modified Eagle's medium (Busby et al., 1964) was supplied 
as a lOx conceive ate by Gibco Limited, U.K. BHK 21/C13 cells were grown 
in IX medium supplemented with 100 units/ml penicillin, 100 ug/ml 
streptomycin, 10% tryptose phosphate broth (TPB) and 10% calf serum 
(ETC^g). The serum concentration was reduced to 5% (ETC^) for 
maintenance of cells. Calf serum was replaced with 5% pooled human 
serum (EH^) to overlay virus titrations.
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Other media included:
EFn .. Eagle's medium containing n% foetal calf serum
PIC .. Phosphate free Eagle's medium containing 1% calf
serum
L-broth .. 170 mM NaCl, 1% (w/v) Difco bactotryptone, 0.5%
(w/v) yeast extract, 100 ug/ml ampicillin or 10-15 
ug/ml tetracycline.
EC^q 1/5 met. EC^q medium containing 1/5 of the normal 
concentration of methionine.
BUFFERS AND SOLUTIONS
Denhardt's buffer - 0.1% (w/v) Ficoll, 0.1% (w/v) polyvinyl- 
(DB) pyrolli^done, 0.1% (w/v) BSA.
Electrophoresis - 36 mM Tris-HCl pH 7.8, 30 mM Na^PO^.^O, 1 mM 
buffer
(E.buffer) EDTA
HEPES buffered - 130 mM NaCl, 4.9 mM KC1, 1.6 mM Na2HP04, 5.5 
saline (HEBS) mM dextrose, 21 mM HEPES (N-2-hydroxyethyl
piperazine-N'-2-ethanosulphonic acid) pH 7.05 
Hybridization - 10 mM Tris-HCl pH 7.5, 3xSSC, 5xDB containing
buffer 100 ug/ml of salmon, sperm DMA
Nick translation - 50 mM Tris-HCl pH 7.5, 5 mM MgCl2 50 ug/ml BSA, 
buffer (NTB) 1 mM DTT
Phosphate buffered- 170 mM NaCl, 3.4 mM KC1, 10 mM Na2HP0 4, 2mM 
saline (PBS) KH2P04 pH 7.2 (Dulbecco and Vogt, 1954)
Reticulocyte - 10 mM KC1, 1.5 mM MgCl2, 10 mM Tris-HCl pH 7.5 
suspension 
buffer (RSB)
SDS Polyacrylamide - 53 mM Tris, 53 mM glycine 1% (w/v) SDS 
gel buffer (lx)
(tank buffer)
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Resolving gel 
buffer
Stacking gel 
buffer 
Polyacrylam ide 
gel fix/stain
Polyacrylamide 
gel destain 
Acrylamide
Boiling mix
Restriction enzyme ■ 
buffers (RE)
10 x for BamHI
10 x for Kpnl -
10 x for Xbal,
Hpal, HindiII 
and Eco RI
1.5 mM Tris-HCl pH 8.9, 0.4% (w/v) SDS
0.49 M Tris-HCl pH 6.7, 0.4% (w/v) SDS
A mixture of methanol, water and acetic acid in 
the ratio of 50/40/7 (v/v) containing 0.2% 
(w/v) Coomassie brilliant blue 
A mixture of methanol, water and acetic acid in 
the ratio of 50/880/70 
30% Acrylamide solution (+5% linker) - 28.5 gms 
acrylamide and 1.5 gm N-N'-Methylenebisacry- 
lamide, used for all gradient gels; made up 
to 100 ml and filtered through a Whatman 
number 2 filter prior to use 
1 ml stacking gel buffer, 0.8 ml 25% SDS, 0.5ml 
2-B mercapto ethanol, 1 ml glycerol and 0.025 
ml of a saturated solution of Bromophenol 
blue. Diluted 1 in 3 parts with distilled 
water, and if necessary, the pH adjusted by 
the addition of NaOH to give a blue colour 
These were prepared as lOx stock according to 
BRL or Maniatis et al (1982)
200 mM Tris-HCl pH 8.0, 1 M NaCl, 70 mM MgCl2 
20 mM 2-Mercapto ethanol and 1 mg/ml BSA 
100 mM Tris-HCl pH 7.5, 100 mM MgCl2, 10 mM DTT 
and 1 mg/ml BSA 
200 mM Tris-HCl pH 8.0, 1 M NaCl, 70 mM MgCl2 
and 1 mg/ml BSA
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Wash buffer
PBSCa
T.E.
NTE
SSC
TBE
Gel Soak I 
Gel Soak II
S.O.C.
Restriction enzyme 
stop mixture 
(RE stop)
Tris saline
Trypsin
Versene
Tryps in-versene
Alkaline lysis 
solution I
solution II
10 x SSC, 0.1% SDS and 4.7N sodium phosphate 
pH 7.0
PBS containing 2% calf serum 
1 mM EDTA, 10 mM Tris-HCl pH 7.4 
10 mM Tris-HCl pH 7.5, 10 mM NaCl and 1 mM EDTA 
150 mM NaCl, 15 mM Tri sodium citrate 
89 mM Tris, 89 mM Borate, 3 mM EDTA 
200 mM NaOH, 600 mM NaCl 
1 M Tris-HCl pH 8.0, 0.59 M NaCl 
2% Bactopeptone, 0.5% yeast extract, 10 mM NaCl
2.5 mM KC1, 10 mM MgCl2, 10 mM MgS04, 20 mM 
Glucose, D.W. to make 100 ml 
■ 10% Ficoll, 100 mM EDTA in 5XE buffer contain­
ing bromophenol blue to colour
140 mM NaCl, 30 mM KC1, 280 mM Na2HP04, 1 mg/ml 
glucose, 0.0015% (w/v) phenol red, 25 mM 
Tris-HCl pH 7.4, 100 units/ml penicillin,
100 ug/ml streptomycin 
0.25% (w/v) Trypsin powder (Difco Limited) in 
tris saline 
0.6 mM EDTA in PBS containing 0.002% (w/v) 
phenol red
1 volume of trypsin mixed with 4 volumes of 
versene
50 mM glucose, 25 mM Tris-HCl pH 8, 10 mM EDTA, 
5 mg/ml lysozyme added just prior to use 
0.2 M NaOH, and 1% SDS
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solution III - 5 M Potassium acetate pH 4.8
Giemsa stain - 1.5 (w/v) suspension of Giemsa in glycerol,
heated at 56°C for 120 min and diluted with 
an equal volume of methanol 
Phenol - phenol for extraction of DNA refers to phenol
(BDH) melted at 60°C by heating in a water 
bath and saturated with an equal volume of 
NTE buffer
Chloroform - Chloroform for extraction of DNA refers to 24
volumes of analar grade chloroform (BDH) 
mixed with 1 volume of isoamyl alcohol
PLASMIDS
The following recombinant plasmids carrying HSV fragments ligated 
into pAT 153 (Twigg & Sherratt, 1980), were transfected into the host 
Escherichia coli K^2 strain HB101 (Boyer & Roulland-Dussoix, 1969) and 
propagated in L-broth containing 100 ug/ml ampicillin for BamHI and 
Hindlll clones or 10-15 ug/ml tetracycline for Kpnl clones. The 
plasmids had previously been constructed in the Institute of Virology, 
Glasgow, by a number of people and were made available by Dr V.G. 
Preston. The map location of the HSV inserts is given below:
Plasmid clone HSV-1 (17 syn+) insert Map location (m.u.)
pGX 121 Kpnl b 0.024 - 0.108
pGX 122 Kpnl c 0.434 - 0.518
pGX 1233 Kpnl d 0.59 - 0.672
pGX 125 Kpnl f_ 0.120 - 0.19
pGX 126 Kpnl £ 0.73 .80
pGX 128 Kpnl i 0.224 - 0.282
pGX 146 Kpnl x 0.42 - 0.434
pGX 148 Kpnl z 0.672 - 0.682
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PGX 92 BamHI v 0.39 - 0.41
PGX 2 BamHI k 0.81 - 0.852
PGX 34 BamHI x 0.95 - 0.964
PGX 60 BamHI ^ 0.964 - 0.978
PGX 40 BamHI z 0.938 - 0.950
HSV-2 (HG52) insert 
pGZ 26 Hind III a 0.524 - 0.736
pGZ 11 Hind III b 0.170 - 0.264
pGZ 15 Hind III h 0.282 - 0.402
Plasmid pSl - containing a 535 bp Sau 3A subfragment of Bam HI _x of 
HSV-1 strain 17 cloned into pAT 153 at the Bam HI site 
was kindly supplied by Dr. Nigel D. Stow.
RADIOCHEMICALS
All radiolabelled compounds were obtained from Amersham 
International pic., Amersham.
CHEMICALS
Analytical grade chemicals were used where available. These were 
obtained from five companies including Sigma Chemical Company; BDH 
Chemicals; Koch Light Laboratories; May & Baker Limited; and James 
Burroughs Limited. Vetalar (Ketamine hydrochloride, 100 mg/ml) was 
supplied by Parke-Davis, U.K. while Rompun (Xylazine, 500 mg/vial) was 
supplied by Bayers Limited, U.K.
MISCELLANEOUS
Plastic petri dishes for tissue culture were supplied by Nunclon 
Limited.
£
Nitrocellulose membranes (0.45 urn) were purchased from Schleicher 
and Schull, West Germany.
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Photographic film was obtained from Kodak Limited, London. 
Disposable ECG electrodes type VL-OO-S were supplied by 
Medicotest, Denmark.
EXPERIMENTAL ANIMALS
New Zealand White rabbits (1.5-2 kg) were obtained from a 
commercial breeder - Hyline Rabbit Farms, U.K.
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METHODS
2.1. GROWTH OF CELLS
BHK21/C13 cells were grown in rotating 80 oz glass culture 
bottles containing 100 ml ETC10 in an atmosphere of 5% 002/ 95% air. 
Confluent bottles of cultured cells (aproximately 3 x 108 cells) were 
harvested by washing the monolayer twice with 25 ml trypsin-versene 
and resuspending the cells in 20 ml ETC10. Cells from one bottle were 
sufficient to seed 10 new bottles. To obtain confluent monolayers in 
24 hr at 37°C. 50 mm and 35 mm plastic petri dishes were seeded at a 
density of 2 x 1 0 8 and 1 x 108 cells per dish respectively while 24 
well Linbro-trays and 96 well microtiter trays were seeded at 5 x 108 
and 5 x 10^ cells/well respectively.
2.2. GRCWTH OF VIRUS
2.2.a. Production of virus stocks
Growth medium from almost confluent BHK 21/C13 monolayers in 80 
oz roller bottles was replaced with 25 ml of EC5 containing 0.003 pfu 
per cell of virus. The infected monolayers were incubated at 31°C 
until extensive cytopathic effect had developed. Infected cells were 
shaken into the. medium and harvested by centrifugation at 1500 x g for 
10 min at 4°C. Cell released virus from the supernatant medium was 
concentrated by centrifugation at 25000 x g for 2 hr at 4°C. Hie virus 
pellet was resuspended in a small volume of supernatant medium, 
sonicated until homogenous and stored at -70°c after checking 
sterility. Cell associated virus was prepared by sonicating the cell 
pellet from the low speed spin in a small volume of ECc> and clarified 
by centrifugation at 1500 x g for 10 min at 4°C. Sonication and 
centrifugation of the cell pellet was repeated if necessary. The 
supernatants, containing cell associated virions were pooled, checked 
for sterility, aliquoted in 1 ml volumes and stored at -70°C.
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2.2.b. Sterility checks on virus stocks
Virus stocks and cells were checked for sterility by streaking a 
loopful of virus or cell suspension on blood agar plates. The plates 
were incubated at 37°C and at room temperature (RT) and checked for 
bacterial or fungal contamination after 1 week. Cells were also 
checked for PPLO contamination by the Cytology section of the 
Institute.
2.2.c. Titration of stock virus
Serial 10 fold dilutions of virus stocks were made in PBSCa.
100 ul aliquots of each dilution were inoculated in duplicate onto 
semiconfluent monolayers of BHK 21/C13 cells in 50 mm petri dishes 
from which the medium had already been removed. Following absorption 
for 45 min at 37°C, monolayers were overlaid with 4 ml of EH^ to 
neutralize unadsorbed virus and to prevent secondary plaque formation. 
After 2 days at 37°C or 3 days at 31°C the monolayers were stained 
with Giemsa for 30 min at RT, washed with tap water and plaques 
counted using a dissection microscope. The virus titers were expressed 
as log pf u/ml.
2.2.d. Plaque purification of virus
The human serum containing medium was drained from BHK21/C13 
plates containing very few plaques (5 to 20) and the monolayers washed 
twice with PBSCa. Using a dissecting microscope, the virus infected 
cells from individual, well seperated plaques were taken up with narrow 
bore tipped 50 ml eppendorf pipjjsttes. These cells were transferred to 
glass vials containing 0.5 ml PBSCa and sonicated. After titration of 
the original plaques the procedure was repeated twice to obtain 
stable, purified virus isolates.
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2.3. VIRUS DNA TECHNIQUES
2.3.a. Preparation of HSV DNA
The methods of Wilkie (1973) and Stow and Wilkie (1976) were 
followed. In brief, nearly 80% confluent monolayers of BHK 21/C13 
cells in 10, 80 oz bottles were infected with HSV at a moi of 0.003 
pfu/cell. When extensive cpe had developed, cells were shaken into the 
medium and pelleted by low-speed centrifugation. Cytoplasmic extracts 
were prepared from the pellet by treating with 0.5% NP40 (v/v) in 10 
ml of RSB. After 10 min incubation on ice, samples were centrifuged at 
700 x g for 3 min to remove nuclei and cell debris. The supernatant 
was pooled with the clarified virus-infected cell medium while the 
pellet was resuspended in RSB/NP4q and extracted once more. Virus from 
the pooled supernatant was pelleted by centrifugation at 250 x g for 2 
hr at 4°C; the virus pellet was resuspended in 8 ml of NTE by 
sonication and lysed with SDS (2%, v/v) in the presence of 10 mM EDTA 
for 10 min on ice. The virus DNA was extracted sequentially, once with 
an equal volume of phenol and once with chloroform; precipitated with 
ethanol; lyophilized and redissolved in a small quantity of distilled 
water.
In some cases the DNA was further purified by caesium chloride 
density gradient centrifugation by adjusting the refractive index of 
the DNA solution to 1.041 by addition of heat inactivated powdered 
caesium chloride. After centrifugation at 150,000 x g (42,000 rpm) for 
18-20 hr at 15°C in a Beckman TV865B rotor, the gradient was dripped 
through a 20 gauge needle, into 12 to 15 fractions. Fractions 
containing DNA detected by ethidium bromide gel electrophoresis and UV 
illumination were pooled, dialysed against several changes of TE for 
16-20 hr, ethanol precipitated, redissolved in distilled water and 
stored at -20°C.
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2.3.b. Estimation of DMA concentration
Estimations of DNA concentration were made by comparison of 
different volumes of a DNA solution with standard ENA of known 
concentration after electrophoresis through an ethidium bromide 
stained agarose gel and visualisation by long wave length (365 nm) UV 
illumination. Bacteriophage lambda DNA or HSV DNA of known 
concentration were used as standards.
2.3.c. In vivo labelling of viral ENA with [^] orthophosphate
Radio-labelling of viral ENA with [^P]orthophosphate was carried
out using the Linbro well technique of Ejonsdale (1979) as modified by 
Brown et al, (1984). Linbrowells seeded 24 hr previously with 5 x 105 
BHK 21/C13 cells in PIC medium were infected with 10 pfu per cell of 
pretitrated virus stocks. Following absorption for 1 hour at 37°C 
infected monolayers were washed twice with PIC and overlaid with 450 
ul of PIC. After a further 2 hr at 31°C, 50 ul of PIC containing 50 
uCi of [32p] orthophosphate was added to each well and incubation 
continued for 48 hr at 31°C. Radio-active [^P]-labelled viral ENA was 
obtained by lysis of the infected cells with 2.5% (w/v) SDS at RT and 
sequential extraction with phenol and chloroform and ethanol 
precipitation. Aliquots of the ENA dissolved in distilled water were 
digested with a range of restriction endonucleases at concentrations 
sufficient to give complete digestion in 4 hr at 37°C. Digests were 
analysed by electrophoresis on agarose gels.
2.3.d. Restriction enzyme digestion of viral ENA
Viral DNA (1-2 ug/sample) to be digested with restriction 
endonucleases was mixed with 3 ul of an appropriate 10 x RE buffer 
containing 2-3 units of endonuclease per ug of DNA in a total volume 
of 30 ul in distilled water. After 4 hr at 37°C enzymatic digestion 
was terminated by adding one-sixth volume of RE stop solution.
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2.3.e. Agarose gel electrophoresis of viral ENA.
Agarose gels (0.5-1.2%) were made by dissolving an appropriate 
amount of agarose in 250 ml of E buffer. The agarose solutions were 
poured into 260 mm x 165 mm glass plate whose edges had been sealed 
with teflon tape and in which a 12 or 15 tooth comb had been inserted 
to form wells. When the gel had set the tape and comb were removed and 
the gel plate placed on a horizontal platform in a tank containing 
enough E buffer to form a shallow layer of liquid on top of the 
agarose. DNA samples (36 ul) containing one sixth volume of RE stop 
were electrophoresed at 2V/cm^ for 16-20 hr following which gels were 
dried at 80°C and autoradiographed by exposing to Kodak X-Omat S film.
2.3.f. Purification of DNA fragments from agarose gels
After electrophoresis and visualisation under U.V. illumination, 
gel slices containg DNA fragments were excised and the DNA eluted from 
the agrose by high voltage electrophoresis in TBE. DNA was further 
purified by treatment with phenol and chloroform (1:1, v/v) and 
precipitated with ethanol.
2.4. TRANSFECTION OF CULTURED CELTS
2.4.a. Cotransfection experiments to construct HSV-1 X HSV-2
RECOMBINANTS
For transfection of BHK21/C13 cells with HSV DNA, the modified 
calcium phosphate technique of Stow and Wilkie (1976) was followed. 
Semi confluent monolayers of BHK 21/C13 cells (4 x 10^ cells) in 50 mm 
dishes from which growth medium had been drained were overlaid with 
400 ml of HEBS containing 10 ug/ml calf thymus DNA, 0.1 to 0.2 ug of 
intact HSV DNA, 1 to 2 ug of the total fragments from Hpal or Xbal 
cleaved McKrae or HG52 DNA (reciprocal to the intact genomes), and 130 
mM calcium chloride.
i
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In cotransfections involving individual HG52 DNA fragments, a 10 
to 15-fold molar excess of the HG52 DNA fragment either purified from 
the gel or plasmid borne was cotransfected with intact McKrae DNA (0.1 
to 0.2 ug per 50 mm dish). Hie concentration of calf thymus DNA was 
either reduced or omitted from the transfection solution to avoid 
saturation of cells with exogenous DNA.
45 min post infection at 37°C dishes were overlaid with 4 ml of 
EC5. Pour to 6 hr post infection at 31°C, EC5 was replaced with 1 ml 
of 25% dimethylsulfoxide (DMSO) in HEBS for 4 min at RT. Residual DMSO 
was removed from the monolayers by gently washing twice with EC5. Four 
ml of EC5 was added to each dish and incubation continued for a 
further 3 to 5 days at 31°^ . Well isolated individual plaques were 
picked into 0.5 ml PBSCa, sonicated, plaque purified and grown into 
50mm plate stocks.
2.5. PLASMID DNA TECHNIQUES
2.5.a. Large scale isolation of plasmid DNA
Large scale isolation of plasmid DNA was achieved by the alkaline 
lysis method of Maniatis et al, (1982). Escherichia coli bacteria 
carrying plasmids containing HSV DNA inserts in pAT were grown in 5 ml 
L-broth culture containing the appropriate antibiotic by inoculating 
25 ul of a glycerol stock of bacteria into the medium and incubating 
at 37°C for 18 hr. Ihis culture was transferred to 500 ml of 
antibiotic containing L-broth and incubated for a further 18 hr at 
37°C in a Gallenkemp orbital incubator. Hie bacteria were pelleted at 
8000 x g for 5 min at 4°C and resuspended by vortexing in 14 ml of 
alkaline lysis solution I. Incubation on ice was continued and 20 ml 
of freshly made solution II and 15 ml of an ice cold solution III were 
sequentially added at 10 min intervals by vortexing. Ten min later 
plasmid DNA was recovered in the supernatant after centrifugation at
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4°C for 30 min at 45,000 x g in a SS34 rotor. DNA was sequentially 
extracted with phenol and chloroform and precipitated with 2 x volumes 
of ethanol at RT and pelletjd at 40,000 x g for 30 min in a SS34 rotor. 
The DNA pellet was washed with 70% ethanol, lyophilized and 
redissolved at 4°C overnight in 8 ml of TE buffer containing 10 ug per 
ml RNAase I. The DNA was further purified by CsCl gradient equilibrium 
centr ifugation.
2.5.b. Caesium chloride gradient purification of plasmid DNA 
Plasmid DNA in a solution containing caesium chloride and
ethidium bromide at final concentrations of 1 g/ml and 600 ug/ml 
respectively (final density 1.55 g/ml), was centrifuged at 130,000 x g 
(40,000 rpm) for 36 hr at 20°C in a Beckman Type-50 or Type-65 rotor 
(Maniatis et al, 1982). Plasmid DNA bands were visualised by long-wave 
UV (365 nm) irradiation and the lower band, containing super coiled 
plasmid DNA, was collected by side puncture of the the tube with a 
needle and syringe. Following removal of ethidium bromide from the 
solution by sequential extractions with isoamyl alcohol saturated with 
caesium chloride, the DNA was dialysed overnight against TE. DNA was 
finally precipitated with ethanol, pelleted by centrifugation and 
redissolved in distilled water and quantified.
2.6. DNA BLOT HYBRIDIZATION
2.6 .a. Transfer of viral DNA fragments to nitrocellulose membranes 
The procedure followed was essentially that of Southern (1975) in
which single stranded DNA is immobilized on a nitrocellulose membrane, 
The agarose gel containing the separated DNA fragments was treated 
with gel soak I for 1 hr to denature the DNA and neutralized in gel 
soak II for 1 hr. The gel was then transferred onto two sheets of 
Whatman 3 mm filter paper which were in contact with, but not covered,
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by 10 x SSC buffer. A sheet of nitrocellulose moistened with SSC was 
placed on top of the gel, followed by four sheets of 3 mm filter paper 
cut 2 mm smaller than the gel size. Finally, a weighted stock of cut 
paper towels was laid on the Whatman paper. Hie following day, the 
nitrocellulose sheet was removed, air dried and baked in a vacuum oven 
at 80°C for 2 hr. Efficient transfer of DNA fragments from the gel was 
monitored by visualizing the blotted gel under UV light.
2.6.b. In vitro (3 2P]-labelling of viral DNA by nick translation 
Viral DNA fragments were labelled with [32p] essentially as
described by Rigby et al, (1977). 0.5ug DNA was labelled with 2 uCi 
[32P] dCTP using 1 unit of DNA polymerase in a 30 ul reaction mixture 
containing 3 ul 10 x nick translation buffer, 2.25 ml each of 0.2 mM 
dATP, dGTP, dTTP; 1 ul each of 1% (w/v) BSA and 1 x 10"*^  mg/ml DNAase. 
Following a 2 hr incubation at 15°C the DNA was precipitated on dry 
ice for 15 min with 0.6 volume of isopropanol and 0.1 volume of 3M 
sodium acetate. Hie DNA pellet, recovered by microfugation for 5 min 
was resuspended in 50 ul distilled water and reprecipitated with 
isopropanol and 3M sodium acetate. Hie labelled DNA, redissolved by 
boiling for 5 min in 100 ul of 80% formaldehyde was used as a probe 
for hybridization.
2.6.C. DNA Blot hybridization procedure
DNA hybridization in aqueous solution, under high stringency 
conditions was carried out according to the procedures of Southern
(1975) and Denhardt (1966). Nitrocellulose membranes containing DNA
CL
fragments were prehybridized in 10 ml of hybridization buffer in sealed 
plastic bags submerged in a shaking water bath at 75°C. After a 
minimum of 2 hr, the buffer was replaced with 10 ml fresh 
hybridization buffer containing the denatured [32P]—labelled nick 
translated DNA probe. Hybridization at 75°C was terminated after 48 hr
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by washing for 1 hr each at 60°C with 4 x 1  litre volumes of wash 
buffer. Blots were air dried and placed in contact with Kodak X-Omat S 
films for 16-24 hr at RT or fluorographed in conjunction with a DuPont 
phosphotungstate intensifying screen at -70°C for 3-4 days.
2.7. ANALYSIS OF VIRUS_INDUCED POLYPEPTIDES
2.7.a. Infection of cells and labelling with J^S]-methionine 
80% confluent BHK21/C13 monolayers in 30mm petri dishes
containing 1 x 10  ^cells were infected with virus at a moi of 20 pfu 
per cell in a 0.1 ml inoculum. After 1 hr adsorption at 37°C, the 
cells were gently washed twice with 1 ml of EC-^ q 1/5 met. medium 
preheated to 37°C to remove unabsorbed virus and were finally overlaid 
with 0.5 ml of the same medium. The infected monolayers were incubated 
at 37°C and at 3 hrs post absorption, 50 uCi of [^S] methionine was 
added to each infected dish.
2.7.b. Sample preparation
Essentially the method of Marsden et al (1976) was followed.
After 18-24 hr incubation at 37°C, the radioactive medium from the 
infected dishes was discarded, the cells were washed twice with PBS, 
and solubilized by incubation for 10 min at 60°C in boiling mix 
diluted 1 in 3 with distilled water. The samples, transferred to glass 
vials were heated to 100°C for 2 min and a 100 ul spotted onto a 
Whatman number 1 filter disc, which was air dried. Following 
sequential washing of the discs twice in ice cold trichloroacetic acid 
(5% w/v) and once with absolute alcohol, the amount of radioactivity 
was measured in each disc in the usual way. The radioactive contents 
in each sample were standardized, using boiling mix as a diluent,so 
that each contained the same amount of radioactivity per unit volume.
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2.7.c. SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Polypeptides were separated on discontinuous slab gels prepared
according to the method of Studier (1973) as modified by Marsden et al
(1976). Gradient gels composed of a 5-12% linear gradient of 
acrylamide cross linked with 1 part in 20 (w/v) N-N'- 
methylenebisacrylamide in resolving buffer were formed using a 
Technicon fractionating pump operating at 1.76mls/min. Polymerization 
was achieved by the addition of ammonium persulphate (0.006% w/v) and 
TEMED (0.004% v/v) to the gel solution just before pouring into the 
gel sandwich, held in a tank containing cold water in order to 
disperse heat during polymerization. The gel was overlaid carefully 
with either resolving gel buffer (1/4 strength) or butan-2-ol, to 
ensure a smooth interface for polymerization. Stacking gel was 
prepared shortly before sample loading and contained 5% acrylamide 
cross linked with 1 part in 30 (w/w) N-N'-methylenebisacrylamide in 
stacking gel buffer. Wells were formed with teflon combs. 0.01ml 
sa-mples of each infected cell extract were loaded into wells and 
electrophoresed in a freshly prepared tank buffer at 40 mAmps for 3 to 
4 hr or at 10 mAmps for 18 hr or until the Bromophenol blue dye front 
emerged from the end of the gel. At the end of electrophoresis the gel 
was removed and fixed/stained for 1 hr at room temperature, destained 
and rehydrated by addition of several changes of destain for 2 hr. The 
gel was dried onto paper using a Bio Rad gel slab drier, operating 
under a vacuum of 30 inches of mercury, and exposed to Kodak X-Omat, 
X-ray films for various lengths of time and developed in a X-Omat film 
processor.
2.8. STUDIES WITH RECOMBINANT VIRUSES IN RABBITS
2.8 .a. Inoculation of rabbit eyes
Individual New Zealand white rabbits were inoculated with 50ul of
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PBS containing 105 to 107 pfu of either HSV-1 McKrae or HSV-2, HG52 or 
McKrae X HG52 recombinants into the lower cul-de-sacs of their left 
eyes. Closed eye lids were gently massaged against the unscarified 
cornea for 1 min. Only the left eye of each rabbit was inoculated to 
abide by the Animal Experimentation Act regulations. Primary ocular 
infections including severe eye inflammation, dendritic or geographic 
ulcerations of the corneal epithelium and stromal involvement were 
confirmed by examination with a strong light in the presence of 
fluorescein stain from days 2 to 7 post infection. The exact titer of 
the virus inoculum was determined by titration of the virus on the 
same day as infection of the rabbit eyes.
2.8.b. Determination of virus shedding from the rabbit eyes
Eye swabs were collected in 0.5ml of PBS containing 1% (v/v) 
bovine foetal calf serum after gently rotating a sterile cotton tipped 
applicator in the upper cul-de-sac then across the cornea and into the 
lower cul-de-sac of the left eye of each rabbit. Swabs were vortexed 
for 1 min and the cotton tipped applicator sequeezed out into the PBS. 
A 150-200ul aliquot of the PBSFc was inoculated onto each of two semi­
confluent BHK21/C13 50mm monolayers. Following absorption for 45 min 
the dishes were overlaid with EC5 or EH5 and incubated at 31°C for one 
week. Monolayers showing extensive cpe were harvested by scraping the 
infected cells into the medium. Virus was released by sonication at - 
70°C. A representative number of individual plaques from the dishes 
overlaid with EH5 were picked into PBSca, grown to plate stocks and 
stored at -70°C till further analysis.
2.8.C. Iontophoresis of epinephrine (adrenalin) to induce shedding of 
virus in the rabbit eyes
Rabbit eyes were iontophoresed with 1-epinephrine (adrenalin) 
essentially as described by Kwon et al (1981). An eye cup was inserted
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with its periphery within the limits of the corneal limbus of the left 
eyes of rabbits pre-anaesthetised with xylazine (4mg/kg, intra­
muscular) and ketamine (20mg/kg, intramuscular). A 0.01% 1-epinephrine 
(w/v, in water) solution was added into the eye cup. The cathode was 
attached to a shaved area of the rabbit trunk through an ECG electrode 
and the anode made a wet contact with the ocular solution through a 
paper wick. A direct current (0.8 mAmp; 7 volts) was applied for 7 
min. Iontophoresis was performed once a day for 3 consecutive days.
Eye swabs were collected each day for a minimum of one week and 
screened for shedding of infectious virus in the tear film by 
inoculation of control BHK21/C13 cells.
2.8.d. Explantation of trigeminal ganglia and corneas
Rabbits failing to shed virus in the tear film for one week, 3-4 
weeks post iontophoresis, were sacrificed and both left and right eye 
balls and the trigeminal ganglia were dissected out in EF25 and 
transferred under aseptic conditions to the laboratory. Tissues were 
washed 3 times in cold EF25. Corneal discs were dissected out from the 
rest of the eye ball, washed again with EF25/ divided into 6 segments 
and explanted into 200-250 ul EF25 in wells of microtiter plates. Each 
trigeminal ganglion was similarly divided into six segments and seeded 
in EF25 in microtiter plates. The latter were incubated at 31°C. 
Supernatant medium (150 to 200ul) from each well explant was added to 
semiconfluent BHK21/C13 cell monolayers grown in 96 well microtiter 
plates and screened for virus daily for the subsequent 4 weeks. 
Infected cells from these wells in which the supernatant produced cpe 
on BHK21/C13 cells within 4 days, were harvested, the virus released 
by sonication and stored at -70°C till further analysis.
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2.8.e. Identification of viral isolates
Viral isolates from ocular swab cultures and tissue explants were 
analysed by restriction endonuclease digestion of [^P] in vivo 
labelled DNA by the method of Ionsdale (1979) as described previously.
2.9. DNA CLONING
2.9.a. Sub-cloning of HSV fragments
The linearised plasmid pSl containing HSV-1 Orig was treated with 
calf intestinal phosphatase at a concentration of 5 units per ug of 
plasmid DNA. After incubation at 37°C for 1 hr, the DNA was extracted 
once with phenol: chloroform (1:1 v/v), once with chloroform, and 
precipitated with ethanol. A 3x molar excess of a purified HSV2 DNA 
fragment (Hindlll h) relative to the phosphatase treated plasmid 
(lOng) was incubated overnight at 15°C in 20ul of ligation buffer 
containing 1 unit of T^ ENA ligase. ENA was sequentially extracted 
once with phenol:chloroform and once with chloroform, ethanol 
precipitated and redissolved in a small volume of ligation buffer.
2.9.b. Transformation of E.coli
One ul (10-20ng) of ligated DNA (HSV-1 Oris plus HG52 Hindlll h) 
was added to 20ul of frozen E.coli DH5 ligation competent cells (BRL) 
in chilled sterile Eppendorf tubes. This suspgsion was incubated on 
ice for 30 min followed by a 40 seconds pulse in a 42°C water bath.
The tubes were then transferred to ice, 80ul S.O.C. added to each and 
shaken at 225 rpm at 37°C for 1 hr before being plated on L-broth agar 
containing ampicillin. After 16-18 hr incubation at 37°C, individual 
colonies were picked, grown in 5ml of Ir-broth as overnight suspension 
cultures and the plasmid DNA analysed for the presence of the HSV 
fragment by digestion with restriction endonucleases. As controls, DH5 
cells were similarly transformed with an equal amount of the HSV 
fragment ENA alone, linear’ised plasmid pSl ENA, and plasmid pSl after
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ligation with T4 ligase. Colonies containing an HSV insert were 
further plaque purified before a large scale plasmid DNA stock was 
prepared.
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CHAPTER 3 
RESULTS
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3.1. INTRODUCTION
The aim of the work presented in this thesis was to determine the 
viral gene(s) controlling reactivation of HSV from latency in the 
rabbit eye model. On the basis of spontaneous virus shedding, 
different strains of HSV have been classified as high frequency 
recurrence (HFRc) phenotype or low frequency recurrence (LFRc) 
phenotype, in the rabbit eye model (Gerdes and Smith, 1983). HSV-1 
strain McKrae and HSV-2 strain HG52 were designated as HFRc and LFRc 
respectively. As both strains were able to go latent in trigeminal 
ganglia (TG) with equal frequencies, it was suggested that the viral 
genes involved in reactivation could be identified by the construction 
of intertypic recombinants between HFRc and LFRc parents. To this end 
a series of McKrae X HG52 recombinants have been constructed and their 
behaviour in vivo compared to the parental McKrae and HG52 strains 
using the rabbit eye model of latency.
3.2. REACTIVATION POTENTIAL OF WILD TYPE HSV-2 (HG52) AND HSV-1
(McKRAE) IN THE RABBIT EYE MODEL OF LATENCY
To confirm the findings of Gerdes and Smith (1983) and to 
determine whether the recurrence phenotype holds true for induced 
reactivation, out bred New Zealand White rabbits were inoculated in 
the left eyes only with 50 ul of virus suspension containing 5xl05, 
5xl06 or 5xl07 pfu of either HSV-1 strain McKrae or HSV-2 strain HG52. 
Rabbits inoculated with 5xl06 and 5xl07 pfu of McKrae either died soon 
after the initial infection or had to be sacrificed within a few days 
post infection because of severe distress including encephalitis. 
Rabbits infected with 5x10^ or 5xl07 pfu of HSV—2 strain HG52 could 
tolerate the infecting dose without any adverse effects. Spontaneous 
shedding of virus was detected by screening tear film swabs from the 
infected eyes on control BHK21/C13 cells. Two to three weeks post
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infection swabs were collected and screened daily for 7 days. 
Reactivation of latent virus was induced by iontophoresis of 
epinephrine (adrenalin) daily for 3 consecutive days between 6-8 weeks 
post infection. Reactivated virus was detected by inoculation, onto 
BHK21/C13 cells, of tear film swabs from the infected eyes for 7 days 
post iontophoresis. Before epinephrine iontophoresis rabbit eyes were 
briefly screened for spontaneous shedding. Results of spontaeous and 
epinephrine induced virus shedding are presented in Table 2. Of the 11 
rabbits infected with 5x10^ pfu of McKrae, all shed virus both 
spontaneously and on induction with epinephrine iontophoresis. 
Spontaneous shedding of virus was detected between day 21 and 34 post 
infection. As the eyes were only monitored once (for 7 days) for 
spontaneous shedding (apart from immediately prior to epinephrine 
iontophoresis), it is possible that virus was being shed in the tear 
films on days when the eyes were not being monitored. Following 
epinephrine iontophoresis, reactivated virus was first detected as 
early as 24 hr post iontophoresis and continued to be shed in some of 
the rabbits up to 8 days post iontophoresis. None of the rabbits were 
shedding spontaneously immediately prior to epinephrine iontophoresis.
Of 154 left eye tear film swabs screened from 22 rabbits infected 
with different doses of HG52, no spontaneous shedding was detected 
from any of the eyes during the period of observation. None of the 9 
rabbits inoculated with either 5xl05 or 5xl06 pfu of HG52 demonstrated 
any evidence of virus reactivation upon iontophoresis of epinephrine. 
However, 2 of the 13 animals each inoculated with 5xl07 pfu of HG52 
shed virus in their tear films after iontophoresis of epinephrine. 
Reactivated virus was first detected on day 3 and continued to be shed 
up to 5 days post iontophoresis.
Two to three weeks after iontophoresis and when the tear films
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TABLE 2
Spontaneous and epinephrine iontophoresis induced reactivation
of HSV1 (McKrae) and HSV2 (HG52) from rabbit eyes
Virus
(dose/rabbit)
Rabbit Left eye 
No. spontaneous shedding 
(days post infection)
Left eye
epinephrine induced 
shedding
(days post iontophoresis
McKrae 
5x105 pfu
1
2
3
4
5
6
7
8 
9
10
11
27-34
27-34
27-34
27-34
27-34
21-25
21-25
21-25
21-25
21-25
21-25
3-5
2-6
3-6
3-6
3-5
1-5
1-5
1-5
2-8 
2-3 
2-5
HG52
5x 0 pfu
5x10** pfu
5x10^ pfu
1
2
3
4
5
6
1
2
3
4
5
6
7
8 
9
10
11
12
13
3-5
3-5
were negative for spontaneous shedding of virus, rabbits were 
sacrificed. Both left and right corneas and trigeminal ganglia (TG) 
were explanted in vitro and screened for 6-8 weeks for the release of 
latent virus. Results of shedding of latent virus from the explanted 
ganglia and corneas are presented in Table 3. From 11 animals infected 
with 5x10^ pfu of McKrae, infectious virus was recovered from all the 
explanted LTG between 5 and 20 days post explantation. Virus was also 
recovered from the RTG of 4 animals between 5 and 20 days post 
explantation. Release of infectious virus was detected between 5 and 
30 days post explantation from all the explanted LTG from 8 rabbits 
infected with either 5x10^ or 5x10^ pfu of HG52. The RTG from one of
7
the rabbits inoculated with 5x10 pfu of HG52 released virus between 
13 and 20 days post explanation.
Left corneal explants from one out of eleven rabbits infected 
with 5x10^ pfu of McKrae released virus between 18 and 21 days post 
explantation. Neither the corneal explants from the rabbits infected 
with HG52 nor the right corneas from the rabbits infected with McKrae 
were positive for release of latent virus.
The results presented in Tables 2 and 3 substantiate the 
spontaneous shedding findings of Gerdes and Smith (1983) and indicate 
that the high frequency recurrence phenotype (HFRc) of HSV-1 strain 
McKrae and low frequency recurrence phenotype (LFRc) of HSV-2 strain 
HG52 are due, at least in part, to virus encoded functions.
3.3. RESTRICTION ENDONUCLEASE MAPPING OF THE McKRAE GENOME
Before constructing recombinants between HSV-1 strain McKrae and 
HSV-2 strain HG52, it was necessary to determine the restriction 
endonuclease profiles of the McKrae virus genome. Hie restriction 
patterns of the McKrae DNA were compared with those of HSV-1 strain 17 
on digestion with various endonucleases. Hie restriction maps of
syn+
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TABLE 3
Release of virus from explanted trigeminal ganglia (TG) and corneas
Virus Rabbit Left TG Right TG Left Cornea Right Cornea
(Dose/rabbit) No. ( D a y s  p o s t  e x p l a n t a t i o n )
McKrae 
5x10^ pfu
HG52 
i) 5x10** pfu
ii) 5xl07 pfu
1 7-8 —
2 6-17 -
3 6-17 7-17
4 5-17 -
5 5-16 5-16
6 12-20 14-20
7 8-20 15-20
8 13-20 -
9 9-13 -
10 9-13 -
11 7-15 —
1 8-20 -
2 11-20 -
3 18-20 -
1 8-20 -
2 8-20 -
3 5-20 -
4 7-20 13-20
5 22-30 -
18-21
HSV—1 strain 17 of Wilkie (1976) and Davison (1981) are shown in 
Figure 28 together with those of HSV-2 strain HG52 (Cortini and 
Wilkie, 1978).
3.3.a. Hindlll profile
Comparison of the Hindlll profile of McKrae ENA with that of 
strain 17 revealed the absence of the 0.5 molar (M) m fragment; the 1M 
n fragment and the two 0.25 M joint fragments f (i+m) and c (d+m) 
(Figure 29A ). Two novel high molecular weight bands can be seen: one 
comigrating with fragments a, b, and the second running slightly below 
fragments d, e. A novel band running slightly above fragments h, ± is 
also observed in the McKrae profile. The data is consistent with the 
absence of the Hindlll m/n site in McKrae giving rise to a fragment 
of 7.4x10** mw (m+n) which is migrating slightly above h, _i (7x10** 
m.w.). The size of the novel joints (m+n+i) 14.4x10** mw i.e. f!' and 
(m+n+d) 25.4x10** mw i.e. c1 is consistent with the positions of the 
bands running below d, e (17.5x10** mw) and with a, b (26x10** mw) 
respectively.
3.3.b. EcoRl profile
The EcoRI restriction profile of the Mckrae genome revealed the 
same number of restriction sites as strain 17 (Figure 29B). The 
mobilities of three bands were different from those of strain 17. 
Fragment h was slightly larger in size and fragments k and 1 were 
slightly smaller.
3.3.c. Bglll profile
Comparison of the Bglll digests of McKrae ENA with that of strain 
17 indicated egual numbers of restriction fragments in each digest. No 
differences in mobilities of the various fragments were observed 
(Figure 30A).
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FUGURE 28
Physical maps of HSV-1 strain 17 and HSV-2 strain HG52 DNAs for 
the restriction endonucleases Xbal, Hindlll, EcoRI, Hpal, Bglll, Kpnl 
and BamHI (Wilkie, 1976; Gortini and Wilkie, 1978; Davison, 1981). The 
restriction sites in HSV-1 are shown above, and those in HSV-2 are 
shown below the prototype genome model of HSV. The origin of the joint 
fragments is as follows:
Strain 17: Xbal, a = d+ [s]; b = g+ [s].
Hindlll, b = d+£; c = d+m; e = _i+£; f, = £+m.
EcoRI, b = e+_k; c = j+k.
’ Hpa I, a. = c+m; d = £+m.
Bgl ii, a = f+h; b = j+h; c = ^+1^ ; e = 2 +1,
Kpnl, a = £+j_; e = r_+k,
BamHI, k. = £+£.
Strain HG52: Xbal, a = h+c, b = _i+c, e = h+£; f - _i+£.
Hindlll, c = k+i, d = k_+£; f_ = m+£; £ = m+£.
EcoRI, b = k+f; c = _k+h; d = m+f, e = m+h.
Hpal, b = £+ [ s ]; c = £+ [ s ].
Bglll, a = k_+d; b = m+d; e = £+h; _f = m+h.
Kpn I, b = c+r; e = £+£.
BamHI, g = v + u.
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FIGURE 29
Autoradiographs of Hindlll (A) and EcoRI (B) restriction digests 
of HSV-1 strain 17 and HSV-1 strain McKrae DNA. [22P]-labelled virus 
DNA was digested with the enzymes under standard conditions and 
electrophoresed on 0.6% agarose gels. Letters refer to specific HSV-1 
fragments (Figure 28). ( <1 ) denotes missing fragments.
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FIGURE 30
Autoradiographs of Bglll (A) and Hpal (B) digests of HSV-1 
strains 17 and McKrae DNAs. [32P]-labelled virus DNA was digested with 
the enzyme under standard conditions and electrophoresed on 0.6%
(Bglll) and 0.8% (Hpal) agarose gels. Letters refer to the specific 
HSV-1 fragments (Figure 28).
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3.3.d. Hpal profile
No differences were observed in the number or sizes of the 
various fragments obtained from a Hpal digest of Mckrae compared to 
that of strain 17 (Figure 3OB).
3.3.e. BamHI restriction profile
The BamHI profile of the McKrae genome showed a number of 
differences when compared with that of strain 17 (Figure 31A). The 1M 
a band is smaller by approximately 1x10^ mw and, therefore, migrates 
closer to the b band. Hie molar j_ J2 hands are larger by 0.1x10^  mw 
and are migrating closer to i_ and m respectively.
Other differences were investigated by Southern blot analysis. As 
shown in Figure 31B, Southern blotting of BamHI digests of McKrae ENA 
with the Kpnl x fragment of strain 17 cloned in plasmid pGXl46 
revealed hybridization with BamHI r_ and with a band of approximately 
1.7x10 mw running below the s t. fragments (B ii). With strain 17 
there was normal hybridization to fragments r_ and w indicating that w 
in McKrae is larger by 0.3x10^  mw. Probing of the BamHI digests of the 
two viruses with the Kpnl jl fragment (cloned in plasmid pGX128) of 
strain 17 gave, as expected, hybridization with the BamHI m, t, a|_ and 
V fragments which were colinear in both digests (B, iii). Similarly 
probing with the BamHI V fragment (cloned in plasmid pGX92) of strain 
17 revealed the colinearity of fragment _v in both strains (B, iv). 
Hydbridization of BamHI digests of both viruses with the BamHI £ 
fragment (cloned in plasmid pGX40) of strain 17 showed that the z 
fragment in McKrae is larger by 1.4x10^ mw than that of strain 17 
(B, v).
3.3.f. Kpnl profile
The Kpnl digest of the McKrae genome exhibited most variation
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FIGURE 31
Mapping of BamHI restriction sites in the McKrae genome relative 
to strain 17.
A. Autoradiographs of [^P] -labelled BamHI digests of strain 17 and 
McKrae DNA. Letters refer to specific HSV-1 BamHI fragments 
(Davison, 1981).
B. Autoradiographs of nitrocellulose blot strips containing BamHI 
restriction fragments of HSV-1 strain McKrae (left track of each 
pair) and HSV-1 strain 17 (right track of each pair) to which 
nick translated ENA probes have been hybridized. Ihe probes were 
HSV-1 strain 17 DNA (i); the recombinant plasmid pGXl46 (Kpnl x) 
DNA (ii);_ the recombinant plasmid pGX128 (Kpnl _i) DNA (iii); the 
recombinant plasmid pGX92 (BamHI v) ENA (iv); and the recombinant 
plasmid pGX40 (BamHI z) DNA (v). Letters denote specific BamHI 
fragments (Figure 28).
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when compared with that of strain 17 (Figure 32A). Three of the 
fragments in the group a b e  and d showed variation in mobilities and 
at least two appeared to be larger. In addition the mobilities of the 
cj, h and £ fragments also appeared to be altered.
Southern blot hybridization of Kpnl digests of McKrae with Kpnl 
cloned fragments of strain 17 (Figure 32B) showed that Kpnl c 
(contained in plasmid pGXl22) hybridized to one of the large fragments 
at the top of the gel (B, iii). In addition Kpnl x (contained in 
plasmid pGX146) also hybridized to this band (B, vii) indicating that 
the Kpnl c/x site in McKrae has been deleted. Similarly hybridization 
of Kpnl d (contained in plasmid pGX123) to the other large fragment 
(B, iv) indicated an increase in the size of d possibly due to removal 
of the d/z site. When Kpnl b and Kpnl g were used as probes, (Bii,
Bvi) there was hybridization to two fragments near the top of the gel 
and to a third fragment running near u. This is interpreted as 
indicating the presence of an additional Kpnl site in both copies of 
R^ such that the b and g fragments are reduced in size by 
approximately 2 x 10^ mw. Hie observed difference in the mobilities of 
the g' b' fragments in tracts in which the BamHI cj and BamHI b 
fragments of strain 17 have been used as probes is due to these tracts 
arising from two independent blots of McKrae DNA digested with Kpnl 
and electrophoresed at two different times. Probing with Kpnl t_ of 
strain 17 (contained in plasmid pGX125) indicated the colinearity of 
this fragment in both McKrae and 17 (B, v).
The major alterations in the restriction sites of McKrae relative 
to strain 17 are depicted in Figure 33.
3.4. OBSTRUCTION OF McKRAE X HG52 RECOMBINANTS
3.4.a. Introduction
As the purpose of this study was to map the viral genes
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FIGURE 32
Mapping of Kpnl restriction enzyme sites in the McKrae genome 
relative to strain 17.
A. Autoradiographs of [^P] -labelled Kpnl digests of McKrae and 
strain 17 virus DNA. Letters refer to specific HSV-1 Kpnl 
fragments (Figure 28).
B. Autoradiographs of nitrocellulose blot strips containing Kpnl 
restriction fragments of HSV-1 McKrae (ii to vii and left trac^ 
in i) and HSV-1 strain 17 (right tracK in i) to which nick 
translated DNA probes have been hybridized. Hie probes were HSV-1 
strain 17 DNA (i); the recombinant plasmid pGX121 (Kpnl b) DNA 
(ii); the recombinant plasmid pGX122 (Kpnl c) DNA (iii); the 
recombinant plasmid pGX123 (Kpnl d) DNA (iv); the recombinant 
plasmid pGX125 (Kpnl J) DNA (v); the recombinant plasmid pGXl26 
(Kpnl cj) DNA (vi) and the recombinant plasmid pGX146 (Kpnl _x) DNA 
(vii). Letters refer to specific Kpnl fragments (Figure 28).
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FIGURE 33
Diagrammatic representation of major alterations in restriction 
endonuclease sites in the McKrae genome relative to strain 17.
H - Hindlll, K - Kpnl site 
A- site deleted, a  extra site
Letters refer to specific Kpnl and Hindlll fragments.
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controlling reactivation of HSV from latency by making recombinants 
between HSV-1 strain McKrae and HSV-2 strain HG52, the logical 
approach was to insert specific cloned fragments of HG52 into the 
intact McKrae genome. The role of specific groups of genes could, 
therefore, be determined in a systematic way.
3.4.b. Use of cloned HG52 DNA fragments
Intact McKrae DNA was cotransfected onto BHK21/C13 cells with 
cloned individual Hindlll fragments of HG52 DNA by the calcium 
phosphate precipitation/DMSO boost method of Stow and Wilkie (1976). 
The HG52 DNA fragments used in independent cotransfection experiments 
included Hind III a, b and h cloned in plasmids pGZ26, pGZll, and 
pGZl5 respectively. In order to find the optimum concentration of DNA 
of the various fragments to be used in transfection experiments, the 
fragments were cotransfected at a 2 to 50-fold molar excess over the 
intact McKrae genomes (0.1 to 0.2 ug per dish). Progeny plaques were 
obtained when up to a 20-fold molar excess of the fragment was used. 
No plaques were obtained at a 50-fold molar excess. A 10-fold to 15- 
fold molar excess of the cloned HG52 DNA fragment was selected as the 
maximum and used in all the cotransfection experiments.
The use of cloned fragments of HG52 ENA in making McKrae X HG52 
recombinants was found to be uniformally unsuccessful in that no 
recombinants were isolated after restriction endonuclease screening of 
1138 progeny plaques. Screening of 748 progeny plaques from 
cotransfections using Hindlll a, b or h fragments excised and purified 
from agarose gels instead of cloned fragments also did not yield any 
recombinant viruses. It should be noted that no selection pressure was 
used in the isolation of progeny plaques.
3.4.C. Marker transfer technique
The inability to isolate any recombinants from the experiments
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outlined above could have been due, at least in part, to an inherent
failure in the system e.g. the BHK21/C13 cells being used may not have
/been efficient for transfection or , poor DNA preparation <t>r a poor
7 A
technique. On the other hand it may merely reflect the inability to
detect recombinants because of lack of a selectable marker.
The technique of marker transfer of ts mutations was used to make
recombinants between McKrae and HG52. Intact McKrae genomes were
cotransfected with HG52 ts mutant DNA (ts!3 or tsl or ts!2). The ts
mutant genomes were digested with appropriate restriction enzyme,
electrophoresed on agarose gels and the DNA fragments containing the
ts mutations were excised from the gels. The DNA was electroeluted and
ethanol precipitated before being used in cotransfection experiments.
The growth of the progeny plaques was compared at the permissive
temperature (PT)-31°C and at the nonpermissive temperature (NPT)-
38.5°C. Of 927 plaques analysed (345 for tsl3, 275 for tsl and 307 for
tsl2), none demonstrated temperature sensitivity indicating that the
HG52 fragments containing the _ts mutations had not been recombined
into the McKrae genomes.
3.4.d. Random genome recombination using intact virion infections
Isolation of intertypic recombinants between different strains of 
HSV-1 and HSV-2 by co-infection of cells with ts mutants of both 
strains and selection of wild-type recombinant viruses at the NPT has 
been reported (Timbury and Subak-sharpe, 1973; Esparza et al, 197£jp 
Morse et al, 1 9 7 7 ) .
To obtain inteijypic recombinants between HSV-1 strain McKrae and 
HSV-2 strain HG52, BHK21/C13 cells were co-infected at 37°C with 5 pfu 
per cell of each virus. Twenty-four hr after infection at 37°C, the 
cells were scraped into the medium, sonicated and the progeny virus 
titrated under an EH^ overlay. Of nearly 500 progeny plaques analysed
by restriction endonuclease digestion of [32p]-orthophosphate labelled 
viral DNA no recombinants were detected.
3.4.e. Intratypic marker rescue of ts mutations
In order to rule out the possibilty that the inability to isolate 
any McKrae X HG52 recombinants from the experiments outlined above 
was due to an inherent failure in the system e.g. the BHK21/C13 cells 
used, being inefficient for transfection; poor DNA preparation; poor 
technique etc., intratypic marker rescue of ts mutations was carried 
out.
0.2 ug of HG52 ts5 DNA was cotransfected at 31°C with 2 ug of 
HG52 ts9 ENA by the calcium phosphate technique as described in 
Methods section 2.4. On development of extensive cpe, the transfected 
cells were scraped into the medium and sonicated to release progeny 
virus. Virus yields at the PT (31°C) and NPT (38.5°C) were compared.
In control experiments the DNA of one of the ts mutants was 
substituted with an equal quantity of calf thymus DNA. The virus 
yields at the PT and NPT expressed in pfu/ml are presented in Table 4.
As expected the individual ts mutant DNAs did not yield progeny 
virus which grew at 38.5°C while a progeny virus titer of 4xl03 pfu/ml 
and 6x10** pfu/ml was obtained at 31°C from ts5 and ts9 DNA 
transfections respectively. When the cells were cotransfected with the 
DNA of both mutants a progeny yield of 7x10^ pfu/ml was obtained at 
38.5°C and 6xl06 pfu/ml at 31°C. The results show that the DNAs of ts5 
and ts9 had transfected efficiently and had recombined to yield wild 
type progeny virus capable of growth at 38.5°C. The results also show 
that the BHK21/C13 cells used throughout this study were capable of 
being transfected and of supporting HSV recombination and that the 
inability to obtain recombinants between McKrae and HG52 was not due 
to the transfection procedure or due to an inherent property of the
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TABLE 4
Intratypic marker rescue of HG52 (ts 5 x ts 9) ts mutants
Mutant Progeny virus yield pfu/ml at
DNA 1 PT (31°C) NPT (38.5°C)
ts 5 4 x 105 < 101
ts 9 6 x 10** < 10^
ts 5 x ts 9 6 x 10** 7 x 10^
cells being used.
3.4.f. Restriction endonuclease cleaved genomes
BHK21/C13 cell monolayers (4x10^  cells) in 50 mm dishes were 
cotransfected with intact McKrae genomes (0.2 ug) and a 10-fold molar 
excess of the total products of either Hpal or Xbal cleaved HG52 
genomes (2 ug per dish). Progeny plaques were picked, their DNA
on
labelled in vivo with ( P) orthophosphate and analysed by digestion 
with various restriction endonucleases.
Of 405 plaques analysed from cotransfection experiments using 
Hpal digested HG52 genomes, 8 recombinants were identified (a 
recombination frequency of 1.97%). Of 236 progeny plaques screened 
from cotransfections using Xbal cleaved HG52 genomes, 3 recombinants 
were identified (a recombination frquency of 1.27%). The overall 
frequency of recombination was 1.72% (11 out of 641).
3.5. CHARACTERIZATION OF THE McKRAE X HG52 RECOMBINANTS
3.5.a. Nomenclature of the recombinant viruses
All the recombinants were plaque purified three times before 
raising virus stocks. Hie recombinants isolated from transfections 
using Hpal cleaved HG52 genomes were designated R10/3/1, R10/3/4/6, 
R10/4/1, R20/4/1, R30/3, R40/2/2, R40/2/4 and R43/2/2. Recombinants 
isolated from transfections involving Xbal cleaved HG52 genomes were 
designated R5/26/1, R47/27/1 and R7/3/3.
3.5.b. Clonal relationship of the recombinant viruses 
Recombinants R10/3/1 and R10/3/4/6 were isolated as separate,
individual plaques from a single transfection experiment. Similarly 
recombinants R40/2/2 and R40/2/4 although from separate plaques were 
from a single transfection. Hie two recombinants from each 
transfection could therefore be clonally related. The other
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recombinants were isolated from independent transfections and were, 
therefore, clonally unrelated.
3.5.c. Genome structure of the recombinant viruses
Hie genome structure of the recombinants was deduced from 
restriction endonuclease analyses of recombinant virus DNA labelled in 
vivo with [32p] orthophosphate and digested with a range of 
restriction enzymes. The boundaries of the heterologous insert 
sequences were mapped by comparing the presence or absence
of restriction sites in the recombinant genomes corresponding to those 
of the type I or type II parent.
(i) Genome analysis of recombinant R10/3/1
Hie genome structure of R10/3/1 was deduced from the analyses of 
Hpal and BamHI restriction endonuclease profiles.
In the Hpal digest the 1M HSV-1 b and h bands are absent (Figure 
34A ) and a novel high molecular weight molar fragment approximately 
18x10^ mw) is migrating at the top of the gel ( ■ ). The absence of 
HSV-1 b and h and not t and f indicates that the Hpal t/b and h/f 
sites of type I are present while the b/h site is deleted. Hie data 
suggest the replacement of b and h of type I with a portion of Hpal d 
of HG52 extending from the h/d site of type II to h/f site of HSV-1. 
The size of the fragment at the top of the gel would be consistent 
with this hypothesis. However, the straight removal of the type I b/h 
site without insertion of type II sequences would also give a band of 
similar size.
A BamHI digest (Figure 34B) of the R10/3/1 DNA showed that the 
HSV-1 bands g, b', v, £, w and d were missing ( > ). Molar bands 
corresponding to b, h', j/, £r X and 1 of 11 are Present ( < )•
Hie presence of type II _j' and o from the area of the genome normally
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FIGURE 34
Autoradiographs of Hpal (A) and BamHI (B) restriction digests of 
viral DNA [^P] -labelled _in vivo. Recombinant R10/3/1 (central lane); 
McKrae DNA (left lane) and HG52 DNA (right lane). Letters refer to 
specific HSV-1 or HSV-2 DNA fragments, the physical map locations of 
which are shown in Figure 28. > represents missing fragments; ■
represents novel fragments compared to the McKrae genome; M 
represents fragments derived from the HG52 DNA.
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occupied by k' and j' of HSV-1 suggests the absence of the latter 
fragments from the recombinant genome.
The presence of type II j and n°t m indicates the presence of the 
HSV-2 BamHI j/m site. Absence of type I d and presence of h indicates 
the retention of the type-I d/h site. The data indicates that the 
right hand end of the HG52 insert extends to the 0.51 m.u. BamHI j/m 
site. The small fragment of approximately 0.7x10^  mw from the right 
hand end of the HSV-1 BamHI d fragment extending between 0.51 m.u. j/m 
site of type II and 0.536 m.u. d/h site of type-I is now migrating at 
the position of HSV-1 BamHI b' ( ■ ). The latter being absent from the 
recombinant genome due to the presence of the HSV-2 o and y fragments.
On the left hand side absence of HSV-1 g. and not e1 and presence 
of HSV-2 b and hence the 1/b site suggests that the crossover must 
have taken place between the HSV-1 e'/g site and the HSV-2 JL'/b site. 
Taken together the restriction endonuclease digests of R10/3/1 
indicate the presence of an insert of HG52 sequences into the McKrae 
genome between 0.35 and 0.51 m.u. Recombination, therefore, must have 
taken place between the intact McKrae genome and HSV-2 sequences 
originating from the Hpal d fragment.
(ii) Genome analysis of recombinant R10/3/4/6
When the BamHI profile of R10/3/4/6 was compared with that of 
McKrae and HG52, inserts of HG52 sequences were present both in the 
long unique (UL) and short region [S] of the genome (Figure 35). In 
the UL, HSV-1 bands cj, v, £, w, b' and d are absent ( > ). Molar bands 
corresponding to HG52 BamHI b, h', o andy are present ( < ). The HG52 
band is comigrating with 1 of type I. The presence of a novel 
0.7x10^ mw fragment ( ■ ) migrating at the position of HSV-1 b' 
delimits the right hand boundary of the HSV-2 insert to 0.51 m.u. as 
in R10/3/1. The presence of the HSV-2 b and hence V/b site suggests a
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FIGURE 35
Autoradiographs of BamHI restriction digests of viral DNA [*^P]- 
labelled in vivo. Recombinant R10/3/4/6 DNA (central lane); McKrae DNA 
(left lane) and HG52 DNA (right lane). Letters refer to specific HSV-1 
or HSV-2 DNA fragments, the physical map locations of which are shown 
in Figure 28. t> represents missing fragments; ■ represents novel 
fragments as compared to the McKrae genome. 4 represents fragments 
originating from the HG52 genome.
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cross over between the _e'/g of type I and jL'/b site of type II as 
observed in Rl0/3/1.
In the short region of the genome HSV-1 BamHI bands £, y, n, £, z 
and x. have been replaced with q', z, e', f\ 1, c\ d’, b', k_', m', 
and a*' of HG52 ( A ). These bands constitute the whole of the short 
regions of the genomes. The joint fragment k in the recombinant genome 
is slightly smaller than its counterpart in McKrae because of 
substitution of type I £ with type II u. The absence of type II _v and 
the presence of type I s and type II u bands in the recombinant 
indicates the cross over at the “ - region of the genome.
Restriction endonuclease analysis of R10/3/4/6 demonstrates that 
the genome consists of HSV-1 sequences between 0.0 to 0.35 m.u. and 
0.51 to 0.82 m.u. and HSV-2 (HG52) sequences from 0.35 to 0.51 m.u. 
and 0.82 to 1.0 m.u. Recombination must have taken place between the 
intact McKrae genome and part of Hpal d plus the intact [S] region of 
HG52.
(iii) Genome analysis of recombinant R10/4/1
BamHI analysis of R10/4/1 (Figure 36) demonstrated that HSV-1 
bands £, v and _r are absent ( > ) while the HSV-2 fragments b, h' and 
_j' are present ( < ). This indicates loss of the HSV-1 £/v, v/r and 
r/k' sites and the presence of HSV-2 b/h' and h'/j.' sites. The 
presence of e1 and, therefore, the e'/£ site of type I and of b and, 
therefore, the JL'/b site of type II indicates that the cross over must 
have taken place in the region of the genome delimited by these two 
sites. On the right hand side the presence of HSV-1 w and therefore, 
the _k'/w site delimits the HG52 sequences up to 0.43 m.u.
Recombinant R10/4/1 thus contains an insert of HG52 DNA sequences 
between m.u. 0.35 and 0.43. Recombination must have taken place 
between the intact McKrae genome and part of the Hpal d fragment (0.35
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FIGURE 36
Autoradiographs of BamHI restriction digests of viral DNA [22p]- 
labelled in vivo. Recombinant R10/4/1 DNA (central lane); McKrae DNA 
(left lane); and HG52 DNA (right lane). Letters refer to specific HSV- 
1 or HSV-2 DNA fragments the physical map locations of which are shown 
in Figure 28. > represents missing fragments; represents novel 
fragments as compared to the McKrae genome. < represents fragments 
originated from the HG52 genome.
i \
oy5
■
► = r
“j
0 * —
p «"r + >
st +**4
w
U V «***| >
z
X
y - « ***
CM
in
O
x
a * 
b
ab
cde
f
9
hi:
IB
i
mn
°P
?
st
uvw
X
yz
b'
cd'
e'
f'
g'
K
d
eT r
Bam HI
- 0.576 m.u.) of HG52.
(iv) Genome analysis of recombinant R20/4/1
Analysis of a Hpal digest of recombinant R20/4/1 (Figure 37A) 
indicates that the HSV-1 b, f_ and h fragments are absent ( > ) and a 
novel high molecular weight (approximately 26x10** mw) fragment is 
present at the top of the gel ( ■ ). The absence of the HSV-1 b, h and 
f^ fragments and hence the Hpal b/h and h/f sites indicates the 
replacement of the McKrae ENA sequences with that of HG52 in this 
region of the genome. Absence of the Hpal e fragment of HG52 limits 
the HG52 insert to the Hpal d/e site (0.576 m.u.). Since the size of 
the novel fragment ( ■ ) (approximately 26x10** mw) is larger than that 
of HG52 d (approximately 22x10** mw) and the HSV-1 f_ fragment is also 
absent, the data are consistent with the fusion between the Hpal d 
fragment of HG52 and part of the HSV-1 f^ fragment extending between 
the d/e site of type II and the h/f site of type I. The cross over has 
therefore, occurred between the h/f site (0.52 m.u.) of McKrae and the 
d/e site (0.576 m.u.) of HG52. On the left hand side absence of the 
Hpal h fragment of HG52 delimits the insert up to the HSV-2 h/d site 
(0.35 m.u.). The cross over must have occurred between the HSV-1 t/b 
site and the HSV-2 h/d site.
Fine mapping of the HG52 insert was obtained from a BamHI digest 
of R20/4/1 DNA (Figure 37B). HSV-1 M bands d, £, _r, w, _v and b' are 
absent ( > ) and have been replaced by HSV-2 bands b, j.r X' Jl* 
j' ( < ). The HSV-1 k.' and _j' bands cannot be seen on this gel but 
their absence from the recombinant genome is deduced by the presence 
of the HSV-2 and o fragments spanning the corresponding region of 
the genome. The presence of the HSV-2 b fragment and hence the V/b 
site (0.35 m.u.) delimits the left hand boundary of the HG52 DNA 
insert. The presence of HSV-1 e' and absence of g indicates that the
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FIGURE 37
Autoradiographs of Hpal (A) and BamHI (B) restriction digests of 
viral DNA [^P] -labelled in vivo. Recombinant R20/4/1 DNA (central 
lane); McKrae DNA (left lane) and HG52 DNA (right lane). Letters refer 
to specific HSV-1 or HSV-2 DNA fragments, the physical map locations 
of which are shown in Figure 28. > represents missing fragments; ■
represents novel fragments compared to the McKrae genome; 4 represents 
fragments derived from the HG52 genome.
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cross over has occurred between the £'/g site of type I and the l'/b 
site of type II. On the right hand side the presence of HSV-2 j and 
not m indicates that the HSV-2 j/m site (0.51 m.u.) has been retained. 
Hie HSV-1 h fragment is larger in size ( ■ ) and is now migrating 
between the e and £ fragments. This increase in the size of h would be 
consistent with the absence of the d/h site of HSV-1 generating a 
larger h fragment running from the j/m site of type II to the h/g' 
site of type I. The crossover has occurred between the d/h site of 
type I and m/e site of type II.
The absence of the Hpal h/f site (0.53 m.u.) of type I (Figure 
37A) together with the absence of the HSV-2 BamHI m fragment and hence 
the m/e site (0.54 m.u.) in R20/4/1 DNA, indicates that the crossover 
has taken place between 0.53 and 0.54 m.u. Recombination, therefore, 
must have taken place between the intact McKrae genome and part (0.35 
m.u. to 0.53 m.u.) of the Hpal d fragment of HG52.
(v) Genome analysis of recombinant R30/3
In a Hpal digest of R30/3 DNA (Figure 38A) the HSV-1 molar bands 
a, c, d and the 0.5M g band are absent ( > ). A novel high mw band 
(■) migrating at the top of the gel can be seen. Hie digest indicates 
that the HSV-1 £ and £ fragments have been replaced with HSV-2 [S].
Hie novel joint fragment consisting of HSV-1 m and HSV-2 [S] is now 
running at the top of the gel ( ■ ). The extra band ( # ) seen running 
above the m fragment is due to additional a sequences- on one of the m 
fragments. The same explanation holds true for the high mw fragment 
( • ) seen migrating slightly above the novel joint fragment ( ■ ). 
Absence of HSV-2 £ and presence of HSV-1 m indicates that the 
crossover has taken place at the j°int region of the genome.
Analysis of the BamHI digest (Figure 38B) indicates that the HSV- 
1 £, _j, n, £, £, v, z, y and x fragments are absent ( > ) and have
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FIGURE 38
Autoradiographs of Hpal (A) and BamHI (B) restriction digests of 
viral DNA [32P] -labelled in vivo. Recombinant R30/3 DNA (central 
lane); McKrae DNA (left lane) and HG52 DNA (right lane). Letters refer 
to specific HSV-1 or HSV-2 DNA fragments, the physical map locations 
of which are shown in Figure 28. > represents missing fragments; ■
represents novel fragments compared to the McKrae genome; < represents 
fragments derived from the HG52 genome; • represents additional 'a' 
sequences on the end and joint fragments.
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been replaced with the HSV-2 b, h1, u, £', e1, V, 1, y_, z, b', c', 
d', a', k.' and m' fragments ( < ), This confirms the presence of HG52 
DNA sequences in the UL and short regions of the genome. In 1^ , the 
left hand boundary of the HG52 DNA insert is mapped at approximately
0.35 m.u. by the presence of HSV-2 BamHI b and the absence of HSV-1 cj. 
On the right hand side the presence of HSV-2 _j and not o delimits the 
HG52 insert at 0.43 m.u. In the short region of the genome the HSV-1 
BamHI q, n, jj, z and x fragments are absent ( > ) and have been 
replaced by The HSV-2 u, g', m', z, e1, £', 1, c', d', k_' and a' tJb 
fragments ( < ). the HSV-1 fragments m', n' and 1_' have run off the 
gel but the presence of £' and d of HSV-2 indicates their absence. The 
data are consistent with the replacement of the short region of HSV-1 
with that of HSV-2.
R30/3, therefore, contains inserts of HG52 DNA between 0.35 and
0.43 m.u. in UL and between 0.82 and 1.00 m.u. in the short region. 
Recombination, therefore, has taken place between the intact McKrae 
genome and an intact Hpal [S] plus part of Hpal d of HG52.
(vi) Genome analysis of recombinant R40/2/2
Precise analysis of the genome structure of R40/2/2 was obtained 
from the Kpnl (Figure 39A), Hpal (Figure 39B), and BamHI (Figure 40) 
digest patterns.
The Kpnl digest (Figure 39A) indicates that the HSV-1 cx, 1, £, v 
and c1 fragments are absent ( > ) and have been replaced with HSV-2 g 
and m and a novel fragment ( a ) running just above HSV-1 f. As HSV-2 
t and HSV-1 a1 comigrate, they are not easily distinguishable.
However, the presence of HSV-2 m and g at each side of t. demonstrates 
that the fragment is type II t and not type I a'.
The presence of HSV-2 m and not j_ and the simultaneous absence of 
£  and not n of type I delimits the HG52 insert to the j/m site of type
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FIGURE 39
Autoradiographs of Kpnl (A) and Hpal (B) restriction digests of 
viral ENA [^ 2p] -labelled in vivo. Recombinant R40/2/2 DNA (central 
lane); McKrae DNA (left lane) an<l HG52 DNA (right lane). Letters refer 
to specific HSV-1 or HSV-2 DNA fragments, the physical map locations 
of which are given in Figure 28. > represents missing McKrae 
fragments; ■ represents novel fragments as compared to the McKrae 
genome; A represents fragments derived from HG52 DNA.
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II. As HSV-1 n and o comigrate, they are not readily distinguishable.
On the right hand side of the HG52 insert, the absence of _c' and not s 
(it is not obvious from the gel that s is present because it 
comigrates with r) of HSV-1 delimits the boundary of the insert to the 
c' s site of type I, thus generating a novel fragment of approximately 
8x10^ mw running from the g/d site of type II to the _c'/s site of type
I. The size of the novel fragment seen on the gel ( ■ ) is consistent 
with this analysis.
In the Hpal digest (Figure 39B) the HSV-1 fragments b, t and g 
are missing ( > ) and have been replaced by fragment d ( a ) of HSV-2. 
The presence of the total HSV-2 d fragment indicates the retention of 
the 0.35 m.u. h/d and 0.576 m.u. d/e sites of HG52 and thus the limits 
of the HG52 insert.
Confirmation of the crossover positions was obtained from the 
BamHI digest of R40/2/2 DNA (Figure 40). The HSV-1 d, £, h, r_, w, v 
and b' fragments ( > ) have been replaced with HSV-2 b, j_, m, o, y
f:
( 4 ) plus a novel fragment e' ( ■ ). The presence of e' (2.8x10 mw) 
migrating just below HSV-2 BamHI m confirms a crossover within the 
HSV-2 e fragment between the m/e site of type II and g', o site of type
I. The presence of the b fragment of type II and hence the 3.', b site 
and the absence of £  and not e of type I indicates that the crossover 
has taken place between the e\ £  site of type I and the V, b site of 
type II.
R40/2/2 contains HG52 DNA between 0.35 and 0.576 m.u. and has 
been generated by recombination of an intact HSV-2 Hpal d fragment 
with an inact McKrae genome.
(vii) Genome analysis of recombinant R40/2/4
A Bam HI digest of recombinant R40/2/4 DNA (Figure 41) revealed
/
absence of the HSV-1 M bands £, v, £, w, b and d (>). HSV-2 fragments
141
FIGURE 40
3 2Autoradiographs of BamHI restriction digests of viral DNA [ P]-
labelled in vivo. Recombinant R40/2/2 DNA (central lane); McKrae ENA 
(left lane) and HG52 DNA (right lane). Letters refer to specific HSV-1 
or HSV-2 DNA fragments, the physical map locations of which are given 
in Figure 28. > represents missing McKrae fragments; ■ novel 
fragments present as compared to the McKrae genome; M represents 
fragments originating from the HG52 genome.
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FIGURE 41
Autoradiographs of BamHI restriction digests of viral DNA [^P]- 
labelled in vivo R40/2/4 (central lane); McKrae ENA (left lane) and 
HG52 DNA (right lane). Letters refer to specific HSV-1 or HSV-2 
fragments, the physical map locations of which are given in Figure 28.
> refers to missing fragments; ■ refers to novel fragments as 
compared to the McKrae genome and < refers to fragments derived from 
HG52 DNA.
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FIGURE 42
Autoradiographs of BamHI restriction digests of viral DNA [^P]- 
labelled in vivo. R43/2/2 (central lane); McKrae DNA (left lane) and 
HG52 DNA (right lane). Letters refer to specific HSV-1 or HSV-2 
fragments the physical map locations of which are given in Figure 28. 
> represents missing fragments compared to the McKrae genome; A 
represents fragments derived from HG52 DNA.
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present from the corresponding region of the genome include b, h, _j, o 
and _y (-4). The absence of cj and presence of e^ of type I in 
conjunction with the presence of b and absence of e of type II 
indicates that the left hand boundary of the HG52 insert is formed by 
crossing over between the eVg site of type I and the lYb site of 
type II. As type II comigrates with h and i, its presence can not be 
determined from the gel. However, the absence of d of type I and of 
type II in conjunction with the presence of HSV-2 % indicates 
retention of the HSV-2 Bam HI y/j[ site. A cross over between this site 
of HSV-2 and within fragment d of HSV-1, would generate a smaller 
fragment d' (■) of approximately 4x10 m w. This fragment appears to 
be comigrating with HSV-1 jl and jj. Hie structure of R40/2/4 is 
therefore McKrae except for an insert of HG52 sequences between 0.35 
and 0.475 m.u. and has been generated by recombination of the intact 
McKrae genome with part of the HSV-2 Hpa I d fragment.
(viii) Genome analysis of recombinant R43/2/2
A Bam HI digest of R43/2/2 is shown in Figure 42. HSV-1 bands cj, 
y_r n, jj, z and _x ( > ) have been replaced by the HSV-2 fragments u, g' 
z, m', e', £', 1, c', d', b', k_' and a' (<). The data indicates that 
the whole of the short region of HSV-1 has been replaced by the 
corresponding region of type II. The presence of u and not v of HSV-2 
indicates that the crossover has taken place around the joint region 
of the genome. Slight reduction in the size of the HSV-1 joint 
fragment _k(s+v) indicates the replacement of HSV-1 c[ by HSV-2 u. The 
genome of R43/2/2 is therefore, type I in the long region and entirely 
typell in the short region. R43/2/2 has been generated by 
recombination between an intact McKrae genome and a HG52 Hpal [S] 
fragment.
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FIGURE 43
Autoradiographs of BamHI restriction digests of viral ENA [^^P]- 
labelled in vivo. R5/26/1 (central lane); McKrae DNA (left lane) and 
HG52 DNA (right lane). Letters refer to specific HSV-1 or HSV-2 
fragments, the physical map locations of which are given in Figure 28. 
> represents missing fragments compared to the McKrae genome. < 
represents fragments derived from HG52 DNA.
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(ix) Genome analysis of recombinant R5/26/1
A Bam HI profile of R5/26/1 is shown in Figure 43. The HSV-1 £/v
and v/r cleavage sites are absent in this recombinant as demonstrated 
by the absence of the g, v and r_ fragments from the digest ( > ). The
presence of HSV-2 fragments b, h' and _j' ( a ) from the corresponding
region of the genome indicates that the cross over must have taken 
place between the HSV-1 e'/g site and the HSV-2 P/b site to form the 
left hand boundary of the HG52 insert. At the right hand end of the 
HG52 insert, the presence of HSV-1 w and hence the k_'/w site and the 
presence of jj'and hence the £'/o site of type II indicates that the 
cross over has taken place between these two sites, to give an insert 
of HG52 sequences between 0.35 and 0.43 m.u.
Sine R5/26/1 was isolated from a co-transfection of intact McKrae
genomes and Xbal cleaved HG52 genomes, recombination must have taken 
place between an intact McKrae genome and the right hand sequences of 
HG52 Xbal £ (0.0 to 0.45 m.u.).
(x) Genome analysis of recombinant R47/27/1
A BamHI digest of R47/27/1 is shown in Figure 44. The HSV-1 
fragments £, v and r_ (>) have been replaced with the HSV-2 b, h' and
£' fragments (A ). Hie presence of HSV-2 b and absence of HSV-1 £
indic&les that the cross over on the left hand side must have taken 
place between the HSV-1 e'/g and HSV-2 P/b sites. Though it is not 
possible to see HSV-1 k_* on this gel, the presence of £* of HSV-2 from 
the corresponding region of the genome indicates the absence of the Jc' 
fragment. The presence of w of type I and absence of £ of type II 
indicates that the cross over on the right hand side must have 
occurred between the jj/o site of type II and the _k'/w site of type I. 
Hie structure of R47/27/1 is therefore, of McKrae except for HG52 
sequences between 0.35 and 0.43 m.u. The recombination leading to a
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FIGURE 44
Autoradioragraphs of BamHI restriction digests of viral DNA 
[32?j-labelled in vivo. R47/27/I (central lane); McKrae DNA (left 
lane) and HG52 DNA (right lane). Letters refer to specific HSV-1 or 
HSV-2 fragments, the physical map locations of which are given in 
Figure 28. > represents missing fragments compared to the McKrae
genome; < represents fragments derived from B352 DNA.
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generation of R47/27/1 must have taken place between an intact McKrae 
genome and the right hand sequences of HG52 Xbal c (0.00 to 0.45 m.u.)
(xi) Genome analysis of recombinant R7/3/3
Comparison of a Bam HI digest of R7/3/3 with that of McKrae and 
HG52 is shown in Figure 45. Hie HSV-1 g, v, and r_ fragments are absent 
(>) and the HSV-2 b and h.' fragments are present M ). The presence 
of HSV-2 h' and not j1 indicates a crossover between the HSV-2 Bam HI 
h'/j1 site and r/k' site of HSV-1. The small fragment ( approximately 
0.2x10^ mw) thus generated is not distinguishable on the gel. The 
presence of b and hence the ¥/b site of type II and of e' and hence 
the e'/g site of type I indicates that a cross over has taken place 
between these two sites.
Recombinant R7/3/3, therefore, contains HG52 sequences between
0.35 and 0.43 m.u. and like R47/27/1 has been generated by 
recombination between HG52 Xbal c and an intact McKrae genome.
The structures of the eleven McKrae x HG52 recombinants in 
relation to HSV-1 and HSV-2 BamHI restriction endonuclease sites are 
shown in Figure 46.
3.6. ANALYSIS OF RECOMBINANT VIRUS INDUCED INFECTED CELL POLYPEPTIDES
The SDS-PAGE technique has been extensively used in the study of 
HSV infected cell polypeptides. The majority of HSV-1 and HSV-2 ts 
mutants have been examined by this method and characteristic 
polypeptide profiles have been recognised for most of the ts mutants 
(Marsden et al., 1976). Analysis of polypeptides induced by intertypic 
recombinants of HSV and correlation of the data with the crossover 
points in the recombinant DNAs has been used to map the genetic loci 
specifying these polypeptides (Marsden et al., 1978; Ruyechan et al., 
1979). Therefore the infected cell polypeptide profiles induced by the 
McKrae X HG52 recombinants with respect to both type I and type II
144
FIGURE 45
Autoradiographs of BamHI restriction digests of viral DNA [^^P]- 
labelled jm vivo. R7/3/3 (central lane); McKrae DNA (left lane) and 
HG52 DNA (right lane). Letters refer to specific HSV-1 or HSV-2 
fragments the physical map locations of which are shown in Figure 28.
> represents missing fragments compared to the McKrae genome;
► reprsents fragments derived from HG52 DNA.
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FIGURE 46
Diagrammatic representation of the crossover sites in BamHI 
digests of eleven McKrae x HG52 recombinant viruses. Locations of the 
BamHI sites in HSV-1 (above the line) and HSV-2 (below the line) are 
indicated by the small vertical lines. Solid horizontal lines 
represent the genome structure of the recombinant viruses. Letters 
refer to specific BamHI fragments, the physical map locations of which 
are given in Figure 28.
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parents, may provide information on the genetic loci encoding a 
particular polypeptide.
To analyse polypeptides induced by the intertypic recombinants, 
the recombinant virus and parental type I and type II virus infections 
were carried out simultaneously using a single batch of BHK 21/C13 
cells and labelled with -methionine as described in Materials and 
Methods (Section 2.7). Infected cell polypeptides induced by HSV-1 
strain 17 were included in each experiment as controls. The 
polypeptides were resolved on 5 to 12% SDS-polyacrylamide gradient 
gell. ;
An autoradiograph of infected cell polypeptide profiles obtained 
following SDS-PAGE of BHK 21/C13 cells infected with HSV-1 strain 
McKrae, HSV-1 strain 17 syn+, recombinants R10/3/1, R10/4/1, R20/4/1, 
R30/3 and HSV-2 strain HG52 is shown in Figure 47. The infected cell 
polypeptide profile obtained from a McKrae infection is in agreement 
with that of strain 17 (Marsden et al., 1976). The infected cell 
polypeptide profiles of R10/4/1 and R30/3 infections are indistin­
guishable from that of a HSV-1 McKrae infection. In R10/3/1 and 
R20/4/1 the infected cell polypeptide of HSV-1, Vmw 28K has been 
replaced with Vmw 29.5K of HG52. The HG52 DNA insert in R10/3/1 and 
R20/4/1 extends to 0.51 and 0.53 m.u. respectively. In R10/4/1 and 
R30/3, which induce Vmw 28K, the HG52 insert in UL extends to 0.43 
m.u. These data indicate that Vmw 29.5K of HSV-2 is encoded by the 
genes located between 0.43 and 0.51 m.u. Vmw 29.5K had already been 
mapped to a similar region of the genome (0.43 to 0.48 m.u.) by 
Marsden et al (1978).
The infected cell polypeptides specified by the other 
recombinants did not provide any new information on the location of 
particular polypeptides.
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FIGURE 47
Autoradiographs of a 5 to 12.5% acrylamide gradient gel, showing 
the infected cell polypeptides induced by recombinants Rl0/3/1, 
R10/4/1, R20/4/1, R30/3, HSV-1 strain 17, HSV-1 strain McKrae, HSV-2 
strain HG52 and in mock infected BHK-21/C13 cells at 37°C. Hie gel 
tracks are, from the left, as follows:
1. Mock infected 6. R20/4/1
2. HSV-1 strain McKrae 7. R30/3
3. HSV-1 strain 17 8. HSV-2 strain HG52
4. Rl 0/3/1 9. Mock infected
5. Rl0/4/1
3 4 8
273
175
155
145
136
118
100
87,85 
82, 
'81
67
64
57
51
43
40
37
36
29-5
28
I *
* *»
tltttft
*•»»»«*»
21
20
12-5
11
3.7. LATENCY REACTIVATION POTENTIAL OF THE McKRAE X HG52 RECOMBINANTS 
IN RABBITS
3.7.a. Recombinant viruses studied in the rabbit eye model
Four of the recombinant viruses were studied for their ability to 
go latent following infections of rabbit eyes and to reactivate both 
spontaneously and on induction with epinephrine iontophoresis. As all 
the recombinants were not isolated at the same time, individual 
recombinants were tested as they became available. The four 
recombinants R10/3/1, R10/3/4/6, R40/2/2 and R43/2/2 chosen for rabbit 
eye infections had genomes with the widest limits of the HG52 inserts. 
The genomes of the other recombinants all had HG52 inserts within the 
limits covered by the four chosen recombinants.
(i) HSV-1 McKrae
Rabbits were inoculated in the left eyes only with 5x10^ pfu of 
McKrae as positive controls for recombinant infections. The data 
presented in Table 5 are from two groups of rabbits consisting of 5 
rabbits in one group and 3 in the second, which were infected at two 
separate times.
Similar to the results described in Tables 2 and 3 all the 
animals had a latent infection as demonstrated by release of virus 
from explanted LTG and in some cases from RTG. In addition, all 
animals shed virus post epinephrine iontophoresis.
However, in the second group of rabbits (6 to 8) no spontaneous 
shedding of virus was detected which may merely indicate that virus 
was not being shed during the period of screening (one week). It 
should also be noted that one out of six segments of the left corneal 
explants from 2 animals, released virus between 28 to 31 and 15 to 18 
days post explantation respectively.
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(ii) Recombinant Rl0/3/1
The left eye of each of 5 rabbits was infected with 2x10** pfu of 
recombinant RlO/3/1 containing a HG52, insert between 0.35 and 0.51 
m.u. All the rabbits developed keratitis leading to corneal ulcers 
within 7 days post infection and could tolerate the infecting dose of 
virus without showing any signs of distress or encephalitis. Results 
of virus shedding following epinephrine iontophoresis induction and 
from the TGs upon explantation are shown in Table 6.
No spontaneous shedding of virus was detected on daily screening 
of the tear films from the infected eyes between 30 and 35 days post 
infection. Epinephrine iontophoresis performed when the eyes were 
negative for spontaneous shedding, induced reactivation of latent 
virus which was detected in the tear films of the left eyes of each 
rabbit. Virus was first detected on day 2 or 3 post iontophoresis and 
continued to be shed for 1 to 3 days. Sixty-one days post infection 
the left trigeminal ganglia were explanted, subdivided into 6 segments 
and cultured in vitro. Some of the ganglion segments from each rabbit 
released infectious virus between days 21 and 33 post explantation. No 
infectious virus was obtained from the RTG and corneal explants up to 
5 weeks of in vitro culture and screening of the explants. BamHI 
digests of the viral DNA of the isolates obtained after epinephrine 
induction and from the explanted trigeminal ganglia showed profiles 
identical to the infecting virus.
Since infectious virus was recovered from the left eyes of all 
five rabbits after induction with epinephrine iontophoresis, it 
appears that recombinant Rl0/3/1 has the HFRc phenotype of its McKrae 
parent and not the LFRc phenotype of the HG52 parent. The genetic 
information between 0.35 to 0.51 m.u. derived from the LFRc parent, 
therefore does not determine the reactivation differential between 
McKrae and HG52.
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(iii) Recombinant R10/3/4/6
As indicated in Table 7, in this recombinant the genetic 
information between 0.35 to 0.51 and 0.82 to 1.00 m.u. of R10/3/4/6 is 
derived from HG52. Each of the 6 rabbits inoculated in the left eyes 
with 1.5x10** pfu of R10/3/4/6 tolerated the infecting dose without any 
signs of distress and exhibited characteristic symptoms of herpes 
virus keratitis within 7 days post infection. Screening of tearfilms 
from the infected eyes daily between 30 to 35 days post infection 
showed no spontaneous virus shedding. Reactivated virus could be 
detected in the tear films taken from the infected eyes as early as 
one day after epinephrine iontophoresis performed when the rabbits 
were, not shedding any spontaneous virus in their tear films. The 
reactivated virus could be detected in the tear film till 7 days post 
iontophoresis.
Explanted left trigeminal ganglia released infectious virus 
between day 16 and day 29 post explantation. Infectious virus was also 
recovered from the right trigeminal ganglion explants from one of the 
animals between 28 and 30 days post explantation. The number of 
ganglionic segments releasing virus varied between 1 and 5. The BamHI 
DNA profiles of reactivated virus isolates and isolates from the 
explanted ganglia were identical to that of input virus.
Since R10/3/4/6 was capable of being reactivated with 100% 
frequency, it was designated to have a HFRc phenotype. The sequences 
between 0.82 and 1.00 m.u. i.e. the whole of the short region, either 
alone or in conjunction with the sequences between 0.35 and 0.51 m.u. 
therefore do not determine reactivation differential between McKrae 
and HG52.
(iv) Recombinant R4Q/2/2
The left eyes of each of 4 rabbits were inoculated with 2x107 pfu
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of the recombinant virus R40/2/2. None of the rabbits, following 
infection with virus, showed any signs of distress, but exhibited 
development of characteristic herpetic ulcers of their left corneas. 
The results of virus infection in rabbtis are shown in Table 8. No 
spontaneously shed virus was detected in the tear films on screening 
for 7 days starting on day 28 post infection. Epinephrine induced 
reactivated virus from the rabbit eyes negative for any spontaneous 
shedding, was detected in all the animals between 1 and 4 days post 
iontophoresis. On in vitro explantation of the left trigeminal ganglia 
9 weeks post infection, virus release was first detected between 16 
and 26 days post explantation. In one of the animals infectious virus 
could be detected up to 33 days post explantation. The number of 
ganglion segments releasing virus varied between 1 and 5. No 
infectious virus was recovered from any of the right trigeminal 
ganglion or corneal segments during a 7 week period of in vitro 
culture.
One of the six segments of the left cornea from one rabbit 
yielded infectious virus between 35 and 49 days post explantation. The 
BamHI restriction profiles of the DNA of the reactivated virus from 
ganglia and that of corneal isolates were identical to that of the 
infecting virus.
Recovery of virus from the left eyes of all the rabbits upon 
epinephrine induction indicates a HFRc phenotype for R40/2/2. As this 
recombinant has an HG52 insert between 0.35 and 0.576 m.u., it appears 
that the sequences between 0.51 and 0.576 too do not determine the 
reactivation differential between McKrae and HG52.
(vi) Recombinant R43/2/2
Each of the three rabbits inoculated with 3xl06 pfu of the 
recombinant virus R43/2/2 into their left eyes could tolerate the
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infecting dose without exhibiting any distress including encephalitis. 
Development of keratitis and corneal ulcers within 7 to 10 days post 
infection as revealed by visual examination of infected eye indicated 
replication of virus in the corneas. The results of the infections, as 
shown in Table 9, indicate that monitoring of tear films from the 
infected eyes between 28 and 35 days post infection showed no signs of 
any spontaneous virus shedding. Following induction with epinephrine, 
reactivated virus could be detected as early as 24 hr post 
iontophoresis and continued for a further 48 hr in two rabbits and 
between 3 and 5 days in the third rabbit. Evidence of latent infection 
of the LTG was supplied by the release of infectious virus from all 
the ganglia between 15 and 25 days in culture. One segment out of 6 of 
the LTG from rabbit number 2 while 3 and 2 segments out of 6 in 
rabbits number 1 and 3 respectively were positive for virus release. 
The ganglia were explanted into culture 10 weeks after the primary 
infection. None of the RTG or right corneal explants released virus 
during the period of jln vitro culture. However, one of the 6 segments 
of the left cornea of one rabbit released virus between 35 and 49 days 
post explantation. The genomic restriction endonuclease profiles of 
the various isolates from eyes or ganglia remained unchanged from the 
infecting virus.
The recombinant R43/2/2 is, therefore, designated as HFRc 
irrespective of the presence of genetic information between 0.82 and
1.00 m.u. from the LFRc parent, thus indicating that the virus genes 
encoded therein do not control reactivation differential between 
McKrae and HG52.
3.8. VIRULENCE OF THE McKRAE X HG52 RECOMBINANT VIRUSES FOR RABBITS
Analysis of the data presented in Tables 2 to 9 indicates that 
the rabbits inoculated in the left eyes only with 5x10-* pfu of HSV—1
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strain McKrae could survive while those inoculated with 5xl06 and
5xl07 pfu died within a few days of infection or had to put down
because of severe distress. On the other hand rabbits could tolerate
up to 5x107 pfu of HSV-2 strain HG52 without any noticeable adverse
effects (Tables 2 and 3).
Much higher doses of the infecting recombinant viruses compared
to the McKrae parent were tolerated by the rabbits. Up to 3, 4, 6 and
40 fold excess doses of the recombinants R10/3/4/6, R10/3/1, R43/2/2
and R40/2/2 respectively were inoculated without any signs of
distress. These preliminary results from a relatively small number of 
mo-*/
samplesj^suggest moderation in the virulence of HSV-1 strain McKrae on 
insertion of HSV-2 strain HG52 genetic information.
Further this reduction in virulence of the recombinant viruses 
was observed irrespective of the location of the HG52 insert i.e. 
either in the long unique region alone (Rl0/3/1 and R40/2/2) or in the 
short region of the genome (R43/2/2) or at both locations (R10/3/4/6). 
The reduction in virulence of the recombinant viruses compared to 
their McKrae parent and irrespective of location of the HG52 insert 
indicates that virulence is not confined to any single region of the 
genome and may be multigenic.
3.9. LIMITS OF THE HG52 DNA INSERTS IN THE McKRAE X HG52 RECOMBINANTS 
Of the recombinants derived from cotransfections of intact McKrae 
genomes with the total products of Hpal cleaved HG52 genomes, all but 
one (R43/2/2) had an HG52 insert in UL which terminated at 
approximately 0.35 m.u. This was determined as precisely as possible 
by BamHI digests of recombinant virus DNAs. The left hand limit of the 
HG52 inserts co-maps with the left hand boundary of the HG52 Hpal d 
fragment (0.35 to 0.576 m.u.).
The right hand boundary of the HG52 insert ended at 0.43 m.u. in
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recombinants R10/4/1 and R30/3; at 0.47 m.u. in R40/2/4; at 0.51 m.u. 
in R10/3/1 and R10/3/4/6; at 0.52 m.u. in R20/4/1 and at 0.576 m.u. in 
R40/2/2. The largest HG52 insert in was observed in the recombinant 
R40/2/2 (0.35 to 0.576 m.u.) whose right hand end comaps with the 
right hand boundary of the HSV-2 Hpal d fragment. This indicated that 
in R40/2/2 the whole of HSV-2 Hpal d has recombined into the McKrae 
genome.
In R10/3/4/6 and R30/3, in addition to the HG52 insert in an 
insert of HG52 sequences was also present in the short region of the 
genome. The recombinant R43/2/2 had an insert of HG52 sequences only 
in the short region of the genome. In the three recombinants the whole 
of the short region (Us + Rs) of the McKrae genome (0.82 to 1.00 m.u.) 
has been replaced by HG52 DNA.. There are no Hpal sites in the short 
region of HG52, therefore R10/3/4/6, R30/3 and R43/2/2 must have been 
generated by recombination between intact McKrae genomes and HG52 Hpal 
[S] fragments.
Recombinants R5/26/1, R47/27/1 and R7/3/3 were obtained from 
independent cotransfections of intact McKrae DNA and the total 
products of Xbal cleaved HG52 DNA. They each contained HG52 DNA 
inserts in between 0.35 and 0.43 m.u. and must have been generated 
by recombination of intact McKrae genomes and sequences derived from 
the right hand end of HG52 Xbal c (0.0 to 0.45 m.u.).
The limits of the HG52 inserts within the recombinants are shown 
diagrammatically in Figure 48.
3.10. LIMITS OF RECOMBINATION WITH RESPECT TO ORIGINS OF VIRUS
REPLICATION (ORIL AND ORIg)
In recombinants derived from cotransfect ion experiments using 
Hpal cleaved HG52 genomes, the HG52 inserts were derived from Hpal d 
or [S] or both. In recombinants derived from cotransfect ions using
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FIGURE 48
Diagrammatic representation of the structure of recombinants 
obtained from cotra^i^ections of intact McKrae genomes v with Hpal 
cleaved (A) and Xbal cleaved (B) HG52 genomes. 'H' indicates the 
prototype arrangement of the HSV genome. The horizontal dotted line 
represents HSV-1 {upper) and HSV-2 (lower) DNA sequences. The solid 
horizontal line represents the structure of the recombinant viruses, 
betters between Hpal and Xbal sites of the HG52 genome refer to 
specific DNA fragments. tSNStindicates to the limits of the HG52 inserts 
for each group of recombinants.
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FRACTIONAL GENOME LENGTH
Xbal cleaved HG52 DNA, the HG52 inserts were derived from the right 
hand end of Xbal c. Hie origins of replication in HSV-1 have been 
located between 0.398 and 0.413 m.u. (OriL) (Weller et al., 1985) and 
at 0.87 and 0.96 m.u. (Orig) (Stow, 1982; Stow and McMonagle, 1983).
In HSV-2 Or i^ and Orig are located in equivalent positions (Lockshon 
and Galloway, 1986) and (Whitton and Clements, 1984a). The map 
coordinates of Hpal d are 0.35 to 0.576 m.u.; of Hpal [S], 0.82 to
1.00 m.u. and of Xbal c, 0.0-0.45 m.u. Each of these fragments 
contains an origin of replication (OriL or Orig).
As evident from the structure of the recombinants (Figure 48), 
R10/3/1, Rl0/4/1, R40/2/2, R40/2/4, R5/26/1, R47/27/1 and R7/3/3 all 
contained OriL of HG52 and Orig of McKrae. In recombinants R10/3/4/6 
and R30/3 besides OriL both copies of Orig were also derived from HG52 
while in recombinant R43/2/2 both copies of Orig were derived from 
HG52 and OriL from McKrae. Hie position of Orig and OriL in relation 
to the limits of the HG52 inserts in the recombinants is shown 
diagrammatically in Figure 49.
It is concluded that when McKrae X HG52 recombinants were 
constructed by cotransfection of intact McKrae genomes and restriction 
endonuclease cleaved HG52 genomes, the HG52 inserts were only derived 
from the restriction endonuclease fragments of HG52 containing an 
origin of replication. Hie isolation of recombinants containing both 
heterologous Orig and OriL indicates that both origins of replication 
are functional in vitro.
3.11. CONSTRUCTION OF HG52 X McRAE REOQMBINAOTS
Td determine whether our hypothesis that sequences from 
restriction endonuclease fragments containing an origin of replication 
were preferentially recombined, was correct, HG52 X McKrae 
recombinants were constructed in a reciprocal manner i.e. by using
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FIGURE 49
Diagrammatic representation of the limits of the HG52 inserts in 
recombinants derived from cotransfections of intact McKrae genomes 
with either Xbal or Hpal cleaved HG52 DNA. Hie inserts are represented 
by the DNA sequences between the vertical dotted lines. The positions 
of HSV origins of replication OriL and Orig are represented ( ▲ ). 
Letters below the solid line represent HG52 Xbal and Hpal fragments.
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intact HG52 genomes and restriction endonuclease cleaved McKrae DNA.
Intact HG52 genomes (0.2 ug) were cotransfected onto BHK21/C13 
monolayers with 2 ug per 50 mm dish of either the total products of 
Xbal or Hpal cleaved McKrae genomes. Progeny plaques were picked and 
viral DNA labelled _in vivo with [^P] orthophosphate and their 
restriction endonuclease profiles determined.
Of the DNA of 231 progeny plaques screened from co-transfection 
experiments using Hpal cleaved McKrae DNA, two recombinants. R17/1 and 
R368/38 were isolated, giving a recombination frequency of 0.86%. 
Analysis of the DNA of 174 progeny plaques from transfections using 
Xbal cleaved McKrae genomes did not show any recombinant genomes.
3.11.a. Clonal relationship and nomenclature of the recombinant viruses 
Since both recombinants (R17/1 and R368/38) were isolated from
independent transfections, they were clonally unrelated and were 
designated R17/1 and R368/38 denoting the plaque number picked from 
the transfection experiments
3.11.b. Analysis of genome structure of R17/1 and R368/38 with respect 
to loctions of Ori^ and Ori^
(i) R17/1
A BamHI digest of R17/1 shown in Figure 50 is similar to that of 
HG52 except for the absence of BamHI g', z, e\ V, 1, c*, d', b', m' 
and k' fragments «). These fragments constitute a major portion of the 
short region of HG52. The type I fragments identifiable are n, _j, z 
and x ( ►). The HSV-2 fragment n appears to be comigrating with HSV-2 
BamHI m indicating an approximately 150 bp insert in the n fragment.
The HSV-2 t fragment appears to be deleted by 150 bp and is now 
migrating slightly above HSV-2 u. However, a deletion in HSV-2 s would 
also result in a band of similar size. The identity of this band was
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FIGURE 50
Autoradiographs of BamHI restriction digests of viral DNA [^P]- 
labelled JLn vivo from recombinants R368/38. R17/1, McKrae (extreme 
left lane) and HG52 (extreme right lane). Letters refer to specific 
HSV-1 or HSV-2 DNA fragments, the physical map locations of which are 
shown in Figure 28. < refers to missing HSV-2 fragments; 
represents HSV-1 fragments present; ■ represents novel fragments 
present in the recombinant genome.
Bam HI i
not investigated further by Southern blotting. The genome structure of 
R17/1 is type II in the UL and RL. It crosses over within BamHI cj' in 
type 11 to y in type I and back again from y in TRs of type I to cj' in 
TRs of type II to generate a novel fragment of approximately 1.4x10^ 
mw from the type II u/g' site to the type I.y/n site. This fragment is 
comigrating with a'of type 1 ( B ) .  Recombination must have taken 
place between the intact HG52 genome and Hpal c and Hpal q or Hpal (c 
+ cj) of McKrae. Both Hpal £ and g of HSV-1 contain one copy each of 
Orig (Figure 51). The genome of R17/1, therefore, contains OriL of 
HG52 and both copies of Orig of McKrae. The structure of R17/1 in 
relation to OriL and Orig is shown diagrammatically in Figure 51.
(ii) R368/38
A BamHI digest of recombinant R368/38 DNA is shown in Figure 50. 
The genome is essentially HG52 except for fragment b. This fragment is 
smaller in size (labelled as Jd' and is migrating slightly below a. The 
only type 1 band identifiable is BamHI v. The structure of the 
recombinant is interpreted as having an insert of BamHI v of the 
McKrae genome that is 1.5x10^ mw. The new b1 thus generated runs from 
the _l'/b site of HG52 to the g/v site of McKrae. The other small 
fragment generated by the insert of type I v runs from the type I v/r 
site to the type II fc>/h' site. The fragment thus generated is not 
apparent on the gel but its size is smaller than type I v and it may 
be comigrating with a'.
Weller et al (1985) located OriL within BamHI v (0.398 to 0.413 
m.u.) of HSV-1. E368/38, therefore, contains OriL of McKrae and both 
copies of Orig of HG52. The structure of R368/38 is shown 
diagrammatically in Figure 51.
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FIGURE 51
Diagrammatic representation of the limits of McKrae DNA inserts 
in recombinants R368/38 and R17/1 derived from cotransfect ions of 
intact HG52 genomes with Hpal cleaved McKrae DNA. The inserts are 
represented by DNA sequences between the vertical dotted lines. The 
positions of HSV origins of replication OriL and Orig are marked (A). 
The short vertical lines above the line represent the relevant Hpal 
restriction sites on the HSV-1 genome. Letters refer to specific HSV-1 
Hpal fragments.
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3.12. CD3NING OF HSV-2 (HG52) DNA FRAGMENTS INTO A PLASMID CONTAINING AN
HSV-1 ORIGIN OF REPLICATION (ORIg)
Isolation of recombinants having intertypic inserts containing 
heterologous origins (S) of replication led to the conclusion that 
either (i) fragments containing an origin of replication are amplified 
in cotransfection experiments and thereby their chance of 
recombination with intact genomes is increased or (ii) replication and 
recombination in HSV are inter-linked.
To determine whether either of these possibilities was tenable 
the HSV-2 Hindlll h fragment (0.29 to 4.00 m.u.) was recloned into the 
plasmid pSl (Stow and McMonagle, 1983) at the Hind III site as 
described in methods (Section 2.9). Of the 96 transformed bacterial 
colonies screened by the miniprep alkaline lysis method (Birnboim and 
Doly, 1979), one was found to contain the desired plasmid. The 
resultant new plasmid containing HSV-2 Hind III h and HSV-1 Orig 
cloned in pAT 153 was named pSlh.
3.12.a. Genome analysis of plasmid pSlh
The presence of the HSV-2 Hindlll h fragment in the plasmid pSlh 
was deduced by analysis of BamHI and Hindlll digests of plasmid pSlh 
DNA. Plasmids pSl and pZ15 were used as controls. Lambda (X ) DNA 
digested with Aval was included in each digest to serve as a molecular 
weight marker control. As seen in Figure 52A, digestion of plasmid pSl 
DNA with Hindlll linearizes the plasmid to generate a single band of 
about 4kb in size. Digestion of plasmid pZl5 with Hindlll cleaves out 
the HSV-2 Hindlll h fragment of approximately 16kb (h), running at the 
top of the gel, and the linearized plasmid vector sequences of 3.6kb
(v). Digestion of plasmid pSlh with Hindlll generates two fragments of 
approximately 16kb and 4kb representing HSV-2 Hindlll h and vector 
sequences (S) of the plasmid pSlh respectively. The second band (h) in
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FIGURE 52
Analysis of recombinant plasmid pSlh.
Photographs showing Hindlll (A) and BamHI (B) restriction digests 
of plasmids pSlh, pZl5 and pSl DNA. Phage lambda DNA (1 ug) digested 
with Aval was included as a molecular size marker control (M). Plasmid 
DNA (1 ug) was digested with the enzyme under standard conditions, 
electrophoresed on a 0.8% agarose gel containing ethidium bromide, 
visualised under U.V. illumination and photographed. The tracts in 
each gel are, from the left, as follows:
M = lambda 1. plasmid pSl; 2. plasmid pZ15; 3. plasmid pSlh. 
Figures on left of the tract marked M indicate the size in bp of 
the lambda DNA fragments.
(c) Diagrammatic representation of the plasmid pSlh containing the 
HSV-2 Hindlll h fragment (h) and HSV-1 origin (Orig) containing 
fragment (0) cloned in the Hindlll and BamHI sites of plasmid 
pATl53 respectively, a, c and d represent the three subfragments 
of HSV-2 Hindlll h generated upon restriction with BamHI.
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Hindlll digestion of pSlh could be due to the partial digestion of a 
very small population of plasmid (pSlh). The slower migration of S in 
digests of plasmid pSlh as compared to the vector sequences v in the 
plasmid pZ15 digest indicates that the increase in size and hence 
slower mobility of S is due to the presence of an approximately 535 bp 
fragment of HSV-1 containing the origin of replication (Orig).
Confirmation of the presence of Orig in the plasmid pSlh came 
from BamHI digests of plasmids pSl, pSlh and pZ15 (Figure 52B). 
Digestion of the plasmid pSl with BamHI cleaves out the origin 
containing HSV-1 fragment of approximately 535 bp ( 0 ) from the 3.6 
kb vector sequences (v). BamHI digestion of plasmid pZ15 yields 4 
bands of approximate sizes 3.2, 4.5, 10 and 3.5 kb designated as a, c, 
d and v respectively. Digestion of plasmid pSlh with BamHI as expected 
generated all the bands seen in the BamHI digest of pZ15 plus an extra 
band of 535 bp ( O ) representing the HSV-1 origin containing insert.
The HSV-2 Hindlll h fragment has, therefore, been recloned into 
the plasmid pSlh without affecting the HSV-1 insert ( 0 ) containing 
an origin of replication (Orig).
3.13. MARKER RESCUE OF ts MUTATIONS WITH VIRUS ORIGIN OF DNA
REPLICATION CONTAINING PLASMID
To determine whether the introduction of an origin of replication 
into a plasmid containing a HSV fragment normally devoid of an origin, 
enhanced the chances of the HSV sequences recombining, the plasmid 
pSlh described in section 2.9 was constructed. As stated in section
3.12.a it contained HSV-2 fragment Hindlll ti (0.29 to 0.40 m.u.) and 
HSV-1 Orig cloned in Hindlll and BamHI sites respectively in plasmid 
pAT. The shortest distance between the sites is 346 bp.
The plasmid pSlh was used in cotransfect ion experiments to rescue 
the ts lesion in the HSV-1 mutant ts 1201 (Preston et al., 1983) which
maps at 0.33 to 0.34 m.u. As controls cotransfections of ts 1201 with 
HSV-2 Hindlll h alone, HSV-& EcoRI f (0.31 to 0.42 m.u.) and HSV-1 
Kpnl n (0.35 to 0.37 m.u.) were set up. A 1-, 5-, 10- and 15-fold 
molar excess of the HSV fragments to the intact ts 1201 genome was 
used. Transfections were carried out using the calcium phosphate/ DMSO 
boost method. One set of the transfections were incubated at 37°C and 
the second at 31°C. Plates were harvested when plaques were evident (3 
to 4 days) and the progeny titrated at 31°C and 38.5°C. The results of 
transfection experiments are shown in Tables 10 and 11.
As shown in Tables 10 and 11 it is evident that when incubation 
of the transfection was at 37°C, the efficiency of rescue of the ts 
mutation in ts 1201 was extremely high for all the fragments. Even 
taking into account that there was some leak through of the mutant as 
evidenced by the growth of plaques at 38.5°C when ts 1201 DNA was 
transfected alone; the figures were still high. The average percentage 
marker rescue for Hindlll h alone was 36.45; for Hindlll h plus Orig 
was 34.4; for EcoRI £ was 83 and for Kpnl n was 22.7. It is also 
evident that there was variation between replica transfections, most 
notably for the Kpnl n fragment. All the fragments would have been 
expected to rescue ts 1201. Kpnl n being the smallest (3kb), it would 
be expected to be the least efficient as it infact appeared to be. 
EcoRI £ and Hindlll h being of virtually equal size (about 16kb) might 
have been expected to rescue equally efficiently but EcoRI £ proved to 
be 2 x as efficient. EcoRI £ contains OriL and Hindlll h does not. 
However, as the Hindlll h fragment was of HSV-2 and EcoRI £ of HSV-1, 
the difference in rescue efficiency is not surprising. The plasmid 
containing Hindlll h coupled to Orig did not rescue any more 
efficiently than Hindlll h alone.
The high efficiency of rescue could have been due to the initial
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TABLE 10
Marker rescue of ts mutations with HSV DNA fragments containing 
or devoid of DNA origins of replication.
Ihe transfections were carried out as outlined in the text. 
Initial incubation was carried out at 37°C before titrating the 
progeny yield at 31°C and 38.5°C. The table shows the per cent marker 
rescue, obtained from cotransfections of ts 1201 DNA with variable 
molar excesses of HSV-1 and HSV-2 specific DNA fragments.
TAHiE 10
Trans­
fection
Plate
Intact
Genome
HSV DNA. fragment Titer in pfu/ml at 
31 °C 38.5°C
% Marker 
rescue
1. ts 1201 - 1.2X109 CI04 0.00063
2. ts 1201 - 1.3x10? 3x104 0.0023
3- ts 1201 - 1.4X109 1x106 0.07
4. ts 1201 - 1.3x109 1x104 0.0007
5* ts 1201 HSV-2 Hindlll h
*
1Qx 1.5x10s 4x1 cP 26.7
6. _ts 1201 -do- -do- 10x 1.3x10? 3-3x1 cP 25-3
7. ts 1201 -do- -do- 15x 1.3x109 8x1 cP 61.5
8. ts 1201 -do- -do- 15x 9-3x1 cP 3x1 cP 32.3
9. ts 1201 1W-2 ffinJIII h + 
Oris
1Qx 109 6.7x107 6 .7
10. ts 1201 -do- -do- 1Qx 2x109 1.2X109 60
11. ts 1201 -do- -do- 15x 9.4x1 cP 6 .6x 1 cP 70.2
12. ts 1201 -do- -do- 15x 5.7x1 cP 2.7x107 4 .7
13. ts 1201 HSV-1 EcoBI f 1Ck 5x 1 cP 5.6x1cP 100
14. ts 1201 -do- -do- 1Ck 9-4x1 oP 1.6X109 100
15. ts 1201 -do- -do- 15x 6.7x107 4-5x107 67
16. ts 1201 -do- -do- 15x N.D. N.D. N.D.
17. ts 1201 HSV-1 Kpnl n 1Qx 7.8x1 cP <10? 0.013
18. ts 1201 -do- -do- 1Qx 3x 1 cP 2x104 0.007
19. ts 1201 -do- -do- 15x 1x1 C? 1x10? 90.9
20. ts 1201 -do- -do- 15x 4x1 cP 2x10? 0.05
10x aid 15x denote molar excess of fragment 
N.D., not dene.
TABLE 11
Marker rescue of ts mutations with HSV DNA fragments containing 
or devoid of DNA origins of replication.
The transfections were carried out as outlined in the text. 
Initial incubation was carried out at 31°C before titrating the 
progeny yield at 31°C and 38.5°C. The table depicts the per cent 
marker rescue of the ts mutation, from cotransfections of ts 1201 DNA 
with different molar excess amounts of HSV-1 and HSV-2 specific DNA 
fragments.
TABUS 11
Trans­
fection
Plate
Intact
Genome
HSV DNA fragment Titer in 
31 °C
pfu/ml at 
38.5°C
% Marker 
rescue
1. ts 1201 - 10*7 3x10* 0.003
2. ts 1201 - 9-5x10? <10? 0.0
3. ts 1201 - 7.2x10? 4.5x10? 0.062
4. ts 1201 - 1.9x10? <10? 0.0
5. ts 1201 HSV-2 Hindlll h
*
1x 1.5x10? 1.5x10? 0.001
6. ts 1201 -do- -do- 1x 10? 7x10* 0.0C7
7. ts 1201 -do- -do- 5x 10? 5x10* 0.005
8. ts 1201 -do- -do- 5x 2.3x10? 7x10? O.C3
9. ts 1201 HSf-2 HindTTT h +
Orig
1x 1.1x10? 1.6X106 0.14
10. ts 1201 -do- -do- 1Qx 10? 1.4x10? 0.014
11. ts 1201 -do- -do- 5x N.D. N.D. N.D.
12. ts 1201 -do- -do- 5x 1.1x10? 1.2x10* 0.01
13- jbs 1201 HSV-1 EcoRI f 1x 1.6x10? 4.5X107 2.8
14. ts 1201 -do- -do- 1x 1x101C' 10? 0.01
15. ts 1201 -do- -do- 5x 5-4x1 C? 6x10? 0.11
16. ts 1201 -do- -do- 5x 3.8x1 C? 5.5x10? 1.4
17. ts 1201 HSV-1 Kpnl n 1x 1.2x10? 8*10* 0.006
18. ts 1201 -do- -do- 1x 1.2x10? <10? 0.0
19- ts 1201 -do- -do- 5x 1.2x10? <10? 0.0
20. ts 1201 -do- -do- 5x 2.8x1 C? 4x10? 0.001
1x a rri 5x denote m olar excess o f fragaen t DMA over the in ta c t genomes 
N .D ., n o t done.
incubation temperature of the transfection or the high molar excess of 
the HSV fragments. For this reason in the second experiment, the 
incubation temperature was changed to 31°C and the fragments were 
cotransfected at a lx and 5x molar excess to the ts 1201 genomes. The 
results indicate that there was still leak through of the ts 1201 at 
38.5°G although again variation was apparent. Ihe average marker 
rescue frequencies were 0.01% for Hindlll h; 0.05% for Hindlll h + 
Oris; 1.08% for EcoRI f^ and 0.002% for Kpnl n. As ts 1201 leaked 
through at 0.02%, the only fragment. which rescue efficiently was EcoRI 
f. Ihe figure of 0.05% for Hindlll h + Orig is only 2.5-fold above 
background and its significance is, therefore, unclear.
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CHAPTER 4
DISCUSSION
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4.1. RECURRENCE OF HERPES SIMPLEX VIRUS IN THE RABBIT EYE MODEL OF
LATENCY
Herpes simplex virus ocular infections manifest themselves in a 
variety of clinical conditions ranging from self-limiting benign 
epithelial disease to necrotizing stromal keratitis and uveitis. 
Patients with HSV infections of the face and eyes typically have 
repeated episodes of the disease that often occur in the same 
location. Following infection of the eye, HSV establishes a latent 
infection of the trigeminal ganglia (TG) as evidenced by the presence 
of latent virus (recoverable by cocultivation or in vitro 
explantation) in the TG of a significant proportion of human cadavers 
(Baringer and Swoveland, 1973). The reactivated virus travels down to 
the neurodermatome and may cause recurrent disease. In fact recurrent 
infections have been shown to be due to reactivation of the endogenous 
virus. Studies by Gerdes et al (1981) and Asbe11 et al (1984) 
demonstrated that the DNA banding patterns of spontaneous isolates 
from recurrent eyelid or mouth infection with HSV-1 were identical.
The identical DNA restriction patterns of spontaneous virus isolates 
from explanted trigeminal, superior cervical and vagus ganglia from 
individual cadavers (Lonsdale et al., 1979) gave rise to the 
hypothesis that each individual carries only one strain of HSV-1 
latent in their ganglia, and that this strain is carried throughout an 
individual's life time.
Experimentally ocular herpes virus infection can be studied in 
the rabbit eye model of latency. Keratitis following inoculation of 
HSV onto the rabbit cornea simulates the natural history of HSV 
keratitis in humans (Williams et al., 1965). Latently infected rabbits 
like humans, do not continuously shed detectable virus but may 
experience periodic recurrent infections during which reactivated
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virus can be found in the eye (Laibson and Kibrick, 196$? Nesburn et 
al., 1972). Previous studies in the rabbit eye model have shown that 
identifiable and reproducible ocular lesions of distinctly different 
size, location, and shape may result from corneal infection with 
different strains of HSV-1 irrespective of the dose of the virus 
(Wander et al., 1980) and several of the characteristics of the 
disease such as morphology of dendritic ulcers, severity of epithelial 
disease, and evidence of stromal disease are determined by the viral 
genome (Centifanto-Fitzgerald et al., 1982). A more serious clinical 
problem is the recurrence of ocular lesions in natural hosts. Factors 
which control recurrence are not understood; various stimuli have been 
implicated and the host's immune response no doubt plays a critical 
role (Easty, 1985).
Different strains of HSV have been shown to vary in their 
recurrence potential. Gerdes and Smith (1983) using the rabbit eye 
model of keratitis demonstrated a close relationship between strains 
of HSV with regard to ocular viral shedding and T.G. latency. HSV-1 
strains 17 and McKrae were designated high frequency recurrence (HFRc) 
phenotypes as spontaneous ocular shedding of the virus was detected in 
80 to 85% of the infected rabbits. Latent virus was recovered by 
cocultivation from 72% of the ipsilateral and 21% of the contralateral 
trigeminal ganglia. The five HSV-2 strains i.e. strain 186, HG52, 
CJ359, 2461 and 2544 studied in rabbits were all designated low 
frequency recurrence phenotype (LFRc) as these recurred in 0 to 25% of 
animals with a maximum of 45% of the eye swab cultures positive for 
infectious virus. HSV-2 strain HG52 recurred in 10% of animals and 
0.15% of eye swabs were positive for infectious virus. Virus was 
isolated from 20% of the ipsilateral ganglia by the cocultivation 
method. The recurrence phenotype of the virus as defined in singly
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infected animals remained unchanged following bilateral infection of 
the same animal with strains of the opposite phenotype, indicating 
that the differences seen in the recurrence phenotypes are maintained 
under identical conditions of immunity i.e. in the same animal. Hie 
restriction enzyme patterns of the recurrent virus isolates were 
identical to the infecting virus indicating the genetic stability of 
the virus during recurrence. However, in animals simultaneously 
infected with two strains of opposite recurrence phenotype, some 
recombinants were also found. These observations demonstrated that 
recurrence of latent virus in the rabbit keratitis model is HSV 
strain-dependent and the viral genes involved in establishment and 
maintenance of latency do not necessarily control recurrence. The 
findings of Gerdes and Smith (1983) described above formed the basis 
of the work presented in this thesis. In order to identify viral 
gene(s) controlling reactivation of the latent virus in the rabbit eye 
model, it was decided to make recombinants between HSV-1 strain 17 and 
HSV-2 strain HG52 and compare their capacity to establish a latent 
infection and reactivation potential with the HFRc, McKrae and LFRc, 
HG52 parental virus.
Our observations on the spontaneous recurrence of McKrae and HG52 
confirmed the findings of Gerdes and Smith (1983). Spontaneous 
shedding of McKrae found in the tear films of 100% of latently 
infected rabbits is in line with the findings of Beriwup and Hill 
(1985) who observed that 96.7% of McKrae inoculated rabbits shed virus 
spontaneously in their tear films at least once during the period of 
observation (20 to 39 days post infection). Spontaneous shedding of 
HSV-2 strain HG52 could not be detected in the tear films of any of 
the rabbits inoculated with 5x10^ or 5x10^ pfu of virus (Table 2). The 
absence of spontaneous shedding of HG52 could be due to either (i) the 
presence of some genetic defect in the HG52 genome or (2) the absence
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of latent infections in the rabbits inoculated with HG52. The recovery 
of latent virus from the TG explants of all the HG52 inoculated 
animals (Table 3) excludes the second possibility.
Induced reactivation of latent virus was achieved by 
iontophoresis of epinephrine. Epinephrine iontophoresis to the rabbit 
cornea has been shown to induce virus shedding into the preocular tear 
film reliably and with a high frequency during the latent phase of 
virus infection and the virus can be isolated from the tear film (Kwon 
et al., 1981, 1982; Hill et al., 1983). Virus shedding following 
iontophoresis has been shown to occur on average for 4 days with 
highest virus titers in the tear film on the third day post 
iontophoresis. Epinephrine being an adrenergic drug is believed to act 
on the sympathetic nerve fibres of post root ganglia resulting in 
reactivation of virus both in the TG and SCG (superior cervical 
ganglia). The virus upon reactivation travels down the axon and is 
shed in the tear film. However, the precise role of epinephrine in 
reactivation of HSV from latency is unknown.
In the present study 100% of rabbits (11/11) infected with 5x10^ 
pfu of McKrae shed virus on induction with iontophoresis of 
epinephrine. The average duration of shedding of virus was 4 days 
(range being 1 to 8 days post iontophoresis; Table 2). These findings 
confirm the findings of virus shedding for 3 to 4 days in the eyes of 
latently infected rabbits upon induction with epinephrine as reported 
by Kwon et al (1982). None of the six rabbits latently infected with 
5x10^ or 5x10^ pfu of HG52 shed virus on induction with epinephrine 
iontophoresis. However, two of the rabbits inoculated with 5x10^ pfu 
of HG52 shed virus post iontophoresis.
These findings on virus shedding post epinephrine iontophoresis 
confirm the recurrence differential demonstrated by Gerdes and Smith
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(1983) on spontaneous shedding of HSV-1 strain McKrae and HSV-2 strain 
HG52. The HFRc phenotype of McKrae and LFRc phenotype of HG52 appear 
to be unchanged and only infrequently and after high inoculating doses 
can HG52 be induced to reactivate from latency. As there were no 
differences in the groups of animals infected with McKrae and HG52, 
the findings on spontaneous and induced shedding point to the viral 
genotype determining the recurrence differential between the two 
strains.
Latent infection of the rabbits was confirmed by isolation of 
virus from explanted trigeminal ganglia. The ipsilateral TG explants 
of all the rabbits inoculated with McKrae or HG52 shed virus between 7 
to 30 days post explantation. Our findings of isolation of virus from 
100% (Table 2) of rabbits latently infected with HG52 is in contrast 
to the findings of Gerdes and Smith (1983) who could recover virus 
from only 20% of HG52 infected rabbits by cocultivation of their TGs. 
One possible explanation for the high incidence of recovery of HG52 in 
the present studies is the efficiency of the screening method i.e. 
straight explantation and growth, versus cocultivation with helper 
cells. As seen in Table 2 in some cases release of virus from TG 
explants was detected as late as 22 days after explantation. Such TGs 
are more likely to be taken as latency negative if screened by the 
cocultivation methods in which the ganglia are incubated be fore 
cocultivation only for 7 to 10 days. Not all the 6 segments of a
trigeminal ganglion explant released virus; most cases varied between
b
1 and 3 segments. Tullo et al (1982j) reported that following ocular 
infection of rabbits with HSV, latent infection of the ophthalmic 
division was more frequent than the mandibular or maxillary divisions 
of the trigeminal ganglion. Our observation of release of virus from 
some but not all segments of explanted TGs support these findings in 
that it is possible that the explanted TG fragments releasing virus
165
may only have originated from the ophthalmic division of the ganglia.
However, the exact anatomical origin of the segments with regard to
recorded
the divisions of a TG was not A in the present study.
Following ocular infection of one eye with HSV, virus may spread 
to the other eye by the neuronal pathways (Pettit et al., 1965) and 
cause disease (Goodpasture and Teague, 1923; Kimura, 1962; Kaufman, 
1982). Gerdes and Smith (1983) observed some strain differences in the 
capability of virus to spread to the contralateral TG on inoculation 
of rabbit corneas with different strains of HSV-1 and HSV-2. The 
frequency of latent infection in the contralateral TG was much less 
than that in ipsilateral ganglia. These findings of Gerdes and Smith 
(1983) are in line with the recovery of both HG52 and McKrae virus 
from the explants of contralateral trigeminal ganglia of the rabbits 
(Table 3).
Taken together the observations of spontaneous and induced 
shedding patterns and the capability of establishing latent infections 
of the trigeminal ganglia confirm, the findings of Gerdes and Smith 
(1983) on the recurrence phenotypes of HSV-1 strain McKrae and HSV-2 
strain HG52.
Some of the corneal explants from the ipsilateral eyes of rabbits 
latently infected with HSV-1 strain McKrae also shed virus between 
days 15 and 35 in organ culture. This finding is discussed in a later 
section.
4.2. RESTRICTION ENDONUCLEASE ANALYSIS OF THE HSV-1 STRAIN McKRAE
GENOME
Since analysis of recombinant virus genome structures is based on 
restriction site polymorphism, it was necessary to know the 
restriction enzyme cleavage patterns of both parental viruses (HSV-1 
strain McKrae and HSV-2 strain HG52) being used to generate
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recombinants. The restriction maps for HG52 have already been 
published (Gortini and Wilkie, 1978). The only previous mapping data 
for McKrae are that of Gerdes and Smith (1983) who reported that the 
HSV-1 strain 17 defined Hindi 11 m/n site, the Kpnl c/x site; a Kpnl m 
site and a Hpal k site were all missing in the McKrae genome. On 
comparison of the Bglll and Hpal digests of McKrae with that of strain 
17 (Figure 30) no differences in the sizes or number of fragments were 
observed. The Eco RI digests disclosed no site loss but both the k_ and 
1 fragments were smaller than those in strain 17 (Figure 29B). Our 
results on Hindlll digests confirmed the absence in the McKrae genome 
of the Hindlll m/n site. The hexanucleotide for the Hindlll m/n site 
in strain 17 begins at residues 862 (McGeoch et al., 1985) within the 
coding region of gene US1 encoding polypeptide Vimw 68. The BamHI a 
fragment was deleted by approximately 1x10^ mw and w was larger by 0.3 
x 106 mw in the McKrae genome. Tie size alterations were not 
investigated further. In addition to the Hindlll m/n site the Kpnl c/x 
site and d/z site were also found to be missing in the McKrae genome. 
Tie Kpnl c/x site and d/z site in HSV-1 strain 17 lie in the coding 
regions of genes UL 31 and UL 46 respectively. The functions of the UL 
31 and UL 46 gene products are unknown. Comparison of the Kpnl 
profiles of McKrae and strain 17 also revealed the presence of an 
extra band of approximately 2 x 10^ mw (Figure 32). Analysis of 
hybridization data indicated the presence of an extra Kpnl site in the 
repeat sequences flanking UL. Tie sequence analysis of the IE-1 gene 
(Perry et al., 1986) encoding Vmw 110 in strain 17 has revealed the 
presence of the Kpnl r/g site at residue 3260 and the 3' terminus of 
IE-1 mRNA is located at residue 5301. In order to generate a fragment 
of approximately 3Kb, the new Kpnl site must lie outside the coding 
region of the IE-1 gene. Sequence analysis of TT^/irl has not revealed
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any other open reading frames in this region. We could not confirm the 
Kpnl m site and Hpal k_ site differences claimed by Gerdes and Smith 
(1983). However, a different strain of HSV-1 (i.e. McIntyre) was used 
in their comparison studies.
The loss of Hindlll m/n, Kpnl c/x and Kpnl d/z sites in McKrae 
could be due to a single base change in the hexanucleotides recognised 
by these enzymes. The additional Kpnl site in TR^/IR^ of McKrae, as 
stated earlier, seems to lie outside the coding sequences for IE-1 
mRNA. This analysis is consistent with induction of similar 
polypeptide profiles by McKrae and strain 17 (Figure 47 traces 2 and 
3).
4.3. CONSTRUCTION OF HSV-1 STRAIN McKRAE X HSV-2 STRAIN HG52
RECOMBINANTS
Our initial approach in constructing McKrae x HG52 recombinants 
was to do cotransfection experiments with intact HSV-1 McKrae DNA and 
either plasmid cloned fragments or restriction endonuclease cleaved 
individual fragments of HG52 DNA isolated from agarose gels. This 
approach would have allowed us to cover all areas of the genome in a 
systematic way. Despite restriction endonuclease analysis of nearly 
1000 plaques resulting from such cotransfection experiments, no 
recombinants were obtained. Attempts to make recombinants by double 
infection of cells with McKrae and HG52 virions were also 
unsuccessful, as restriction endonuclease analysis of 490 progeny 
plaques from separate mixed infections did not yield any recombinant 
virus. The lack of isolation of recombinants using these techniques is 
not fully understood. Alterations in various parameters especially the 
molar ratios of the intact and fragmented DNA and different 
multiplicities of infection were used. The lack of selection pressure 
in the isolation procedure no doubt plays a prominent role.
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HSV-1 X HSV-2 intertypic recombinants have previously been 
isolated by plaque purification of progeny virus from mixed infections 
of cells with HSV-1 and HSV-2 virions in which the parents contained 
selectable markers e.g. a temperature sensitive (ts) mutation (Timbury 
and Subak-Sharpe, 1973; Preston et al., 1978), a ts mutation in 
addition to a mutation conferring resistance to a drug like phosphono 
acetic acid (Morse et al., 1977; Marsden et al., 1978) or a ts 
mutation and a plaque morphology (syn/syn*~) mutation (Halliburton et 
al., 1977). Inter typic recombinants of HSV-1 and HSV-2 have also been 
generated by intertypic marker rescue of ts mutations in HSV-1 with 
restriction endonuclease cleaved fragments, either individual (Knipe 
et al., 1978) or unseparated (Stow et al., 1978) of HSV-2 wild-type 
virus DNA. In each case the isolation of recombinants has been 
facilitated by a selection system i.e. sensitivity to temperature, or 
to a particular drug or by plaque morphology. We are unaware of any 
report describing isolation of intertypic recombinants of HSV without 
a selection system. Alternative explanations for lack of success in 
obtaining unselected HSV intertypic recombinants could be (i) an 
inherent failure in the system e.g. the BHK21/C13 cells used being 
inefficient for transfection or recombination; poor DNA preparation; 
poor technique etc. (ii) inability to detect recombinants by the
method of restriction enzyme profile analysis, (iii) incompatability
freely
of McKrae and HG52 resulting in an inability to recombine^ The results
of the marker rescue experiments presented in Tables 4, 10 and 11
indicate both high efficiency of intratypic as well as intertypic
may
marker rescue of ts mutations andy( argue against the first possibility. 
Deduction of genome structure of HSV intertypic recombinants by 
restriction enzyme analysis in the past (Preston et al., 1978; Stow et 
al., 1978; Preston, 1981 and also this study) invalidates the second 
possibility. However, the possibility exists that a recombinant having
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a very small insert of heterologous DNA not involving any restriction 
enzyme site may escape detection by this technique.
As the McKrae genome has minor differences in terms of 
restriction enzyme site deletions/additions and sizes of fragments 
compared to strain 17 it seems unlikely that its genome is unable to 
recombine with HG52 because of gross non-homology. As strain 17 and 
HG52 recombine albeit inefficiently, explanation (iii) is untenable.
It seems likely that the inability to isolate recombinants by the 
cotransfect ion of intact genomes and restriction enzyme cleaved or
individual cloned fragments was due to a lack of a selection system
restricted or
and a^low level of recombination between HSV-1 and HSV-2 genomes.
Eleven McKrae X HG52 recombinants (out of 641 progeny plaques 
screened) were isolated successfully in the absence of selection 
pressure following cotransfection of intact McKrae DNA with Hpal or 
Xbal cleaved unseparated products of HG52 DNA. Restriction enzyme 
cleaved unseparated fragments of HSV-2 DNA have successfully been used 
in marker rescue of intertypic ts mutations (Stow, et al., 1978). It 
has also been reported that transfection of cells with restriction 
endonuclease cleaved unseparated fragments of HSV-2 did not yield any 
progeny virus (Stow et al., 1978) possibly due to inability of the 
fragments to religate and generate infectious virus. The frequency of 
intertypic recombination in the present study was found to be 1.8% 
which probably in part explains the failure to isolate recombinants 
when using individual or cloned fragments of HG52 DNA. All the 
putative recombinants were plaque purified three times before virus 
stocks were grown and their DNA analysed.
4.4. STRUCTURE OF THE RECOMBINANTS
The structure of the intertypic recombinants was deduced from the 
analysis of their DNA restriction enzyme patterns. The restriction
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endonuclease maps of HSV-1 and HSV-2 differ markedly from each other
in terms of the positions of sites and sizes of fragments and
therefore can be used to determine the crossover points in intertypic
recombinants (Halliburton, 1980). Hie accuracy with which the
crossover points can be determined is largely related to the
frequency of cleavage with a particular enzyme. Hie restriction
enzymes Xbal, Hindlll, Bglll, EcoRI, Hpal and Kpnl have been used in
the past to analyse the DNA structure of the majority of HSV-1 X HSV-2
recombinants (Timbury and Subak-Sharpe, 1973; Halliburton et al.,
1977; Preston et al., 1978; Marsden et al., 1978; Stow and Wilkie,
1978). Analysis of recombinants with these enzymes involves 56
cleavage sites in HSV-1 ENA and 40 in HSV-2 DNA (Halliburton, 1980).
In the present study, BamHI was used in addition to some of the above
enzymes. Hiere are 41 BamHI cleavage sites in HSV-1 and 42 in HSV-2
DNA (Figure 28). Analysis of the BamHI restriction endonuclease
patterns of the recombinant genomes determined the location of HG52 
with c i
DNA inserts^considerable presiqrj without fine mapping. Of the 1L
recombinants isolated, R43/2/2 had a single crossover in the short
region of the genome (crossover frequency of 9.091%). Hie recombinants
having 2 and 3 crossovers were observed at frequencies of 72% (8/11)
and 18.1% (2/11) respectively. Hiese crossover frequencies are in
contrast to the observations of Halliburton (1980) who from
restriction sites polymorphism of 99 recombinants determined crossover
frequencies of 19.2%, 42.4% and 6.1% for 1, 2 and 3 crossover
containing recombinant genomes respectively. Hie small number (11) of
recombinants isolated in this study has probably contributed to the
observed differences between crossover frequencies.
However, within the limits of the small number of recombinants, 
it is obvious that the number of recombinants 10/11 containing inserts
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of heterologous sequences in UL (0.35 to 0.576 m.u.) is more than 
those (3/11) containing inserts in the [S] region (0.82 to 1.00) of 
the genome. Except for R43/2/2, all the recombinants contained inserts 
of HG52 sequences in UL. One interpretation of the data could be the 
presence of 'hot spots' or preferential sites for recombination in 
particular regions of the genome. Preferential crossover sites between 
map units 0.40 to 0.45 and 0.60 to 0.70 reported by Morse et al (1977) 
from the anlyses of 28 selected intertypic recombinants concords with 
our findings of increased recombination frequency between 0.35 and 
0.576 m.u. Halliburton (1980) from analysis of the genome structure of 
79 selected intertypic recombinants observed that the most frequent 
crossover events lie between 0.025 and 0.250, 0.40 and 0.45, 0.825 and 
0.85, and 0.650 and 0.675 m.u. but there were no obvious hot spots for 
recombination.
Each of the 11 recombinants isolated after restriction 
endonuclease analysis of 641 plaques derived from cotransfection of 
intact McKrae DNA with the total restriction endonuclease cleaved 
products of HG52 DNA contained HG52 sequences between 0.35 and 0.576 
m.u. and/or 0.82 and 1.00 m.u. (Figure 48). As far as could be 
determined by BamHI analysis no other HG52 DNA fragments were present 
in any of the recombinants. Hie left hand end of the type II inserts 
in the long region of the genome always terminated at approximately 
0.35 m.u. i.e., the crossover was around the BamHI eVg site of HSV-1 
such that whole of BamHI fc> of type II was present in all the 
recombinants except R43/2/2. BamHI analysis does not unequivocally 
determine the origin of the DNA present in the region delimited by the 
HSV-1 BamHI e'/g site and the HSV-2 BamHI 1/b site. For the 
recombinants derived from Hpal cleaved HG52 fragments (R10/3/1,
R10/3/4/6, R10/4/1, R20/4/1, R30/3, R40/2/2 and R40/2/4) the 0.35 map
apparently
position is i coincidental with the Hpal h/d site of HSV-2 (Figure 48).
N
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It could, therefore, be postulated that the left hand end of the- 
insert was determined by the left hand end of the Hpal d fragment. 
However, the left hand end of the type II inserts in recombinants 
R5/26/1, R47/27/1 and R7/3/3 derived from cotransfection involving 
Xbal cleaved HG52 genomes also terminated approximately at 0.35 m.u. 
Recent sequencing analysis of HSV-1 strain 17 (D.J. McGeoch, personal 
communication) has shown that the 3' ends of the transcripts of genes 
UL 26 and UL 27 terminate in a fco-it to tail fashion (Figure 5) at this 
position. UL 26 codes for the packaging polypeptide p40 (Preston et 
al., 1983) and UL 27 codes for gB (Bzik et al., 1984). The 3’ end of 
the mRNA of UL 26 stops at nucleotide position 52796 and the 3' end of 
UL 27 stops at nucleotide position 53028. Hie nucleotide sequence of 
HG52 in this region is not known but it could be envisaged that there 
would be a high degree of homology between gB of HSV-1 and HSV-2 
thereby facilitating recombination and that the 200 bp intervening 
sequence (368 bp non-coding sequence) may not be highly homologous 
such that the crossover is likely to have occurred within gB. This 
model would require the viruses to tolerate a recombinant 
glycoprotein.
The HG52 UL inserts in recombinants derived from Hpal cleaved 
HG52 DNA were of variable length. Hie right hand end of the largest 
insert in UL seen in R40/2/2 extended up to the HG52 Hpal d/e site 
such that whole of the Hpal d fragment had recombined into the McKrae 
genome. Hie right hand boundary of the HG52 UL inserts in recombinants 
derived from Xbal cleaved HG52 genomes terminated at 0.43 m.u. 
comapping with the HG52 BamHI jVo site. Sequence analysis of HSV-1 
strain 17 (D.J. McGeoch, personal communication) has revealed that the 
genes located between 0.35 and 0.576 m.u. include UL 26 to UL 38. UL 
26, UL 27, UL 29 and UL 30 code for the packaging polypeptide p40, gB,
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DBP and ENA polymerase respectively. The functions of the gene 
products encoded by UL 31 to UL 38 are as yet unknown.
Inserts of HG52 DNA sequences in the short region of the genome 
as determined by the restriction endonuclease analysis were located 
between 0.82 and 1.00 m.u. i.e. the entire short region. The DNA
sequence comparison of the short region of HSV-1 strain 17 and HSV-2,
except gG
HG52 has indicated colinearity of the genes j^Whitton and Clements, 
1984a,b; Whitton et al., 1983; McGeoch et al., 1985, 1987).
4.5. POLYPEPTIDE ANALYSIS
The electrophoretic mobility of the infected cell polypeptides 
induced with HSV-1 strain McKrae was to that of strain 17
except for a - cnange in mobility of Vmw 21K induced by McKrae.
In an analysis of polypeptides induced by HSV isolates from human 
trigeminal ganglia an interstrain variability in the mobility of the 
21K polypeptide was reported by Lonsdale et al (1979). Dargan and 
Subak-Sharpe (1984) reported a similar shift in the mobility of Vmw 
21K in a study of polypeptides induced with ts+ revertants of HSV-1. 
DNA sequencing of the US 11 gene encoding Vmw 21K has revealed the 
presence of a short 18 bp sequence which is present as 3 tandem 
repeats in HSV-1 strain 17 syn* (Rixon and McGeoch, 1984), but only as 
two tandem repeats in HSV-1 strain Patton (Watson and Vande Woude, 
1982). The corresponding sequence in the McKrae genome is not known.
It has been suggested (Rixon and McGeoch, 1984) that variation in the 
number of repeats of this 18 bp sequence may account for the 
inter strain variability in the molecular weight and hence the mobility 
shift of Vmw 21 reported by Lonsdale et al (1979) and hence may 
account for the difference in the 21K polypeptides of strain 17 and 
McKrae.
Close correlation has been reported between the genome structure
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and the polypeptides induced by intertypic recombinants and this 
formed the basis of mapping of genes specifying particular 
polypeptides (Marsden et al., 1978; Ruyechan et al., 1979). Analysis 
of the polypeptides induced by the McKrae x HG52 recombinants and 
their genome structures has allowed the assignment of the gene coding 
for Vmw 29.5 of HG52 to 0.43 and 0.51 m.u. of the genome. This 
polypeptide had previously been mapped to 0.43 - 0.48 m.u. (Marsden et 
al., 1978).
4.6. REACTIVATION POTENTIAL OF THE McKRAE X HG52 RECOMBINANTS IN THE
y
RABBIT EYE MODEL
As all the recombinants were not isolated at the same time, it 
was necessary to check, as they became available, their latency 
recurrence phenotypes in rabbits. Obviously it would have been 
advantageous to be able to screen the recombinants with the longest 
HSV-2 inserts first but this was not possible. However, as the 
recombinants had similar structures in terms of HSV-2 sequence inserts 
it was possible to limit the number of recombinants for test to 4 
(R10/3/1, R10/3/4/6, R40/2/2 and R43/2/2). In this way there was as 
little duplication as possible. Ihe four recombinants were fully able 
to produce a latent infection as evidenced by recovery of virus from 
explanted trigeminal ganglia between days 15 and 33 post explantation 
(Tables 5 to 8). The trigeminal ganglia from the four recombinant 
infected animals when compared to those from McKrae infected animals 
shed virus for the same number of days (10-15).
However, there was an initial delay in shedding of virus from the 
trigeminal ganglia of rabbits latently infected with the recombinants 
(15 to 26 days) compared to McKrae infected animals (5 to 7 days). The 
possible reasons for the delay in releasing virus from the left 
trigeminal ganglia of rabbits infected with the recombinants could be
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that (a) there were fewer ganglionic cells infected with the virus
and/or (b) there was less virus being released from the trigeminal
(c) inserts of HG52 DNA alters timinq of reactivation 
ganglia explants^ In either case a longer time will be needed for
c
virus amplication before detection. Since quantitajlon of virus in the 
TG was not done during these studies, it is not possible to exclude 
either of the above possibilities. Recovery of virus from one of the 
six segments of the explanted right trigeminal ganglia from one of the 
rabbits (Table 5) infected with R10/3/4/6 is similar to the isolation 
of virus from the right trigeminal ganglion of rabbits infected with 
the McKrae parent and concords with the findings of Gerdes and Smith 
(1983) in which virus was isolated from cocultivated contralateral 
ganglia. Recovery of virus from the contralateral ganglia on
explantation indicates active spread in contrast to passive transport
(ii)cross contamination during explantation 
of HSV within the nervous system^ However, no attempts were made to
quantitate virus released in the tear films or from the explanted ,
ganglia, to determine the role of replication of virus.
Spontaneous shedding of HSV in the tear films of latently 
infected rabbits has been reported to be intermittent (Berman and 
Hill, 1985). Gerdes and Smith (1983) observed that in rabbits latently 
infected with McKrae virus the frequency of spontaneous shedding of 
virus in the preocular tear film was 85% and that 90% of animals were 
latently infected. However only 5.4% of eye swabs were positive for 
virus at a given time point. These observations of Gerdes and Smith 
(1983) and Berman and Hill (1985) explain our inability to detect any 
infectious virus when the rabbit eyes were screened for spontaneous 
shedding of virus. Since the eyes were screened only once (except 
immediately prior to iontophoresis for spontaneous shedding) albeit 
for 7 days, it seems likely that virus was not being shed at that 
particular time point. It is possible that virus could have been 
detected in the tear films had the eyes been screened throughout the
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infection.
On induction with epinephrine iontophoresis all the rabbits 
inoculated with the recombinants were positive for virus shedding in 
their tear films and the duration of shedding was similar to that with 
McKrae infected rabbits (Tables 4 to 8). In other words, each of the 4 
recombinant viruses exhibited a high frequency recurrence phenotype 
(HFRc) like their McKrae parent and not a low frequency recurrence 
phenptype (LFRc) like the HG52 parent. It follows that the genes 
encoded in the [S] region of HSV do not determine the recurrence 
differential and similarly the genes between 0.35 and 0.576 m.u. 
either alone or in concert with those in [S] are not involved in the
reactivation differential from latency between McKrae and HG52 at
least in the rabbit eye model except possibly a modification in timings of
reactivation due to HG52 insert(s). The genes between 0.35 and 0.**3 m.u. m
HSV-1 strain 17 have been sequenced (Quinn and McGeoch, 1985). The 
genes for DNA polymerase (UL 30) and the major DNA binding protein (UL 
29) are arranged in a head to head manner with an origin of DNA 
replication located between them. Recent sequencing has assigned two 
open reading frames to the left of UL 29 i.e., UL 27 which codes for 
gB and UL 28 whose polypeptide product has not yet been defined. The 
genes to the right of UL 30 have also now been defined (D.J. McGeoch, 
personal communication; Figures 5 and 6). Hie sequence of the short 
region of the HSV-1 genome has been determined (Murchie and McGeoch, 
1982; McGeoch et al., 1985). The genes encoded in the short unique 
region of HSV-1 have been shown to be dispensable hi vitro with the 
possible exception of the US 6 gene coding gD (Longnecker and Roizman, 
1987; Weber et al., 1987). DNA sequence comparison of the short region 
of HSV-1 strain 17 and a major portion of Us of HSV-2 HG52 has 
indicated a colinearity of sequences with the exception of US 4 which 
in HG52 is larger by 1460 bp (McGeoch et al., 1987). In both viruses
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US 4 encodes glycoprotein gG. Viral mutants lacking HSV-2 (HG52) US 
10, 11 and 12 and one copy of the IE-3 gene and Orig have been shown 
to grow in cell culture indicating that these genes are dispensable 
for lytic growth of virus (Brown and Harland, 1987). It would appear 
from our work that these genes are not involved in determining 
recurrence phenotype.
4.7. HERPES SIMPLEX VIRUS LATENCY IN RABBIT CORNEAS
Isolation of HSV from corneal explants in addition to trigeminal 
ganglion explants is one of the interesting findings of this study. 
Release of virus from the corneal explants of 3 rabbits infected with 
McKrae, one infected with R40/2/2 and one with R43/2/2 was observed 
between days 15 and 31 post explantation for McKrae and 35 and 49 for 
the recombinants. In general, the corneas were a longer time in 
culture than ganglia before the first detection of released virus and 
the virus was detected in only one of the six corneal segments 
cultured from each animal. In each case the restriction endonuclease 
patterns of the viral DNA released from the corneas were identical to 
those of the infecting virus (data not shown).
The isolation of HSV from latently infected rabbit corneas can be 
attributed to one of 3 possibilities; (i) virus was latent in the 
cells of the cornea (ii) virus was present as a chronic low grade 
infection undetectable by eye swab (iii) virus had recently been 
transported to the corneas and needed amplification by growth in 
cultured cells before detection.
The virus was first detected from the five positive corneal 
explants on days 18, 28 and 15 from 3 rabbits latently infected with 
McKrae virus and on 35 days post explantation from rabbits latently 
infected with R40/2/2 and R43/2/2. In each case, therefore, there was 
a considerable delay before virus isolation and the delay was similar
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to that found in isolation of virus from latently infected ganglia 
(12, 8, 12, 26 and 15 days post explantation). The long delay in 
release of virus from corneas, counter argues the possibility of a 
chronic low grade infection or of the recent transport of a small 
amount of virus from the TG to the cornea which is only detectable 
after amplification. In either case amplification and therefore, 
detection of infectious virus would probably have occurred within 2 to 
3 days of explantation. The homogenization of corneal tissues 
immediately after explantation could have demonstrated the presence of 
a chronic low grade persistence but paucity of material, the low 
frequency of isolation and the small number of positive segments 
precluded homogenization immediately after explantation. The isolation 
of virus from only one of the six segments in each case is in line 
with the results obtained in the human study where HSV was only 
released from clinically diseased segments of corneas. It could be 
that only certain parts of rabbit corneas were initially infected.
The corneal explants from rabbits latently infected with 
recombinant viruses were a longer time in culture before releasing 
virus compared to those latently infected with McKrae. It is possible 
that during the primary infection of corneas, McKrae had multiplied 
faster and infected more corneal cells compared to the recombinant 
viruses.
The frequency of HSV isolation from rabbit corneas (19.2%, 5 out 
of 26) compared to ipsilateral ganglia (100%, 26 out of 26) suggests 
that dorsal root ganglia (TG) are the preferred site for establishment 
of a latent infection following eye infection, but that some corneal 
cells also support and maintain HSV in a latent state. In vitro 
studies have shown that cultured rabbit corneal cells are capable of 
supporting a latent infection (Cook and Brown, 1986, 1987) and support 
the finding of latent virus in corneal explants. The isolation of
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virus from rabbit corneas after a long period of time in organ culture 
taken together with isolation from only a portion of the corneas 
strongly suggests that HSV can become latent in some corneal cells.
4.8. HERPES SIMPLEX VIRUS VIRULENCE
Heterogeneity among strains of HSV in relation to virulence has 
been known for some time. The correlation of data on virulence of 
intertypic recombinants with their genome structure has been used to 
identify the genes involved in type specific virulence (Thonjison et 
al., 1983, 1985; Rosen and Darai, 1985; Rosen et al., 1985, 1986).
Doses of 5 x 106 pfu and 5 x 10^ pfu of McKrae inoculated onto 
rabbit corneas caused death or could not be tolerated (Section 3.2).
On the other hand doses of at least 5 x 10^ pfu of HG52 per animal
could be used with no adverse effects. Similarly rabbits were able to
C- 7
tole^te at least 2 x 10' pfu of ^recombinant virus suggesting that the 
inserts of HG52 information had reduced considerably the virulence of 
McKrae.
It is possible that the particleipfu ratio of the virus stocks 
could have modified the virulence of the recombinants. The 
particleipfu ratios of the parental virus and the recombinants ranged 
from 10^ to 10^ and the virus with the highest particleipfu ratio 
(R43/2/2) did not cause death at 3 x 106 pfu/inoculation. It is also 
possible that reduction in virulence of the recombinants could have 
been due to inability of the virus to replicate in the corneas or the 
inability to spread in the nervous system. Although exact virus levels 
were not titrated in either the eye or ganglia, there are several 
observations which suggest that reduced replication by the recombinant 
viruses did not occur. First the length of the acute phase of the 
disease was identical in most cases for eyes infected with the 
parental McKrae or HG52 strains or the recombinant viruses. If
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replication in the eye had been restricted, the duration of the acute 
phase as evidenced by the presence of characteristic herpetic corneal 
ulcers on visual examination by fluorescein staining would have been 
decreased, ihe fact that 100% of the recombinant infected rabbits were 
shown to be latently infected as well as the length of time required 
to recover virus from the explanted TG in conjunction with shedding of 
virus from the contralateral TG in one of the rabbits inoculated with 
R10/3/4/6 (Table 7), strongly suggest that replication in the cornea 
or spread of virus in the TG was not restricted.
Moderation in virulence of the McKrae genomes was observed 
irrespective of the location of HG52 sequences in [S] or Ul or both 
regions of the genome, indicating the involvement of genes in both 
regions in the determination of virulence.
regions
Studies on virulence of HSV have implicated different * of . 
the genome. Centifanto-Fitzgerald et al (1982) have shown that the
0.710 to 0.830 m.u. region of HSV-1 contains genes that control the 
pattern of corneal involvement in the case of herpetic eye disease in 
rabbits. ThonSjson et al (1983, 1985) using mice and Rosen et al (1985) 
using tree shrews have reported that HSV DNA from 0.710 to 0.830 m.u. 
is associated with the functions responsible for neurovirulence. On 
the other hand Halliburton et al (1987) on intraperitoneal inoculation 
of mice with 31 HSV intertypic recombinants having crossovers along 
the length of the genomes observed an attenuation in virulence 
independent of the parental viruses and concluded that factors 
controlling virulence of HSV are multigenic. Similarly Sedarati and 
Stevens (1987) from studies on the virulence phenotype of three 
strains of HSV-1 in mice concluded that the avirulent phenotype was 
related to different loci in the 3 viruses.
Our studies do not implicate the region of the HSV-1 genome
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(0.710 to 0.830) mapped by Centifanto-Fitzgerald (1982) or Thoirjson et 
al (1983, 1985) but support the concept that virulence of HSV is 
controlled multigenically, an observation already reached for HSV1 x 
HSV2 intertypic recombinants and for intertypic strains of HSV-1 in 
mice (Halliburton et al., 1987; Sedarati and Stevens, 1987).
4.9. STRUCTURE OF McKRAE X HG52 RECOMBINANTS IN RELATION TO ORIGINS OF
VIRUS DNA REPLICATION
On cotransfect ion of intact McKrae genomes and the total products 
from restriction endonuclease cleaved HG52 genomes, 11 identifiable 
recombinants were isolated. The restriction endonuclease profile 
analysis of the recombinant genomes indicated that when Xbal cleaved 
HG52 DNA fragments were used, only sequences from the right hand end 
of Xbal c (0.0 to 0.45 m.u.) were inserted into the McKraa genome. 
When Hpal cleaved HG52 fragments were used, only information from Hpal 
d (0.35 to 0.576 m.u.) or [S] or Hpal d plus [S] were inserted. The 
common feature between Xbal c, Hpal d and the whole of the [S] region 
is that each contains an origin of replication, either OriL or Orig. 
There are no other shared characteristics in terms of gene coding 
between the sequences in [S] and those between 0.35 and 0.576 m.u. 
Isolation of recombinants containing both Ori^ and Orig of HSV-2 
suggests that both origins i.e. OriL and Orig are functional in vitro.
We propose that the preferential insertion of HG52 sequences from 
the above listed restriction fragments into the McKrae genomes is due 
to the presence of an origin of replication in each of these 
fragments. Preferential recombination in these regions of the genome 
could be due to (a) amplified replication of fragments containing an 
origin such that these fragments are increased in number and are 
therefore more readily available for recombination and/or (b) an 
interrelationship between replication and recombination exists such
182
that in the process of replication, recombination is more efficient 
due to dispersed DNA strands being freely available (c) heterogeneity 
along the genome in terms of potential for recombination. The absence 
of an origin of replication in the other restriction endonuclease 
cleaved fragments would preclude possibilities (a) and (b).
If preferential recombination was due to amplification of the
origin containing fragments i.e. increased copy number making them
more available, it would not be necessary for the inserted fragment
always to contain an origin of replication. If abundance was the only
criterion for recombination, then it would be expected that any region
of the origin containing fragment would be equally available for
recombination. When Xbal fragments were used for cotransfection, only
OriL containing sequences from the extreme right (0.35 to 0.45) of the
Xbal £ fragment (0.0 to 0.45 m.u.) were inserted. This would suggest
that preferential recombination between origin containing fragments 
may be
and intact genomes A. ^ related to replication and the frequency could be 
inversely proportional to the distance from the origin: the highest 
, degree of recombination around OriL being concentrated between 0.35 
and 0.43 m.u.
It could also be postulated that the preferential recombination 
demonstrated is due to a high degree of homology in these regions of 
the genome. The fact that proteins involved in replication, i.e. the 
major DNA binding protein and HSV DNA polymerase are located between
0.38 to 0.43 m.u. and are presumably highly conserved in HSV-2 may 
give credence to this possibility. The genes in the short region of 
HSV-1 and HSV-2 are also highly conserved. However, there are other 
regions of the genome which are highly conserved between HSV-1 and 
HSV-2 and yet no recombination has been demonstrated between them.
Experiments to generate HG52 x McKrae recombinants by 
cotransfection of intact HSV-2 DNA with Hpal digested McKrae DNA has
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so far led to the isolation of two recombinants. One has a McKrae 
insert between 0.85 and 0.98 m.u. and contains two copies of Orig of 
McKrae. Hpal cleaves McKrae at 0.93 m.u. in [S ] into c and q 
fragments. This recombinant has therefore been generated by 
recombination between c plus £ and the intact HG52 genome (presumably 
due to inefficient cleavage by Hpal such that the c/q site has not 
been cut). The second recombinant contains approximately 2.3 Kb of 
type 1 sequences. The 2.3 Kb contains the long origin of replication 
of type 1 (located within the BamHI v fragment). The reason for the 
type I insert being so small is not immediately apparent. The insert 
presumably contains most if not all the UL 29 and UL 30 genes at 
either side of OriL. Recombination must therefore have taken place 
within these presumably highly conserved genes or in adjacent 
homologous sequences.
The fact that there were only 2 recombinants identified from 405 
progeny plaques screened, and that both contained a heterologous
origin of replication is consistent with our hypothesis that the
/
presence of a replication origin in a fragment appreciably enhances
its chances of recombination after cotransfection.
The frequencies of intertypic marker rescue of ts mutations were
found to be independent of the presence of an origin of virus DNA
replication in the rescuing fragment of heterologous DNA (Tables 10
and 11) This may indicate that DNA origin of virus DNA replication,
Orig present in the plasmid pSlh was functionally inactive thereby not
increasing the copy number of the HSV DNA fragment. The parent plasmid
o) was found to be active in transfection experiments 
pSl (pAT + Orib
(Stow and McMonagle, 1983) and therefore invalidates the possibility
of Orig being inactive. However, the possibility of Oris being 
acted
inactiv^ during the recloning process cannot be ruled out.
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Alternatively, as proposed, if recombination is linked with 
replication of HSV, the inability to obtain enhanced recombination 
with the plasmid pSlh may be due to the presence of 346 bp plasmid pAT 
DNA sequences intervening Orig and the HSV-2 Hindlll h fragment.
Recombinants from transfection involving Xbal cleaved fragments 
had HG52 inserts only extending as far as 0.35 m.u. on the left hand 
side and 0.43 m.u. on the right hand side, when the fragment from 
which the insert was derived i.e. c extended from 0.0 to 0.45 m.u. The 
limitation on the extent of the insert being concentrated about OriL
i.e., 0.41 m.u., gives credence to the proposal that replication and 
recombination are interlinked and fits in with the marker rescue 
results obtained with the plasmid pSlh.
Recombination has been shown to be linked with replication in 
adenoviruses and T4 phage. Using ts mutants in the adenovirus DNA 
polymerase and DNA binding protein, it has been observed that no 
recombination occurs until 24 hr post infection at which time a 
limited amount of DNA replication was detected (Stillman et al.,
1982). Similarly Young et al (1984) using two ts mutants of adenovirus 
having different restriction site alleles demonstrated that the 
recombinant products could be detected just after the onset of DNA 
replication. If virus replication was blocked with viral DNA 
inhibitors such as cytosine arabinoside no recombinants were detected, 
whereas reversal of the block allowed recombination to occur. The 
precise relationship between adenovirus DNA replication and 
recombination is unknown. Two possibilities have been put forward: (1) 
some polypeptides such as DNA polymerase and the DNA binding protein 
may be needed in both pathways or (2) the single stranded DNA produced 
by replication might serve as a substrate for recombination (Flint et 
al., 1976; Meselson and Radding, 1975; also see Figure 53) which would 
be analogous to the situation in bacteriophage T4, where DNA
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replication and recombination are tightly linked (Mosig, 1983; Stahl, 
1979; Figure 54).
It can be argued that by analogy to adenovirus, recombination in 
HSV may also occur contemporaneously during the course of the 
replicative cycle. In this context it is worth mentioning the role of 
the major DNA binding protein in HSV replication. It has been observed 
that the HSV major DBP keeps single stranded ENA in an extended 
configuration during HSV DNA replication (Ruyechan, 1983) and it can 
be argued that this extended single strand of DNA might act as a 
substrate for homologous recombination with the input DNA of the 
heterologous strain of HSV.
4.10. CONCLUSIONS
The present studies were carried out to investigate the viral 
gene(s) controlling reactivation of herpes simplex virus from latency. 
Using the rabbit eye model of latency HSV-1 strain McKrae and HSV-2 
strain HG52, on induction with iontophoresis of epinephrine, were 
found to recur with a frequency of 100% and 10% (2 out of 21) 
respectively. Both strains produced latent infections in trigeminal 
ganglia with equal frequency (100%). Intertypic recombinants between 
McKrae and HG52 strains were constructed and screened in the rabbit 
eye model for their reactivation potential in order to map the gene(s) 
controlling reactivation differential from latency. Genome structure 
analysis of the recombinant viruses revealed some interesting 
observations with respect to recombination per se in HSV. Hie 
important conclusions of the present studies are as follows:
1. It has ' been demonstrated that the presence of HSV-2
HG52 DNA inserts between 0.35 and 0.576 m.u. and 0.82 and 1.00
preclude
m.u. in the HSV-1 McKrae genome do not • the reactivation
186
FIGURE 54
c
Role of recombination in T4 DNA replication (Broker, 1973). 
i, Linear duplex DNA; li, formation of bidirectional replicating loop
(a single origin is shown for simplicity); -----, parental DNA;
  , newly replicated DNA; -- ^ 3' terminus; # , gene 32
protein; iii, further replicated DNA showing discontinuous synthesis; 
iv, two replicated DNA molecules; v, recombination at incompletely 
replicated ends; vi, presumed trimming of single-stranded ends by gene 
46 and 47 products; vii, covalently sealed recombinant molecule.
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potential of the McKrae genome. In other words genes located
between 0.35 and 0.576 and 0.82 and 1.00 m.u. either alone or in
essential for 
concert are not a in reactivation from latency.
2. Isolation of infectious virus from corneal explants (of latently 
infected rabbits) after-a long period of in vitro culture 
indicates that HSV may be capable of establishing a latent 
infection in corneal cells. These findings substantiate the 
previous work on the isolation of HSV from diseased human 
corneas.
3. The preliminary observations from a limited number of rabbits 
inoculated with wild-type McKrae, HG52 or McKrae x HG52 
recombinants suggest that the presence of HG52 DNA inserts 
in McKrae x HG52 recombinants results in moderation in virulence 
of the McKrae genome. The reduction in virulence of the McKrae 
genome was independent of the location of the insert indicating 
that the gene(s) controlling virulence are not confined to a 
particular part of the genome i.e. virulence is controlled 
multigenically.
4. Isolation of McKrae x HG52 intertypic recombinants containing 
both HG52 origins of DNA replication (Orig and OriL) in a 
predominantly McKrae genome indicates that both origins are 
functional in vitro.
5. Restriction enzyme analysis of plaque purified McKrae x HG52 or 
HG52 x McKrae intertypic recombinants has revealed that the 
inserts of heterologous DNA were derived from limited areas of 
the genome and the inserts always contained a heterologous origin 
of replication OriL or Orig or both. These results indicate that 
either the (1) presence of an origin of replication in a
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restriction fragment amplifies the copy number of the fragment
thereby increasing the chance of at least part of that fragment
/ *
recombining with intact genomes in cotransfection experiments or 
(2) recombination and replication may be interlinked. The results 
of preliminary experiments carried out to investigate the role of 
the origin of DNA replication in fragment amplification by 
ligating an origin of replication to a heterologous DNA fragment 
normally devoid of an origin counter argues the involvement of 
fragment amplification in the recombination process and gives 
credence to the proposal that in HSV replication and 
recombination may occur simultaneously.
4.11. FUTURE PROSPECTS
The work described in this thesis has shown that the HSV genes 
encoded between 0.35 and 0.576 and 0.82 and 1.00 map units do not 
control reactivation from latency in the rabbit eye model. Future work 
will require to address itself to the role of the genes in the long 
region outwith 0.35 to 0.576 map units. However as considerable effort 
has been put into constructing recombinants covering these regions of 
the genome without any success, it would seem sensible to introduce a 
selectable marker into the system before constructing recombinants.
The introduction of the Lac-Z gene into specific endonuclease cloned 
fragments will allow the selection of blue coloured recombinant 
plaques from the progeny from transfections. In this way a systematic 
screening of the genome can be carried out and selected recombinants 
tested in vivo for their reactivation potential.
A similar approach can be taken in determining genes controlling 
virulence. The findings on a small number of recombinants tested 
indicates that virulence may be multigenic but of course different 
animal model systems and different routes may give variable results.
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Unexpectedly the construction of intertypic recombinants to study 
latency reactivation has shown that in cotransfection experiments 
involving intact genomes of one parent and the total endonuclease 
cleavage products of a second parent, the only recombinants isolated 
were those derived from restriction endonuclease fragments containing 
an origin of replication. This suggested either amplification of a 
fragment increasing its chances of recombining or that recombination 
and replication were interlinked. Preliminary results with a plasmid 
containing an origin of repliction, linked to a HSV fragment not 
normally containing an origin, point to amplification not being the 
controlling factor in the observed preferential recombination and 
possibly to a close relationship between replication and 
recombination. It would obviously be pertinent to expand the 
experiments using a range of fragments linked either directly to an 
origin of replication or with intervening plasmid sequences. 
Comparison of the recombination potential of such fragments compared 
to fragments naturally containing an origin will hopefully throw some 
light on the replication/recombination relationship. These experiments 
can be carried out with selectable markers such as temperature 
sensitivity or drug resistance. This should facilitate the analysis 
which otherwise without a selectable marker, would involve the 
restriction endonuclease analysis of thousands of plaques to determine 
recombinant structures.
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*AL-SAADI,S.(19 84). Herpes simplex virus type 2 latency: 
Experimental studies with wild type virus and 13 
temperature sensitive mutants. PhD thesis,University of 
Glasgow.
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SUMMARY
T h e  e f f e c t  of  t h e  d e p o s i t i o n  of  c a r b o n a c e o u s  r e s i d u e s  on t h e  
p e r f o r m a n c e  of  two d i f f e r e n t  P t / t f - A h O 3 b i f u n c t i o n a l  r e f o r m i n g  
c a t a l y s t s  h a s  b e e n  s t u d i e d  d u r i n g  c o n t i n u o u s  f low e x p e r i m e n t s  
p e r f o r m e d  a t  500°C a n d  9 .5  a t m .  u s i n g  n - h e p t a n e  a s  a model  
h y d r o c a r b o n  f e e d s t o c k .  With b o t h  c a t a l y s t s ,  t h e  d e p o s i t i o n  
o f  c a r b o n a c e o u s  r e s i d u e s  r e s u l t e d  in an  o v e r a l l  d e c l i n e  in 
c a t a l y t i c  a c t i v i t y .  T h i s  d e c l i n e  o c c u r r e d  m o s t  r a p i d l y  d u r i n g  
t h e  e a r l y  s t a g e s  of t h e  r e a c t i o n  b u t  p r o g r e s s i v e l y  s lo w ed  w i t h  
i n c r e a s i n g  t i m e - o n - s t r e a m  u n t i l  e v e n t u a l l y  a s t a b l e  c a t a l y t i c  
a c t i v i t y  w a s  a t t a i n e d .  S i g n i f i c a n t  v a r i a t i o n s  in c a t a l y s t  
s e l e c t i v i t y  w e r e  o b s e r v e d  to  o c c u r  a s  a c o n s e q u e n c e  of t h e  
d e p o s i t i o n  o f  c a r b o n a c e o u s  r e s i d u e s .  I n c r e a s e s  in i s o m e r i s a t i o n  
s e l e c t i v i t y  of  11% a n d  16% o c c u r r e d  f o r  t h e  tw o  c a t a l y s t s .  
C o r r e s p o n d i n g  d e c r e a s e s  o c c u r r e d  in  t h e  a r o m a t i s a t i o n  s e l e c t i v i t i e s  
(4% a n d  10%) a n d  h y d r o c r a c k i n g  s e l e c t i v i t i e s  (5% a n d  6%) of t h e  
c a t a l y s t s ,  w h i l s t  t h e  s e l e c t i v i t i e s  w i t h  r e s p e c t  of h y d r o g e n o l y s i s  
r e m a i n e d  e s s e n t i a l l y  c o n s t a n t .  T h e s e  s e l e c t i v i t y  c h a n g e s  a r e  
i n t e r p r e t e d  in  t e r m s  of a c o k i n g  p r o c e s s  in w h i c h  t h e  meta l l ic  
f u n c t i o n  of  t h e  b i f u n c t i o n a l  r e f o r m i n g  c a t a l y s t s  i s more  s e l e c t i v e l y  
p o i s o n e d  t h a n  t h e  ac id ic  f u n c t i o n .  I t  i s  t h e r e f o r e  d e d u c e d  t h a t  
c a r b o n a c e o u s  r e s i d u e s  p r e f e r e n t i a l l y  r e s i d e  on t h e  meta l l ic  f u n c t i o n  
of  b i f u n c t i o n a l  r e f o r m i n g  c a t a l y s t s .  D i f f e r e n c e s  in t h e  n a t u r e  of 
t h e  i n d i v i d u a l  p r o d u c t  y ie ld  a n d  s e l e c t i v i t y  c h a n g e s  o b s e r v e d  f o r  
t h e  tw o  d i f f e r e n t  c a t a l y s t s  w i t h  t h e  d e p o s i t i o n  of c a r b o n a c e o u s  
r e s i d u e s ,  a r e  i n t e r p r e t e d  in t e r m s  of  t h e  d i f f e r e n t  meta l  l o a d i n g s  
of  t h e  c a t a l y s t s .
I n  a d d i t i o n ,  p u l s e - f l o w  e x p e r i m e n t s  h a v e  b e e n  p e r f o r m e d  w i th  
n - h e p t a n e  a t  500°C in t h e  a b s e n c e  of  h y d r o g e n  g a s .  T h e s e  
e x p e r i m e n t s  h a v e  r e v e a l e d  t h a t ,  u n d e r  t h e s e  c o n d i t i o n s ,  t h e  
c a t a l y t i c  a c t i v i t y  is e n h a n c e d  b y  t h e  p r e s e n c e  of s u r f a c e  
c a r b o n a c e o u s  r e s i d u e s .  T h e  n a t u r e  of  t h e  y ie ld  a n d  s e l e c t i v i t y
